| Y0001552 |
Abacavir for peak identification CRS |
10 mg |
188062-50-2 |
|
| Y0001551 | Abacavir for system suitability CRS | 10 mg | 188062-50-2 | |
| Y0001561 | Abacavir sulfate CRS | 20 mg | 188062-50-2 | |
| Y0002199 | Acamprosate calcium CRS | 80 mg | 773377-73-6 | |
| Y0000055 | Acamprosate calcium - reference spectrum | n/a | n/a | |
| Y0000116 | Acamprosate impurity A CRS | 110 mg | 3687-18-1 | |
| Y0000500 | Acarbose CRS | 100 mg | 56180-94-0 | |
| Y0000354 | Acarbose for identification CRS | 10 mg | 56180-94-0 | |
| Y0000427 | Acarbose for peak identification CRS | 20 mg | 56180-94-0 | |
| A0040000 | Acebutolol hydrochloride CRS | 50 mg | 34381-68-5 | |
| Y0000359 | Acebutolol impurity B CRS | 10 mg | N/A | |
| Y0000127 | Acebutolol impurity C CRS | 20 mg | 40188-45-2 | |
| Y0000128 | Acebutolol impurity I CRS | 0.004 mg | N/A | |
| Y0000056 | Aceclofenac - reference spectrum | n/a | n/a | |
| Y0000085 | Aceclofenac impurity F CRS | 15 mg | 100499-89-6 | |
| Y0000086 | Aceclofenac impurity H CRS | 10 mg | 1216495-92-9 | |
| Y0001094 | Aceclofenac for peak identification CRS | 10 mg | 89796-99-6 | |
| Y0001915 | Aceclofenac impurity I CRS | 15 mg | 15362-40-0 | |
| Y0000810 | Acemetacin CRS | 100 mg | 53164-05-9 | |
| Y0000811 | Acemetacin impurity A CRS | 10 mg | 74-11-3 | |
| Y0000842 | Acemetacin impurity mixture CRS | 0.06 mg | 53164-05-9 | |
| A0070000 | Acesulfame potassium CRS | 50 mg | 55589-62-3 | |
| A0070020 | Acesulfame potassium impurity B CRS | 15 mg | 72827-08-8 | |
| A0100000 | Acetazolamide CRS | 100 mg | 59-66-5 | |
| Y0001084 | Acetazolamide for system suitability CRS | 0.007 mg | 59-66-5 | |
| Y0000002 | Acetylcholine chloride CRS | 50 mg | 60-31-1 | |
| A0150000 | Acetylcysteine CRS | 50 mg | 616-91-1 | |
| A0152000 | Acetylcysteine impurity C CRS | 10 mg | 5545-17-5 | |
| A0153000 | Acetylcysteine impurity D CRS | 10 mg | 18725-37-6 | |
| Y0000565 | ß-Acetyldigoxin CRS | 50 mg | 5355-48-6 | |
| Y0000642 | ß-acetyldigoxin for peak identification CRS | 10 mg | 5355-48-6 | |
| A0200000 | Acetylsalicylic acid CRS | 10 mg | 50-78-2 | |
| Y0001460 | Acetylsalicylic acid for peak identification CRS | 10.3 mg | 50-78-2 | |
| Y0001462 | Acetylsulfadiazine CRS | 0.002 mg | 127-74-2 | |
| A0208000 | N-Acetyltryptophan CRS | 125 mg | 1218-34-4 | |
| A0202000 | N-Acetyltyrosine CRS | 200 mg | 537-55-3 | |
| Y0000693 | Acholeplasma laidlawii BRP | 1 ml | n/a | |
| Y0002053 | Achyranthes bidentata root dry extract for system suitability HRS | 10 mg | | |
| A0220000 | Aciclovir CRS | 75 mg | 59277-89-3 | |
| Y0001954 | N-acyl-phosphatidylethanolamine from Soya bean CRS | 40 mg | | |
| Y0002242 | Aciclovir for impurity C identification CRS | 0.3 mg | n/a | |
| Y0002244 | Aciclovir for impurity G identification | 0.004 mg | 59277-89-3 | |
| Y0001271 | Aciclovir for peak identification 1 CRS | 0.3 mg | 59277-89-3 | |
| Y0001269 | Aciclovir for peak identification 2 CRS | 0.004 mg | 59277-89-3 | |
| Y0001264 | Aciclovir for system suitability CRS | 10 mg | 59277-89-3 | |
| Y0002245 | Aciclovir for system suitability A CRS | 20 mg | n/a | |
| A0225000 | Acitretin CRS | 100 mg | 55079-83-9 | |
| Y0001987 | Acitretin for impurity A identification CRS | 5 mg | n/a | |
| Y0001464 | Actaea racemosa dry extract for system suitability HRS | 1200 mg | n/a | |
| Y0001543 | Actaea racemosa for assay CRS | 300 mg | 53956-04-0 | |
| Y0001463 | Actaea racemosa HRS | 1200 mg | n/a | |
| Y0001121 | Adapalene CRS | 100 mg | 106685-40-9 | |
| Y0001120 | Adapalene impurity C CRS | 10 mg | n/a | |
| Y0001119 | Adapalene for peak identification CRS | 2.02 mg | 106685-40-9 | |
| A0230000 | Adenine CRS | 50 mg | 73-24-5 | |
| A0230200 | Adenosine CRS | 50 mg | 58-61-7 | |
| Y0000110 | Adipic acid CRS | 50 mg | 124-04-9 | |
| Y0000882 | Adrenaline CRS | 5 mg | 51-43-4 | |
| Y0002246 | Adrenaline impurity F CRS | 0.008 mg | 51-43-4 | |
| Y0000740 | Adrenaline impurity mixture CRS | 0.005 mg | N/A | |
| A0300000 | Adrenaline tartrate CRS | 100 mg | 51-42-3 | |
| Y0000707 | Adrenaline tartrate with impurity A CRS | 15 mg | 51-42-3 | |
| Y0000883 | Adrenaline with impurity F CRS | 0.008 mg | 51-43-4 | |
| Y0001527 | Aescin for LC assay HRS | 150 mg | 6805-41-0 | |
| Y0001724 | Agnus castus fruit dry extract HRS | 350 mg | N/A | |
| A0325000 | Alanine CRS | 60 mg | 56-41-7 | |
| A0325100 | Albendazole CRS | 50 mg | 54965-21-8 | |
| Y0001964 | Albendazole for system suitability CRS | 10 mg | N/A | |
| Y0001959 | Albendazole impurity mixture CRS | 0.003 mg | N/A | |
| A0325200 | Alcuronium chloride CRS | 50 mg | 15180-03-7 | |
| E1515000 | Erythropoietin BRP | 6 mg | 11096-26-7 | |
| A0325450 | Alfacalcidol CRS | 5 mg | 41294-56-8 | |
| A0325451 | Alfacalcidol - reference spectrum | n/a | n/a | |
| Y0002137 | Alfacalcidol for impurity B identification CRS | 5 mg | n/a | |
| Y0002125 | Alfacalcidol for system suitability A CRS | 5 mg | n/a | |
| A1225000 | Alfadex CRS | 150 mg | 10016-20-3 | |
| Y0002067 | Alfentanil hydrochloride hydrate CRS - * narc | 30 mg | 69049-06-5 | |
| A0325500 | Alfentanil hydrochloride - reference spectrum | n/a | n/a | |
| Y0002070 | Alfentanil impurity D CRS | 0.02 mg | | |
| Y0001883 | Alfuzosin for peak identification CRS | 10 mg | 81403-68-1 | |
| Y0001906 | Alfuzosin for system suitability A CRS | 10 mg | 81403-68-1 | |
| A0325800 | Alfuzosin hydrochloride CRS | 10 mg | 81403-68-1 | |
| Y0001583 | Alimemazine hemitartrate CRS | 15 mg | 4330-99-8 | |
| Y0001581 | Alimemazine for system suitability CRS | 5 mg | 4330-99-8 | |
| A0349000 | Allantoin CRS | 60 mg | 97-59-6 | |
| A0350000 | Allopurinol CRS | 100 mg | 315-30-0 | |
| A0350010 | Allopurinol impurity A CRS | 10 mg | 27511-79-1 | |
| A0350020 | Allopurinol impurity B CRS | 10 mg | 22407-20-1 | |
| A0350030 | Allopurinol impurity C CRS | 15 mg | 1346604-13-4 | |
| A0350040 | Allopurinol impurity D CRS | 15 mg | 6994-25-8 | |
| A0350050 | Allopurinol impurity E CRS | 20 mg | N/A | |
| A0351000 | Allylstrychnine bromide CRS | 10 mg | N/A | |
| Y0000235 | Almagate CRS | 50 mg | 66827-12-1 | |
| Y0000255 | Almagate - reference spectrum | n/a | n/a | |
| Y0002140 | Almotriptan for system suitability CRS | 10 mg | n/a | |
| A0357000 | Alprazolam CRS - * psy | 100 mg | 28981-97-7 | |
| A0360000 | Alprenolol hydrochloride CRS | 100 mg | 13707-88-5 | |
| Y0000054 | Alprostadil CRS | 25 mg | 745-65-3 | |
| Y0000606 | Altizide CRS | 150 mg | 5588-16-9 | |
| Y0000843 | Altizide impurity B CRS | 15 mg | n/a | |
| Y0000687 | Alverine citrate CRS | 5 mg | 5560-59-8 | |
| Y0001819 | Alverine impurity C CRS | 40 mg | N/A | |
| Y0000607 | Alverine impurity D CRS | 10 mg | n/a | |
| A0363000 | Amantadine hydrochloride CRS | 100 mg | 665-66-7 | |
| A0363700 | Ambroxol hydrochloride CRS | 125 mg | 23828-92-4 | |
| Y0002074 | Amfetamine sulfate CRS - * narc | 10 mg | 60-13-9 | |
| A0365000 | Amidotrizoic acid dihydrate CRS | 100 mg | 50978-11-5 | |
| Y0001461 | Amidotrizoic acid for system suitability CRS | 0.08 mg | N/A | |
| A0368000 | Amikacin CRS | 200 mg | 37517-28-5 | |
| Y0001117 | Amikacin for system suitability CRS | 15 mg | 39831-55-5 | |
| Y0001467 | Amikacin impurity I CRS | 20 mg | 40371-51-5 | |
| A0365900 | Amikacin sulfate CRS | 200 mg | 39831-55-5 | |
| Y0001902 | Amiloride for peak identification CRS | 10 mg | 17440-83-4 | |
| A0370000 | Amiloride hydrochloride CRS | 100 mg | 17440-83-4 | |
| Y0000020 | Amiloride impurity A CRS | 20 mg | 1458-01-1 | |
| Y0000173 | 4-Aminobenzoic acid CRS | 60 mg | 150-13-0 | |
| A0420000 | Aminocaproic acid CRS | 50 mg | 60-32-2 | |
| A0460000 | 7-Aminodesacetoxycephalosporanic acid CRS | 20 mg | 22252-43-3 | |
| A0496000 | Aminoglutethimide CRS | 125 mg | 125-84-8 | |
| A0496005 | Aminoglutethimide impurity A CRS | 20 mg | N/A | |
| A0496020 | Aminoglutethimide impurity D CRS | 10 mg | N/A | |
| A0575000 | Amiodarone hydrochloride CRS | 50 mg | 199774-82-4 | |
| Y0000129 | Amiodarone impurity D CRS | 20 mg | N/A | |
| Y0000130 | Amiodarone impurity E CRS | 10 mg | n/a | |
| A0590000 | Amisulpride CRS | 10 mg | 71675-85-9 | |
| Y0001534 | Amisulpride for system suitability CRS | 1.0015 mg | 71675-85-9 | |
| Y0000563 | Amitriptyline hydrochloride CRS | 10 mg | 549-18-8 | |
| Y0000049 | Amlodipine besilate CRS | 150 mg | 111470-99-6 | |
| Y0001068 | Amlodipine impurity A CRS | 15 mg | n/a | |
| Y0001069 | Amlodipine impurity B CRS | 15 mg | N/A | |
| Y0001070 | Amlodipine impurity G CRS | 10 mg | n/a | |
| Y0002043 | Ammonio methacrylate copolymer CRS | 25 mg | N/A | |
| Y0001067 | Amlodipine for peak identification CRS | 10 mg | 111470-99-6 | |
| A0650000 | Amobarbital CRS - * psy | 500 mg | 57-43-2 | |
| A0700000 | Amobarbital sodium CRS - * psy | 500 mg | 64-43-7 | |
| Y0002062 | Amorolfine for peak identification CRS | 10 mg | n/a | |
| Y0001794 | Amorolfine hydrochloride CRS | 10 mg | 78613-38-4 | |
| Y0001795 | Amorolfine for system suitability CRS | 10 mg | 78613-38-4 | |
| A0800000 | Amoxicillin trihydrate CRS | 200 mg | 61336-70-7 | |
| Y0002144 | Almotriptan malate CRS | 70 mg | 181183-52-8 | |
| Y0001521 | Amoxicillin trihydrate for performance verification CRS | 5000 mg | 61336-70-7 | |
| Y0000005 | Amphotericin B CRS | 100 mg | 1397-89-3 | |
| Y0001361 | Amphotericin B for microbiological assay CRS | 100 mg | 1397-89-3 | |
| Y0001014 | Amphotericin B for peak identification CRS | 10 mg | 1397-89-3 | |
| A1000000 | Ampicillin (anhydrous) CRS | 180 mg | 69-53-4 | |
| A1100000 | Ampicillin trihydrate CRS | 150 mg | 7177-48-2 | |
| Y0002192 | Amprolium hydrochloride CRS | 50 mg | 137-88-2 | |
| Y0001244 | Amylmetacresol CRS | 300 mg | 1300-94-3 | |
| Y0001245 | Amylmetacresol for peak identification CRS | 10 mg | 1300-94-3 | |
| Y0001522 | Anastrozole CRS | 100 mg | 120511-73-1 | |
| Y0001531 | Anastrozole impurity E CRS | 10 mg | n/a | |
| Y0001870 | Andrographis herb HRS | 2050 mg | N/A | |
| Y0001866 | Andrographolide CRS | 15 mg | 5508-58-7 | |
| Y0001753 | Anemarrhena rhizome for system suitability HRS | 150 mg | N/A | |
| Y0001386 | Angelica dahurica root HRS | 160 mg | n/a | |
| Y0001385 | Angelica pubescens root HRS | 500 mg | n/a | |
| A1200000 | Anhydrotetracycline hydrochloride CRS | 25 mg | 13803-65-1 | |
| Y0001466 | Anhydrous Docetaxel CRS | 15 mg | 114977-28-5 | |
| A1210000 | Antazoline hydrochloride CRS | 50 mg | 2508-72-7 | |
| Y0001777 | Apigenin 7-glucoside CRS | 25 mg | 578-74-5 | |
| Y0001465 | Apomorphine hydrochloride hemihydrate CRS | 15 mg | 41372-20-7 | |
| Y0001471 | Apomorphine impurity B CRS - * narc (see Add info) | 40 mg | 6211-15-0 | |
| Y0001825 | Aprepitant CRS | 150 mg | 170729-80-3 | |
| Y0001826 | Aprepitant for system suitability CRS | 15 mg | N/A | |
| Y0001154 | Aprotinin for system suitability CRS | 2.7 mg | 9087-70-1 | |
| A1250000 | Aprotinin solution BRP | 0.5 mL | 9087-70-1 | |
| A1269000 | L-Arabinitol CRS | 10 mg | 7643-75-6 | |
| Y0000806 | Arbutin CRS | 110 mg | 497-76-7 | |
| A1270000 | Arginine CRS | 60 mg | 74-79-3 | |
| Y0000304 | Arginine aspartate CRS | 20 mg | 7675-83-4 | |
| A1271000 | Arginine hydrochloride CRS | 60 mg | 1119-34-2 | |
| Y0001649 | Aripiprazole CRS | 170 mg | 129722-12-9 | |
| Y0001650 | Aripiprazole impurity F CRS | 15 mg | 573691-09-5 | |
| Y0001323 | Aristolochia HRS | 140 mg | n/a | |
| Y0002004 | Arsenic solution CRS | 10 mL | | |
| Y0001185 | Aristolochic acid I CRS | 11 mg | 313-67-7 | |
| Y0001175 | Aristolochic acid for system suitability CRS | 1 mg | 10190-99-5 | |
| Y0000079 | Articaine hydrochloride CRS | 200 mg | 23964-57-0 | |
| Y0000080 | Articaine impurity A CRS | 20 mg | n/a | |
| Y0000081 | Articaine impurity E CRS | 10 mg | n/a | |
| Y0001091 | Artichoke leaf dry extract HRS | 60 mg | n/a | |
| A1300000 | Ascorbic acid CRS | 100 mg | 50-81-7 | |
| Y0001024 | Ascorbic acid impurity C CRS | 20 mg | 342385-52-8 | |
| Y0001170 | Ascorbic acid impurity D CRS | 15 mg | n/a | |
| Y0000800 | Ascorbyl palmitate CRS | 10 mg | 137-66-6 | |
| Y0001206 | Asiaticoside CRS | 40 mg | 16830-15-2 | |
| Y0002076 | Asparagine impurity C CRS | 10 mg | | |
| Y0000305 | Asparagine monohydrate CRS | 60 mg | 5794-13-8 | |
| A1320000 | Aspartame CRS | 40 mg | 22839-47-0 | |
| A1321000 | Aspartame impurity A CRS | 10 mg | 5262-10-2 | |
| A1330000 | Aspartic acid CRS | 50 mg | 56-84-8 | |
| Y0001171 | Astragaloside IV CRS | 40 mg | 84687-43-4 | |
| Y0002064 | Atazanavir for system suitability CRS | 10 mg | | |
| Y0002052 | Atazanavir impurity K CRS | 10 mg | 162537-11-3 | |
| Y0002059 | Atazanavir sulfate CRS | 100 mg | 229975-97-7 | |
| A1340000 | Atenolol CRS | 30 mg | 29122-68-7 | |
| Y0001089 | Atenolol for system suitability CRS | 5 mg | 29122-68-7 | |
| Y0001587 | Atomoxetine for impurity A identification CRS | 10 mg | 82248-59-7 | |
| Y0001586 | Atomoxetine hydrochloride CRS | 110 mg | 82248-59-7 | |
| Y0001588 | Atomoxetine impurity B CRS | 10 mg | 83015-26-3 | |
| Y0001589 | Atomoxetine impurity D CRS | 5 mg | N/A | |
| Y0001327 | Atorvastatin calcium trihydrate CRS | 150 mg | 344423-98-9 | |
| Y0002229 | Atorvastatin for system suitability CRS | 15 mg | n/a | |
| Y0001328 | Atorvastatin impurity A CRS | 5 mg | n/a | |
| Y0001329 | Atorvastatin impurity B CRS | 10 mg | n/a | |
| Y0001330 | Atorvastatin impurity C CRS | 5 mg | n/a | |
| Y0001331 | Atorvastatin impurity D CRS | 5 mg | n/a | |
| Y0001332 | Atorvastatin impurity E CRS | 5 mg | n/a | |
| Y0001572 | Atovaquone CRS | 270 mg | 95233-18-4 | |
| Y0001573 | Atovaquone for system suitability CRS | 10 mg | 95233-18-4 | |
| Y0000424 | Atracurium besilate CRS | 120 mg | 64228-81-5 | |
| Y0000503 | Atracurium for impurity F identification CRS | 15 mg | 64228-81-5 | |
| Y0000504 | Atracurium for peak identification CRS | 5 mg | 64228-81-5 | |
| Y0000878 | Atropine CRS | 30 mg | 51-55-8 | |
| Y0000845 | Atropine for peak identification CRS | 0.25 mg | 51-55-8 | |
| Y0000816 | Atropine impurity B CRS | 10 mg | N/A | |
| A1400000 | Atropine sulfate CRS | 20 mg | 5908-99-6 | |
| Y0000029 | Azaperone CRS | 50 mg | 1649-18-9 | |
| A1500000 | Azathioprine CRS | 100 mg | 446-86-6 | |
| Y0001240 | Azathioprine impurity A CRS | 10 mg | 4531-54-8 | |
| Y0001246 | Azathioprine impurity G CRS | 5 mg | 5581-52-2 | |
| Y0000326 | Azelastine hydrochloride CRS | 25 mg | 79307-93-0 | |
| Y0000327 | Azelastine impurity B CRS | 5 mg | n/a | |
| Y0000328 | Azelastine impurity D CRS | 5 mg | n/a | |
| Y0000329 | Azelastine impurity E CRS | 5 mg | n/a | |
| Y0000306 | Azithromycin CRS | 410 mg | 117772-70-0 | |
| Y0000637 | Azithromycin for peak identification CRS | 20 mg | 117772-70-0 | |
| Y0000641 | Azithromycin for system suitability CRS | 0.05 mg | N/A | |
| Y0000307 | Azithromycin impurity A CRS | 10 mg | n/a | |
| Y0000285 | B19 virus DNA for NAT testing BRP | 150 mg | N/A | |
| B0070000 | Bacampicillin hydrochloride CRS | 120 mg | 37661-08-8 | |
| Y0001867 | Bacitracin for system suitability CRS | 40 mg | 1405-89-6 | |
| B0100000 | Bacitracin zinc CRS | 150 mg | 1405-89-6 | |
| Y0002014 | Rotigotine impurity B CRS | 10 mg | | |
| Y0002018 | Rotigotine impurity H CRS | 15 mg | | |
| B0200000 | Baclofen CRS | 130 mg | 1134-47-0 | |
| B0200050 | Baclofen impurity A CRS | 60 mg | 22518-27-0 | |
| Y0002206 | Bambuterol impurity mixture CRS | 0.002 mg | n/a | |
| Y0001273 | Baicalin CRS | 10 mg | 21967-41-9 | |
| B0250000 | Bambuterol hydrochloride CRS | 100 mg | 81732-46-9 | |
| B0300000 | Barbital CRS - * psy | 500 mg | 57-44-3 | |
| Y0001525 | Basic butylated methacrylate copolymer CRS | 20 mg | 24938-16-7 | |
| B0305000 | Beclometasone dipropionate anhydrous CRS | 150 mg | 5534-09-8 | |
| Y0000469 | Beclometasone dipropionate for peak identification CRS | 10 mg | 5534-09-8 | |
| Y0000352 | Beclometasone dipropionate for system suitability CRS | 15 mg | 5534-09-8 | |
| Y0001073 | Beclometasone dipropionate impurities F and N CRS | 0.052 mg | n/a | |
| Y0000351 | Beclometasone dipropionate monohydrate CRS | 10 mg | 5534-09-8 | |
| Y0001607 | Belamcanda chinensis rhizome HRS | 110 mg | n/a | |
| Y0001025 | Benazepril hydrochloride CRS | 170 mg | 86541-74-4 | |
| Y0001026 | Benazepril impurity A CRS | 10 mg | N/A | |
| Y0001038 | Benazepril for system suitability CRS | 0.016 mg | 86541-74-4 | |
| B0400000 | Bendroflumethiazide CRS | 100 mg | 73-48-3 | |
| Y0000564 | Bendroflumethiazide impurity A CRS | 5 mg | 211-506-8 | |
| B0470000 | Benperidol CRS | 100 mg | 2062-84-2 | |
| Y0002115 | Benserazide for peak identification A CRS | 10 mg | n/a | |
| B0477000 | Benserazide hydrochloride CRS | 50 mg | 14919-77-8 | |
| B0477010 | Benserazide impurity A CRS | 15 mg | n/a | |
| Y0001071 | Benserazide impurity C CRS | 15 mg | n/a | |
| Y0001064 | Benzaldehyde CRS | 150 mg | 100-52-7 | |
| Y0001060 | Benzalkonium chloride for system suitability CRS | 20 mg | 8001-54-5 | |
| B0490000 | Benzarone CRS | 10 mg | 1477-19-6 | |
| B0500000 | Benzathine benzylpenicillin CRS | 200 mg | 1538-09-6 | |
| Y0002000 | Benzathine benzylpenicillin for peak identification CRS | 10 mg | | |
| Y0002039 | Benzathine phenoxymethylpenicillin for system suitability CRS | 20 mg | N/A | |
| Y0002001 | Benzathine phenoxymethylpenicillin CRS | 100 mg | 5928-84-7 | |
| Y0000775 | Benzbromarone CRS | 10 mg | 3562-84-3 | |
| B0550000 | Benzethonium chloride CRS | 100 mg | 121-54-0 | |
| B0600000 | Benzocaine CRS | 50 mg | 94-09-7 | |
| Y0001470 | Benzoic acid CRS | 30 mg | 65-85-0 | |
| Y0000647 | Benzophenone CRS | 40 mg | 119-61-9 | |
| Y0002118 | Benzydamine for system suitability CRS | 10 mg | | |
| Y0002123 | Benzydamine Hydrochloride | 10 mg | 132-69-4 | |
| Y0000167 | Benzyl alcohol CRS | 70 mg | 100-51-6 | |
| B0670000 | Benzyl benzoate - reference spectrum | n/a | n/a | |
| B0680000 | S-Benzylmercaptoacetyltriglycine CRS | 10 mg | 123228-56-8 | |
| Y0001889 | Benzylpenicillin for system suitability CRS | 10 mg | | |
| B0700000 | Benzylpenicillin potassium CRS | 100 mg | 113-98-4 | |
| B0900000 | Benzylpenicillin sodium CRS | 200 mg | 69-57-8 | |
| Y0001149 | Berberine chloride CRS | 20 mg | 633-65-8 | |
| Y0002054 | Beta-Ecdysterone CRS | 20 mg | 5289-74-7 | |
| Y0001615 | Beta-sitosterol CRS | 25 mg | 83-46-5 | |
| Y0002268 | beta-sitosterol for peak identification | 10 mg | 83-46-5 | |
| Y0002050 | Betacarotene CRS | 110 mg | 7235-40-7 | |
| Y0002073 | Betacarotene for system suitability CRS | 10 mg | 7235-40-7 | |
| B0950000 | Betadex CRS | 180 mg | 7585-39-9 | |
| Y0000391 | Betahistine dihydrochloride CRS | 50 mg | 5579-84-0 | |
| B0990000 | Betahistine mesilate CRS | 50 mg | 54856-23-4 | |
| B1000000 | Betamethasone CRS | 60 mg | 378-44-9 | |
| B1030000 | Betamethasone acetate CRS | 100 mg | 987-24-6 | |
| B1040000 | Betamethasone dipropionate CRS | 200 mg | 5593-20-4 | |
| Y0001416 | Betamethasone dipropionate for peak identification CRS | 10 mg | 5593-20-4 | |
| B1045000 | Betamethasone sodium phosphate CRS | 100 mg | 151-73-5 | |
| Y0001925 | Betamethasone dipropionate for system suitability A CRS | 10 mg | 5593-20-4 | |
| B1054000 | Betamethasone 17-valerate CRS | 50 mg | 2152-44-5 | |
| B1055000 | Betamethasone 21-valerate CRS | 15 mg | 2240-28-0 | |
| Y0001027 | Betamethasone valerate for system suitability CRS | 20 mg | 2152-44-5 | |
| Y0001065 | Betamethasone valerate impurity mixture CRS | 0.018 mg | n/a | |
| B1103000 | Betaxolol hydrochloride CRS | 60 mg | 63659-19-8 | |
| B1103100 | Betaxolol impurity A CRS | 10 mg | n/a | |
| Y0001354 | Betaxolol impurity C CRS | 5 mg | n/a | |
| Y0001360 | Betaxolol for peak identification CRS | 15 mg | 63659-19-8 | |
| Y0002216 | Betiatide CRS | 20 mg | 103725-47-9 | |
| Y0002217 | Betiatide impurity D CRS | 10 mg | 144616-07-9 | |
| B1115000 | Bezafibrate CRS | 100 mg | 41859-67-0 | |
| Y0001444 | Bicalutamide CRS | 160 mg | 90357-06-5 | |
| Y0001448 | Bicalutamide for system suitability CRS | 15 mg | 90357-06-5 | |
| Y0001078 | Bicisate labelling kit CRS | 24 mg | n/a | |
| B1110000 | Bifonazole CRS | 50 mg | 60628-96-8 | |
| Y0001421 | Bifonazole for system suitability CRS | 10 mg | 60628-96-8 | |
| Y0001788 | Bilberry dry extract HRS | 400 mg | N/A | |
| B1116000 | Biotin CRS | 20 mg | 58-85-5 | |
| Y0001978 | Biotin for system suitability CRS | 10 mg | 58-85-5 | |
| B1120000 | Biperiden hydrochloride CRS | 60 mg | 1235-82-1 | |
| B1121000 | Biperiden impurity A CRS | 20 mg | N/A | |
| B1140000 | Bisacodyl CRS | 50 mg | 603-50-9 | |
| Y0000608 | Bisacodyl for peak identification CRS | 10 mg | 603-50-9 | |
| Y0000694 | Bisacodyl for system suitability CRS | 5 mg | 603-50-9 | |
| Y0000812 | Bisoprolol fumarate CRS | 50 mg | 104344-23-2 | |
| Y0000877 | Bisoprolol for peak identification CRS | 1 mg | 104344-23-2 | |
| Y0000813 | Bisoprolol for system suitability CRS | 1.003 mg | 104344-23-2 | |
| B1141000 | Bleomycin sulfate CRS | 7 mg | 9041-93-4 | |
| Y0000434 | Boldine CRS | 30 mg | 476-70-0 | |
| Y0002060 | Boldine for system suitability CRS | 20 mg | n/a | |
| Y0001780 | Boldo leaf dry extract HRS | 550 mg | 84649-96-7 | |
| B1142000 | Bordetella pertussis mouse antiserum BRP | 100 mg | n/a | |
| Y0001634 | Brimonidine for system suitability CRS | 1.3 mg | N/A | |
| Y0001658 | Brimonidine tartrate CRS | 5 mg | 70359-46-5 | |
| B1143000 | Bromazepam CRS - * psy | 60 mg | 1812-30-2 | |
| Y0000645 | Bromazepam for system suitability CRS - * psy (Bromazepam) | 15 mg | 1812-30-2 | |
| B1145000 | Bromhexine hydrochloride CRS | 200 mg | 611-75-6 | |
| Y0001757 | Bromhexine for system suitability CRS | 15 mg | 611-75-6 | |
| B1150000 | Bromocriptine mesilate CRS | 30 mg | 22260-51-1 | |
| Y0000677 | Bromocriptine mesilate for system suitability CRS | 5 mg | 22260-51-1 | |
| B1152000 | Bromperidol CRS | 100 mg | 10457-90-6 | |
| B1152050 | Bromperidol decanoate CRS | 60 mg | 75067-66-2 | |
| B1153000 | Brompheniramine maleate CRS | 100 mg | 980-71-2 | |
| Y0000468 | Brotizolam CRS - * psy | 10 mg | 57801-81-7 | |
| Y0000470 | Brotizolam impurity B CRS | 10 mg | 57801-97-5 | |
| Y0001196 | Brucine CRS | 40 mg | 357-57-3 | |
| B1157300 | Budesonide CRS | 110 mg | 51333-22-3 | |
| Y0001148 | Budesonide for system suitability CRS | 10 mg | 51333-22-3 | |
| B1156000 | Bufexamac CRS | 100 mg | 2438-72-4 | |
| Y0001729 | Bufexamac impurity A CRS | 10 mg | 4547-57-3 | |
| Y0001730 | Bufexamac impurity B CRS | 15 mg | 29056-06-2 | |
| B1157400 | Buflomedil hydrochloride CRS | 100 mg | 35543-24-9 | |
| Y0001731 | Bufexamac impurity C CRS | 15 mg | 1185726-73-1 | |
| Y0001732 | Bufexamac impurity D CRS | 10 mg | 3413-59-0 | |
| B1157410 | Buflomedil impurity B CRS | 20 mg | n/a | |
| Y0001529 | Buflomedil for peak identification CRS | 0.45 mg | 35543-24-9 | |
| B1158000 | Bumetanide CRS | 50 mg | 28395-03-1 | |
| Y0000309 | Bumetanide impurity A CRS | 5 mg | n/a | |
| Y0000310 | Bumetanide impurity B CRS | 5 mg | n/a | |
| B1160000 | Bupivacaine hydrochloride CRS | 100 mg | 73360-54-0 | |
| Y0000088 | Bupivacaine impurity B CRS | 20 mg | 65797-42-4 | |
| Y0000089 | Bupivacaine impurity E CRS | 20 mg | 1330172-81-0 | |
| Y0001575 | Bupivacaine impurity F CRS | 70 mg | 87-62-7 | |
| Y0001108 | Buprenorphine CRS - * psy | 10 mg | 52485-79-7 | |
| Y0001122 | Buprenorphine for system suitability CRS - * psy (see Add info) | 10 mg | 52485-79-7 | |
| Y0001109 | Buprenorphine hydrochloride CRS - * psy | 10 mg | 53152-21-9 | |
| B1168000 | Buserelin CRS | 2 mg | 68630-75-1 | |
| Y0001814 | Buserelin for NMR identification CRS | 2 mg | 68630-75-1 | |
| Y0001740 | Buserelin for peak identification CRS | 1 mg | 68630-75-1 | |
| B1168020 | D-His-Buserelin CRS | 0.5 mg | n/a | |
| Y0000131 | Buspirone hydrochloride CRS | 5 mg | 33386-08-2 | |
| Y0000471 | Buspirone for system suitability CRS | 2 mg | 33386-08-2 | |
| B1170000 | Busulfan CRS | 50 mg | 55-98-1 | |
| Y0001487 | Butyl methacrylate CRS | 100 mg | 97-88-1 | |
| Y0001304 | Butyl methanesulfonate CRS | 30 µL | 1912-32-9 | |
| B1217000 | Butyl parahydroxybenzoate CRS | 150 mg | 94-26-8 | |
| Y0001357 | Butyl parahydroxybenzoate impurity E CRS | 15 mg | 4247-02-3 | |
| B1212000 | Butylhydroxyanisole CRS | 60 mg | 25013-16-5 | |
| B1215000 | Butylhydroxytoluene CRS | 100 mg | 128-37-0 | |
| Y0000472 | Cabergoline CRS | 170 mg | 81409-90-7 | |
| Y0001997 | Cadmium solution CRS | 10 mL | | |
| C0100000 | Caffeine CRS | 70 mg | 58-08-2 | |
| Y0000787 | Caffeine for system suitability CRS | 10 mg | 58-08-2 | |
| C0166000 | Calcifediol CRS | 5 mg | 63283-36-3 | |
| C0166001 | Calcifediol - reference spectrum | n/a | n/a | |
| Y0002040 | Calcifediol for impurity D identification CRS | 5 mg | n/a | |
| Y0000499 | Calcipotriol (anhydrous) - reference spectrum | n/a | n/a | |
| Y0002041 | Calcipotriol for system suitability CRS | 5 mg | | |
| Y0000473 | Calcipotriol monohydrate CRS | 10 mg | 147657-22-5 | |
| Y0000474 | Calcipotriol monohydrate - reference spectrum | n/a | n/a | |
| C0200000 | Calcitonin (salmon) CRS | 1 mg | 47931-85-1 | |
| Y0000632 | Calcitonin-Gly CRS | 1 ml | N/A | |
| C0200010 | N-acetyl-cys1-calcitonin CRS | 20 mg | N/A | |
| C0225000 | Calcitriol CRS | 10 mg | 32222-06-3 | |
| C0226000 | Calcitriol - reference spectrum | n/a | n/a | |
| C0249000 | Calcium ascorbate - reference spectrum | n/a | n/a | |
| C0250000 | Calcium folinate CRS | 110 mg | 1492-18-8 | |
| Y0002071 | Calcium folinate for system suitability CRS | 10 mg | 1492-18-8 | |
| C0299000 | Calcium glucoheptonate CRS | 60 mg | 17140-60-2 | |
| C0300000 | Calcium gluconate CRS | 50 mg | 18016-24-5 | |
| C0340000 | Calcium levulinate dihydrate CRS | 250 mg | 5743-49-7 | |
| C0350000 | Calcium oxalate monohydrate CRS | 100 mg | 5794-28-5 | |
| C0400000 | Calcium pantothenate CRS | 60 mg | 137-08-6 | |
| C0405000 | Camphor (racemic) CRS | 50 mg | 76-22-2 | |
| Y0001388 | Candesartan cilexetil CRS | 60 mg | 145040-37-5 | |
| Y0001387 | Candesartan cilexetil for peak identification CRS | 10 mg | 145040-37-5 | |
| Y0001389 | Candesartan cilexetil for system suitability CRS | 10 mg | 145040-37-5 | |
| C0410000 | Canrenone CRS | 15 mg | 976-71-6 | |
| Y0001858 | Cape jasmine fruit for system suitability HRS | 260 mg | N/A | |
| Y0001642 | Capecitabine CRS | 150 mg | 154361-50-9 | |
| Y0001643 | Capecitabine impurity A CRS | 5 mg | 66335-38-4 | |
| Y0001644 | Capecitabine impurity B CRS | 5 mg | 154361-50-9 | |
| Y0001645 | Capecitabine impurity D CRS | 10 mg | 154361-50-9 | |
| C0426000 | Caprylic acid CRS | 100 mg | 124-07-2 | |
| Y0000671 | Capsaicin CRS | 50 mg | 404-86-4 | |
| C0430000 | Captopril CRS | 10 mg | 62571-86-2 | |
| Y0001219 | Captopril impurity B CRS | 15 mg | n/a | |
| Y0001220 | Captopril impurity C CRS | 15 mg | n/a | |
| Y0001221 | Captopril impurity D CRS | 15 mg | n/a | |
| Y0000435 | Captopril impurity E CRS | 15 mg | n/a | |
| Y0001450 | Captopril impurity J CRS | 10 mg | 64838-55-7 | |
| Y0001182 | Captopril for system suitability CRS | 20 mg | 62571-86-2 | |
| Y0000113 | Carbachol CRS | 50 mg | 51-83-2 | |
| C0450000 | Carbamazepine CRS | 180 mg | 298-46-4 | |
| Y0000033 | Carbamazepine impurity A CRS | 20 mg | 3564-73-6 | |
| C0451000 | Carbasalate calcium - reference spectrum | n/a | n/a | |
| Y0001161 | Carbasalate impurity B CRS | 5 mg | 530-75-6 | |
| C0455000 | Carbenicillin sodium CRS | 50 mg | 4800-94-6 | |
| C0460000 | Carbidopa CRS | 50 mg | 38821-49-7 | |
| Y0001713 | Carbidopa for system suitability CRS | 10 mg | 38821-49-7 | |
| Y0001716 | Carbidopa impurity mixture CRS | 0.008 mg | N/A | |
| C0465000 | Carbimazole CRS | 100 mg | 22232-54-8 | |
| C0470000 | Carbocisteine CRS | 60 mg | 638-23-3 | |
| C0499900 | Carbon dioxide - reference spectrum | n/a | n/a | |
| Y0001353 | Carbon monoxide - reference spectrum | n/a | n/a | |
| C0550000 | Carboplatin - reference spectrum | n/a | n/a | |
| Y0000475 | Carboprost trometamol CRS | 40 mg | 58551-69-2 | |
| Y0000536 | Carboprost trometamol - reference spectrum | n/a | n/a | |
| Y0000035 | Carisoprodol CRS | 50 mg | 78-44-4 | |
| Y0000036 | Carisoprodol impurity A CRS | 10 mg | n/a | |
| Y0001214 | Carmellose CRS | 10 mg | 9000-11-7 | |
| Y0002128 | Carmustine CRS | 60 mg | 154-93-8 | |
| C0580010 | Carmustine impurity A CRS | 20 mg | 2214-72-4 | |
| Y0000846 | Carprofen CRS | 30 mg | 53716-49-7 | |
| Y0000884 | Carprofen for system suitability CRS | 5 mg | 53716-49-7 | |
| Y0000192 | Carteolol hydrochloride - reference spectrum | n/a | n/a | |
| Y0000193 | Carteolol for system suitability CRS | 30 mg | 51781-21-6 | |
| Y0001427 | Carvedilol CRS | 50 mg | 72956-09-3 | |
| Y0000103 | Carvedilol impurity C CRS | 15 mg | 72955-94-3 | |
| Y0001426 | Carvedilol for system suitability CRS | 10 mg | 72956-09-3 | |
| Y0002142 | Catalpol CRS | 15 mg | | |
| C0600000 | Casein BRP | 100000 mg | 9000-71-9 | |
| C0630000 | Cefaclor CRS | 450 mg | 70356-03-5 | |
| C0640000 | Delta-3-Cefaclor CRS | 15 mg | 152575-13-8 | |
| C0650000 | Cefadroxil CRS | 150 mg | 66592-87-8 | |
| C0675000 | Cefalexin monohydrate CRS | 150 mg | 23325-78-2 | |
| C0682000 | Cefalotin sodium CRS | 170 mg | 58-71-9 | |
| Y0000505 | Cefalotin for impurity B identification CRS | 10 mg | 58-71-9 | |
| C0682300 | Cefamandole nafate CRS | 125 mg | 42540-40-9 | |
| Y0000240 | Cefapirin sodium CRS | 100 mg | 24356-60-3 | |
| C0682400 | Cefatrizine propylene glycol CRS | 150 mg | 57235-40-2 | |
| C0682410 | Cefatrizine impurity A CRS | 60 mg | n/a | |
| C0682800 | Cefazolin CRS | 150 mg | 25953-19-9 | |
| Y0000633 | Cefepime dihydrochloride monohydrate CRS | 150 mg | 123171-59-5 | |
| Y0001336 | Cefepime impurity E CRS | 10 mg | 111390-01-3 | |
| Y0000634 | Cefepime dihydrochloride monohydrate for system suitability CRS | 15 mg | 123171-59-5 | |
| C0684000 | Cefixime CRS | 200 mg | 125110-14-7 | |
| C0684750 | Cefoperazone dihydrate CRS | 110 mg | 62893-19-0 | |
| C0684800 | Cefoperazone sodium - reference spectrum | n/a | n/a | |
| C0685000 | Cefotaxime sodium CRS | 20 mg | 64485-93-4 | |
| Y0000420 | Cefotaxime acid CRS | 20 mg | 63527-52-6 | |
| Y0000506 | Cefotaxime for peak identification CRS | 10 mg | 64485-93-4 | |
| C0688000 | Cefoxitin sodium CRS | 100 mg | 33564-30-6 | |
| Y0001496 | Cefoxitin for peak identification CRS | 15 mg | 33564-30-6 | |
| Y0001305 | Cefpodoxime proxetil CRS | 80 mg | 87239-81-4 | |
| Y0001318 | Cefpodoxime proxetil for impurity H identification CRS | 10 mg | 87239-81-4 | |
| Y0001306 | Cefpodoxime proxetil for peak identification CRS | 10 mg | 87239-81-4 | |
| Y0001371 | Cefprozil CRS | 120 mg | 121123-17-9 | |
| Y0001372 | Cefprozil impurity A CRS | 25 mg | 22818-40-2 | |
| Y0001367 | Cefprozil for peak identification CRS | 10 mg | 121123-17-9 | |
| Y0001368 | Cefprozil impurity mixture CRS | 10 mg | n/a | |
| C0690000 | Cefradine CRS | 300 mg | 38821-53-3 | |
| Y0000568 | Cefradine for peak identification CRS | 15 mg | 38821-53-3 | |
| Y0001174 | Cefradine impurity mixture CRS | 0.04 mg | n/a | |
| C0690500 | Ceftazidime CRS | 200 mg | 78439-06-2 | |
| Y0001111 | Ceftazidime for peak identification CRS | 13 mg | N/A | |
| C0691000 | Ceftriaxone sodium CRS | 100 mg | 104376-79-6 | |
| C0692000 | Ceftriaxone impurity A CRS | 10 mg | n/a | |
| C0694990 | Cefuroxime axetil CRS | 70 mg | 64544-07-6 | |
| C0695000 | Cefuroxime sodium CRS | 70 mg | 56238-63-2 | |
| Y0001445 | Celecoxib CRS | 200 mg | 169590-42-5 | |
| Y0001446 | Celecoxib impurity A CRS | 10 mg | n/a | |
| Y0001447 | Celecoxib impurity B CRS | 10 mg | n/a | |
| Y0000239 | Celiprolol for peak identification CRS | 20 mg | 57470-78-7 | |
| Y0002214 | Celiprolol for system suitability CRS | 20 mg | n/a | |
| Y0000311 | Celiprolol hydrochloride CRS | 10 mg | 57470-78-7 | |
| Y0000312 | Celiprolol impurity I CRS | 0.02 mg | n/a | |
| Y0000784 | Cellulose acetate CRS | 40 mg | 9004-35-7 | |
| Y0001585 | Cellulose acetate butyrate CRS | 60 mg | 9004-36-8 | |
| Y0001054 | Cellulose acetate phthalate CRS | 10 mg | 9004-38-0 | |
| Y0001764 | Centella dry extract HRS | 150 mg | N/A | |
| C0700000 | Cephaeline hydrochloride CRS | 15 mg | 5853-29-2 | |
| C0980650 | Cetirizine dihydrochloride CRS | 100 mg | 83881-52-1 | |
| C0980651 | Cetirizine impurity A CRS | 10 mg | 303-26-4 | |
| Y0001197 | Cetirizine for peak identification CRS | 1 mg | 83881-52-1 | |
| C0984100 | Cetostearyl isononanoate - reference spectrum | n/a | n/a | |
| C0990000 | Cetyl alcohol CRS | 300 mg | 36653-82-4 | |
| Y0000073 | Cetyl palmitate 15 CRS | 60 mg | 540-10-3 | |
| Y0000074 | Cetyl palmitate 95 CRS | 50 mg | 540-10-3 | |
| C1000000 | Cetylpyridinium chloride CRS | 20 mg | 6004-24-6 | |
| C1050000 | Chenodeoxycholic acid CRS | 125 mg | 474-25-9 | |
| Y0000104 | Chitosan hydrochloride CRS | 30 mg | 9012-76-4 | |
| C1100000 | Chlorambucil CRS | 100 mg | 305-03-3 | |
| Y0001298 | Chlorambucil for system suitability CRS | 10 mg | 305-03-3 | |
| Y0001299 | Chlorambucil with impurity G CRS | 10 mg | 305-03-3 | |
| C1200000 | Chloramphenicol CRS | 100 mg | 56-75-7 | |
| C1300000 | Chloramphenicol dipalmitate CRS | 100 mg | n/a | |
| C1350000 | Chloramphenicol disodium disuccinate CRS | 45 mg | n/a | |
| Y0001869 | Chloramphenicol for peak identification CRS | 15 mg | 56-75-7 | |
| C1400000 | Chloramphenicol palmitate isomer CRS | 100 mg | n/a | |
| C1425000 | Chloramphenicol sodium succinate CRS | 30 mg | 982-57-0 | |
| C1435000 | Chlorcyclizine hydrochloride CRS | 100 mg | 14362-31-3 | |
| C1450000 | Chlordiazepoxide CRS - * psy | 50 mg | 58-25-3 | |
| C1500000 | Chlordiazepoxide hydrochloride CRS - * psy | 100 mg | 438-41-5 | |
| Y0000476 | Chlordiazepoxide impurity A CRS | 10 mg | n/a | |
| C1510000 | Chlorhexidine CRS | 50 mg | 55-56-1 | |
| C1520000 | Chlorhexidine diacetate CRS | 10 mg | 56-95-1 | |
| C1540000 | Chlorhexidine dihydrochloride CRS | 50 mg | 3697-42-5 | |
| Y0001545 | Chlorhexidine for system suitability CRS | 10 mg | N/A | |
| Y0001653 | Chlormadinone acetate CRS | 120 mg | 302-22-7 | |
| Y0001656 | Chlormadinone acetate impurity G CRS | 10 mg | 302-23-8 | |
| Y0001638 | Chlormadinone acetate for system suitability CRS | 10 mg | 302-22-7 | |
| Y0002037 | Chlorobutanol CRS | 50 mg | 57-15-8 | |
| Y0002029 | Chlorobutanol hemihydrate CRS | 50 mg | 6001-64-5 | |
| Y0000569 | Chlorogenic acid CRS | 25 mg | 327-97-9 | |
| C1650000 | Chloroquine sulfate CRS | 110 mg | 6823-83-2 | |
| C1700000 | Chlorothiazide CRS | 10 mg | 58-94-6 | |
| C1800000 | Chlorphenamine maleate CRS | 20 mg | 113-92-8 | |
| Y0000436 | Chlorphenamine impurity A CRS | 0.01 mg | n/a | |
| Y0000437 | Chlorphenamine impurity C CRS | 10 mg | n/a | |
| C1900000 | Chlorpromazine hydrochloride CRS | 200 mg | 69-09-0 | |
| Y0000507 | Chlorpromazine impurity A CRS | 15 mg | N/A | |
| Y0000479 | Chlorpromazine impurity D CRS | 10 mg | N/A | |
| Y0000508 | Chlorpromazine impurity E CRS | 10 mg | 92-39-7 | |
| Y0001449 | Chlorpromazine impurity F CRS | 2 mg | n/a | |
| Y0002088 | Chlorprothixene for system suitability CRS | 1 mg | n/a | |
| C1915000 | Chlorprothixene hydrochloride CRS | 50 mg | 6469-93-8 | |
| C1950000 | Chlortalidone CRS | 150 mg | 77-36-1 | |
| Y0002129 | Chlortalidone for system suitability CRS | 1.02 mg | n/a | |
| Y0001451 | Chlortetracycline for system suitability CRS | 10 mg | 64-72-2 | |
| C2000000 | Chlortetracycline hydrochloride CRS | 100 mg | 64-72-2 | |
| C2100000 | Cholecalciferol CRS | 500 mg | 67-97-0 | |
| C2150000 | Cholecalciferol for system suitability CRS | 1 mL | 67-97-0 | |
| C2155000 | Cholesterol CRS | 80 mg | 57-88-5 | |
| C2158000 | Cholic acid CRS | 60 mg | 81-25-4 | |
| Y0000280 | Chondroitin sulfate sodium CRS | 350 mg | N/A | |
| Y0000593 | Chondroitin sulfate sodium (marine) CRS | 100 mg | N/A | |
| C2160000 | Chymotrypsin BRP | 100 mg | 9004-07-3 | |
| Y0001553 | Ciclesonide CRS | 150 mg | 126544-47-6 | |
| Y0001554 | Ciclesonide containing impurity A CRS | 15 mg | 126544-47-6 | |
| Y0001555 | Ciclesonide impurity B CRS | 10 mg | 161115-59-9 | |
| Y0001556 | Ciclesonide impurity C CRS | 10 mg | n/a | |
| Y0000040 | Ciclopirox CRS | 75 mg | 29342-05-0 | |
| C2162701 | Ciclopirox impurity A CRS | 40 mg | n/a | |
| C2162702 | Ciclopirox impurity B CRS | 40 mg | 14818-35-0 | |
| C2162700 | Ciclopirox olamine CRS | 150 mg | 41621-49-2 | |
| C2163000 | Ciclosporin CRS | 100 mg | 59865-13-3 | |
| Y0000361 | Ciclosporin for system suitability CRS | 1 mg | 59865-13-3 | |
| Y0002292 | Ciclosporin for system suitability A | 1 mg | | |
| C2170000 | Cilastatin sodium CRS | 25 mg | 81129-83-1 | |
| Y0001651 | Cilastatin for system suitability 1 CRS | 5 mg | 81129-83-1 | |
| Y0001652 | Cilastatin for system suitability 2 CRS | 5 mg | 81129-83-1 | |
| C2174000 | Cilazapril CRS | 50 mg | 92077-78-6 | |
| C2174002 | Cilazapril impurity A CRS | 25 mg | 106860-19-9 | |
| C2174005 | Cilazapril impurity D CRS | 10 mg | n/a | |
| C2175000 | Cimetidine CRS | 60 mg | 51481-61-9 | |
| C2175500 | Cimetidine hydrochloride CRS | 100 mg | 70059-30-2 | |
| Y0001130 | Cimetidine for peak identification CRS | 10 mg | 51481-61-9 | |
| Y0001146 | Cimetidine for system suitability CRS | 0.51 mg | 51481-61-9 | |
| C2177000 | Cinchocaine hydrochloride CRS | 60 mg | 61-12-1 | |
| Y0002033 | Cinchocaine Impurity A CRS | 10 mg | 87864-14-0 | |
| Y0002032 | Cinchocaine Impurity B CRS | 10 mg | 15733-89-8 | |
| Y0000176 | Cineole CRS | 180 µL | 470-82-6 | |
| C2180000 | Cinnarizine CRS | 100 mg | 298-57-7 | |
| Y0000362 | Ciprofibrate CRS | 5 mg | 52214-84-3 | |
| Y0000363 | Ciprofibrate for system suitability CRS | 5 mg | 52214-84-3 | |
| Y0000198 | Ciprofloxacin CRS | 20 mg | 85721-33-1 | |
| C2190000 | Ciprofloxacin hydrochloride CRS | 100 mg | 86393-32-0 | |
| Y0000199 | Ciprofloxacin hydrochloride for peak identification CRS | 10 mg | 86393-32-0 | |
| C2190050 | Ciprofloxacin impurity A CRS | 25 mg | 86393-33-1 | |
| Y0001766 | Cisatracurium besilate CRS | 130 mg | 96946-42-8 | |
| Y0001768 | Cisatracurium for peak identification CRS | 5 mg | N/A | |
| Y0001767 | Cisatracurium for system suitability CRS | 5 mg | N/A | |
| C2210000 | Cisplatin CRS | 100 mg | 15663-27-1 | |
| Y0001018 | Cisplatin impurity A CRS | 15 mg | 14913-33-8 | |
| Y0001019 | Cisplatin impurity B CRS | 15 mg | n/a | |
| Y0001008 | Citalopram hydrobromide CRS | 5 mg | 59729-32-7 | |
| Y0001007 | Citalopram hydrochloride CRS | 5 mg | n/a | |
| Y0000855 | Citalopram for system suitability CRS | 0.065 mg | 59729-32-7 | |
| A1202000 | Citric acid (anhydrous) CRS | 50 mg | 77-92-9 | |
| C2219000 | Citric acid monohydrate CRS | 50 mg | 5949-29-1 | |
| Y0000639 | Cladribine CRS | 100 mg | 4291-63-8 | |
| Y0000610 | Cladribine impurity C CRS | 5 mg | 1839-18-5 | |
| Y0000609 | Cladribine for peak identification CRS | 10 mg | 4291-63-8 | |
| Y0000320 | Clarithromycin CRS | 160 mg | 81103-11-9 | |
| Y0000321 | Clarithromycin for peak identification CRS | 10 mg | 81103-11-9 | |
| Y0001193 | Clazuril CRS | 10 mg | 101831-36-1 | |
| Y0000269 | Clazuril for system suitability CRS | 10 mg | 101831-36-1 | |
| C2221000 | Clebopride malate CRS | 100 mg | 57645-91-7 | |
| C2223000 | Clemastine fumarate CRS | 100 mg | 14976-57-9 | |
| Y0001613 | Clemastine for system suitability CRS | 0.165 mg | 14976-57-9 | |
| C2248000 | Clenbuterol hydrochloride CRS | 30 mg | 21898-19-1 | |
| C2248010 | Clenbuterol impurity B CRS | 10 mg | n/a | |
| C2250000 | Clindamycin hydrochloride CRS | 200 mg | 21462-39-5 | |
| C2269000 | Clindamycin phosphate CRS | 250 mg | 24729-96-2 | |
| Y0001680 | Clindamycin phosphate for system suitability CRS | 10 mg | 24729-96-2 | |
| Y0000364 | Clioquinol CRS | 5 mg | 130-26-7 | |
| Y0000205 | Clobazam - reference spectrum | n/a | n/a | |
| Y0000241 | Clobazam impurity A CRS | 10 mg | 22316-55-8 | |
| Y0000559 | Clobetasol propionate CRS | 50 mg | 25122-46-7 | |
| Y0000571 | Clobetasol impurity J CRS | 0.4 mg | n/a | |
| Y0002164 | Clobetasol propionate for peak identification CRS | 2 mg | n/a | |
| C2285000 | Clobetasone butyrate CRS | 50 mg | 25122-57-0 | |
| Y0001137 | Clobetasone butyrate for system suitability CRS | 20 mg | 25122-57-0 | |
| Y0000888 | Clodronate disodium tetrahydrate CRS | 5 mg | 22560-50-5 | |
| Y0000885 | Clodronate impurity D CRS | 5 mg | n/a | |
| Y0000313 | Clofazimine CRS | 150 mg | 2030-63-9 | |
| Y0000358 | Clofazimine for system suitability CRS | 10 mg | 2030-63-9 | |
| C2300000 | Clofibrate CRS | 0.5 ml | 637-07-0 | |
| C2320000 | Clomifene citrate CRS | 50 mg | 50-41-9 | |
| Y0002180 | Clomifene citrate for ID and assay CRS | 50 mg | | |
| C2332000 | Clomifene citrate for performance test CRS | 50 mg | 50-41-9 | |
| Y0002252 | Clomifene for impurities G and H identification | 20 mg | | |
| Y0002251 | Clomifene for peak identification | 20 mg | | |
| Y0002178 | Clomifene for system suitability CRS | 25 mg | n/a | |
| C2360000 | Clomipramine hydrochloride CRS | 50 mg | 17321-77-6 | |
| Y0000132 | Clomipramine impurity C CRS | 20 mg | n/a | |
| Y0000133 | Clomipramine impurity D CRS | 10 mg | 3589-22-8 | |
| Y0000134 | Clomipramine impurity F CRS | 10 mg | n/a | |
| C2385000 | Clonazepam CRS - * psy | 50 mg | 1622-61-3 | |
| Y0000286 | Clonazepam - reference spectrum | n/a | n/a | |
| C2385015 | Clonazepam impurity B CRS | 5 mg | n/a | |
| C2400000 | Clonidine hydrochloride CRS | 25 mg | 4205-91-8 | |
| Y0000801 | Clonidine impurity B CRS | 20 mg | 54707-71-0 | |
| Y0000833 | Clopamide CRS | 40 mg | 636-54-4 | |
| Y0000848 | Clopamide for system suitability CRS | 10 mg | 636-54-4 | |
| Y0001852 | Clopidogrel besilate CRS | 10 mg | 744256-69-7 | |
| Y0001334 | Clopidogrel for system suitability CRS | 70 mg | 120202-66-6 | |
| Y0001857 | Clopidogrel hydrochloride CRS | 100 mg | 120202-65-5 | |
| Y0001333 | Clopidogrel hydrogen sulfate CRS | 60 mg | 120202-66-6 | |
| Y0001335 | Clopidogrel impurity A CRS | 10 mg | N/A | |
| Y0000392 | Closantel sodium dihydrate CRS | 20 mg | 61438-64-0 for anhydrous form | |
| Y0000393 | Closantel for system suitability CRS | 20 mg | 61438-64-0 | |
| C2424400 | Clostridia (multi-component) rabbit antiserum(for vaccines-vet.use)BRP | 1 mg | N/A | |
| C2424550 | Clostridium tetani guinea pig antiserum (for vaccines - human use) BRP | 1 mg | N/A | |
| C2424500 | Clostridium tetani guinea pig antiserum (for vaccines - vet. use) BRP | 1 mg | N/A | |
| C2425600 | Clostridium tetani rabbit antiserum (for vaccines - vet. use) BRP | 1 mg | N/A | |
| C2430000 | Clotrimazole CRS | 100 mg | 23593-75-1 | |
| Y0000818 | Clotrimazole impurity E CRS | 15 mg | 08/03/5162 | |
| Y0000849 | Clotrimazole for peak identification CRS | 1.005 mg | 23593-75-1 | |
| C2450000 | Cloxacillin sodium CRS | 230 mg | 7081-44-9 | |
| C2460000 | Clozapine CRS | 60 mg | 5786-21-0 | |
| Y0000758 | Clozapine for peak identification CRS | 0.41 mg | 5786-21-0 | |
| Y0001472 | Coagulation Factors V, VIII, XI and XIII plasma BRP | 1 mg | N/A | |
| Y0000162 | Cocaine hydrochloride - reference spectrum | n/a | n/a | |
| C2480000 | Cocoyl caprylocaprate CRS | 40 mg | N/A | |
| Y0000722 | Codeine CRS - * narc (Codeine monohydrate) | 20 mg | 6059-47-8 | |
| C2500000 | Codeine - reference spectrum | n/a | n/a | |
| Y0001984 | Codeine for system suitability - * narc CRS | 10 mg | N/A | |
| Y0000334 | Codeine impurity A CRS | 15 mg | 2859-16-7 | |
| Y0001974 | Codeine hydrochloride dihydrate CRS - * narc | 10 mg | 5916-29-0 | |
| C2500100 | Codeine hydrochloride dihydrate - reference spectrum | n/a | n/a | |
| C2510000 | Codergocrine mesilate CRS | 60 mg | 8067-24-1 | |
| Y0001500 | Coix seed HRS | 1300 mg | n/a | |
| C2580000 | Colchicine CRS | 15 mg | 64-86-8 | |
| Y0001958 | Colchicine for system suitability A CRS | 10 mg | N/A | |
| Y0000374 | Colestyramine CRS | 10 mg | 11041-12-6 | |
| C2600000 | Colistimethate sodium CRS | 26.2 mg | 8068-28-8 | |
| Y0001888 | Colistimethate sodium for peak identification CRS | 20 mg | 8068-28-8 | |
| Y0001999 | Colistin for system suitability CRS | 10 mg | | |
| C2700000 | Colistin sulfate for microbiological assay CRS | 25 mg | 1264-72-8 | |
| Y0002138 | Copovidone CRS | 60 mg | n/a | |
| Y0001748 | Copper tetramibi tetrafluoroborate CRS | 15 mg | 103694-84-4 | |
| C2800000 | Cortisone acetate CRS | 250 mg | 50-04-4 | |
| Y0002057 | Corydalis rhizome dry extract HRS | 110 mg | | |
| Y0001307 | Costunolide CRS | 10 mg | 553-21-9 | |
| C2900000 | Cotton wool standard for neps CRS | 1000 mg | n/a | |
| Y0000438 | Coumarin CRS | 160 mg | 91-64-5 | |
| Y0001053 | Crospovidone CRS | 25 mg | 9003-39-8 | |
| C2970000 | Crotamiton CRS | 100 mg | 483-63-6 | |
| C2970005 | Crotamiton impurity A CRS | 35 mg | N/A | |
| Y0001061 | Cyanidin chloride CRS | 25 mg | 528-58-5 | |
| C3000000 | Cyanocobalamin CRS | 20 mg | 68-19-9 | |
| Y0002203 | Cyanocobalamin for peak identification CRS | 15 mg | 68-19-9 | |
| Y0002204 | Cyanocobalamin for system suitability CRS | 15 mg | n/a | |
| Y0002181 | Cyasterone CRS | 10 mg | 17086-76-9 | |
| C3090000 | Cyclizine hydrochloride CRS | 50 mg | 303-25-3 | |
| Y0000886 | Cyclizine impurity A CRS | 15 mg | 109-01-3 | |
| Y0000887 | Cyclizine impurity B CRS | 15 mg | 91-01-0 | |
| C3200000 | Cyclobenzaprine hydrochloride CRS | 20 mg | 6202-23-9 | |
| C3230000 | Cyclohexa-1,4-dienylglycine CRS | 15 mg | 26774-88-9 | |
| C3245000 | Cyclopentolate hydrochloride CRS | 80 mg | 5870-29-1 | |
| Y0001088 | Cyclopentolate for system suitability CRS | 20 mg | 5870-29-1 | |
| C3250000 | Cyclophosphamide CRS | 50 mg | 6055-19-2 | |
| C3280000 | Cyproheptadine hydrochloride CRS | 15 mg | 41354-29-4 | |
| Y0001095 | Cyproheptadine impurity C CRS | 5 mg | 4046-24-6 | |
| C3283000 | Cyproterone acetate CRS | 30 mg | 427-51-0 | |
| Y0001390 | Cyproterone acetate for peak identification CRS | 5 mg | 427-51-0 | |
| Y0001223 | Cyproterone impurity mixture CRS | 0.01 mg | n/a | |
| C3290000 | Cysteine hydrochloride monohydrate CRS | 100 mg | 7048-04-6 | |
| C3300000 | Cystine CRS | 100 mg | 56-89-3 | |
| C3350000 | Cytarabine CRS | 150 mg | 147-94-4 | |
| Y0000733 | Dacarbazine CRS | 20 mg | 4342-03-4 | |
| Y0000734 | Dacarbazine impurity A CRS | 20 mg | 63907-29-9 | |
| Y0000735 | Dacarbazine impurity B CRS | 15 mg | 360-97-4 | |
| D0070000 | Dalteparin sodium CRS | 250 mg | 9041-08-1 | |
| Y0000600 | Danaparoid sodium CRS | 10.5 mg | 24967-94-0 | |
| D0100000 | Dapsone CRS | 100 mg | 80-08-0 | |
| D0125000 | Daunorubicin hydrochloride CRS | 120 mg | 23541-50-6 | |
| D0120000 | Daunorubicinone CRS | 15 mg | 21794-55-8 | |
| Y0002196 | Deferasirox CRS | 70 mg | 201530-41-8 | |
| Y0002197 | Deferasirox for system suitability CRS | 10 mg | 201530-41-8 | |
| Y0002198 | Deferasirox impurity B CRS | 10 mg | 1218-69-5 | |
| Y0002195 | Deferasirox impurity F CRS | 20 mg | 619-67-0 | |
| Y0001976 | Deferiprone CRS | 120 mg | 30652-11-0 | |
| D0160000 | Deferoxamine mesilate CRS | 30 mg | 138-14-7 | |
| Y0001934 | Deferoxamine for system suitability CRS | 15 mg | N/A | |
| Y0001937 | Deferoxamine for peak identification CRS | 20 mg | | |
| D0201000 | Dehydrohexetidine CRS | 50 mg | n/a | |
| Y0000611 | Dembrexine hydrochloride monohydrate CRS | 10 mg | 52702-51-9 | |
| Y0001707 | Demeclocycline for system suitability CRS | 10 mg | 64-73-3 | |
| D0300000 | Demeclocycline hydrochloride CRS | 100 mg | 64-73-3 | |
| D0350000 | N-Demethylerythromycin A CRS | 15 mg | 992-62-1 | |
| Y0000228 | Demethylflumazenil - reference spectrum | n/a | n/a | |
| D0406200 | Deptropine citrate CRS | 60 mg | 2169-75-7 | |
| D0430000 | Dequalinium chloride CRS | 50 mg | 522-51-0 | |
| D0431000 | Dequalinium chloride for performance test CRS | 50 mg | 522-51-0 | |
| Y0001321 | Dermatan sulfate and over-sulfated chondroitin sulfate CRS | 1 mL | n/a | |
| D0480000 | Desacetylvinblastine CRS | 1 mg | 3352-69-0 | |
| Y0000879 | Desflurane - reference spectrum | n/a | n/a | |
| Y0000807 | Desflurane impurity A CRS | 0.5 mL | 67429-44-1 | |
| D0500000 | Desipramine hydrochloride CRS | 100 mg | 58-28-6 | |
| D0600000 | Deslanoside CRS | 160 mg | 17598-65-1 | |
| Y0001584 | Desloratadine CRS | 100 mg | 100643-71-8 | |
| D0630000 | Desmethylmetrifonate CRS | 25 mg | n/a | |
| Y0001582 | Desloratadine for system suitability CRS | 5 mg | 100643-71-8 | |
| D0650000 | Desmopressin CRS | 1 mg | 62288-83-9 | |
| Y0000509 | Desogestrel CRS | 50 mg | 54024-22-5 | |
| Y0000510 | Desogestrel for system suitability CRS | 10 mg | 54024-22-5 | |
| D0400000 | Desoxycortone acetate CRS | 100 mg | 56-47-3 | |
| Y0000001 | Detomidine hydrochloride CRS | 100 mg | 90038-01-0 | |
| D0660020 | Detomidine impurity B CRS | 20 mg | n/a | |
| D0700000 | Dexamethasone CRS | 70 mg | 50-02-2 | |
| Y0001593 | Dexamethasone for peak identification CRS | 10 mg | 50-02-2 | |
| Y0001177 | Dexamethasone for system suitability CRS | 10 mg | 50-02-2 | |
| D0710000 | Dexamethasone acetate CRS | 150 mg | 1177-87-3 | |
| Y0001842 | Dexamethasone acetate for peak identification CRS | 10 mg | 1177-87-3 | |
| Y0001169 | Dexamethasone acetate impurity E CRS | 0.013 mg | n/a | |
| Y0000538 | Dexamethasone isonicotinate CRS | 10 mg | 2265-64-7 | |
| Y0000511 | Dexamethasone isonicotinate for impurity C identification CRS | 10 mg | 2265-64-7 | |
| D0718000 | Dexamethasone pivalate CRS | 50 mg | 1926-94-9 | |
| D0720000 | Dexamethasone sodium phosphate CRS | 130 mg | 2392-39-4 | |
| Y0001477 | Dexamethasone sodium phosphate for peak identification CRS | 10 mg | 2392-39-4 | |
| Y0002072 | Dexamfetamine sulfate CRS - * narc | 10 mg | 51-63-8 | |
| D0720800 | Dexchlorpheniramine maleate CRS | 60 mg | 2438-32-6 | |
| D0730000 | Dexpanthenol CRS | 20 mg | 81-13-0 | |
| Y0002234 | Dexpanthenol impurity B CRS | 15 mg | | |
| D0731000 | Dextran CRS | 25 mg | 9004-54-0 | |
| D0731005 | Dextran 1 CRS | 50 mg | 9004-54-0 | |
| D0733000 | Dextran 4 for calibration CRS | 50 mg | n/a | |
| D0734000 | Dextran 10 for calibration CRS | 50 mg | n/a | |
| D0735000 | Dextran 40 for calibration CRS | 30 mg | n/a | |
| D0738000 | Dextran 40 for performance test CRS | 50 mg | n/a | |
| D0739000 | Dextran 60/70 for performance test CRS | 50 mg | n/a | |
| D0736000 | Dextran 70 for calibration CRS | 50 mg | n/a | |
| D0737000 | Dextran 250 for calibration CRS | 50 mg | n/a | |
| D0732000 | Dextran Vo CRS | 10 mg | n/a | |
| Y0000744 | Dextranomer CRS | 50 mg | N/A | |
| D0740000 | Dextromethorphan hydrobromide CRS | 100 mg | 6700-34-1 | |
| Y0000261 | Dextromethorphan impurity A CRS | 5 mg | n/a | |
| Y0001058 | Dextropropoxyphene hydrochloride CRS - * narc | 10 mg | 1639-60-7 | |
| Y0001150 | Dextropropoxyphene for system suitability CRS - * narc (see Add info) | 5 mg | 1639-60-7 | |
| Y0001595 | Diacerein CRS | 150 mg | 13739-02-1 | |
| Y0001596 | Diacerein impurity B CRS | 20 mg | 481-72-1 | |
| Y0001597 | Diacerein impurity mixture CRS | 0.014 mg | 13739-02-1 | |
| Y0000454 | Diacetylfluorescein CRS | 120 mg | 596-09-8 | |
| D0940000 | Diazepam CRS - * psy | 10 mg | 439-14-5 | |
| Y0000596 | Diazepam for system suitability CRS - * psy (Diazepam) | 0.5 mg | 439-14-5 | |
| D0950000 | Diazoxide CRS | 50 mg | 364-98-7 | |
| D0970000 | Dibenzocycloheptene CRS | 20 mg | 256-81-5 | |
| D1000000 | Dibenzosuberone CRS | 30 mg | 1210-35-1 | |
| Y0000480 | Dibrompropamidine diisetionate CRS | 10 mg | 614-87-9 | |
| Y0000481 | Dibrompropamidine for system suitability CRS | 20 mg | 614-87-9 | |
| D1010000 | Dibutyl phthalate CRS | 1 ml | 84-74-2 | |
| Y0001620 | 2,4-Dichlorobenzyl alcohol CRS | 250 mg | 1777-82-8 | |
| Y0001621 | 2,4-Dichlorobenzyl alcohol impurity A CRS | 25 mg | 34145-05-6 | |
| Y0001622 | 2,4-Dichlorobenzyl alcohol impurity C CRS | 25 mg | 1805-32-9 | |
| Y0000275 | Dichlorodiaminocyclohexaneplatinum CRS | 15 mg | n/a | |
| Y0000264 | Diclazuril for veterinary use - reference spectrum | n/a | n/a | |
| Y0000259 | Diclazuril for system suitability CRS | 20 mg | 101831-37-2 | |
| D1039990 | Diclofenac potassium CRS | 70 mg | 15307-81-0 | |
| S0765000 | Diclofenac sodium CRS | 100 mg | 15307-79-6 | |
| Y0001635 | Diclofenac for system suitability CRS | 1 mg | 15307-79-6 | |
| D1050000 | Dicloxacillin sodium CRS | 250 mg | 13412-64-1 | |
| D1060000 | Dicycloverine hydrochloride CRS | 100 mg | 67-92-5 | |
| Y0001864 | Dicycloverine for system suitability CRS | 15 mg | 67-92-5 | |
| Y0001900 | Dicycloverine impurity A CRS | 20 mg | 60263-54-9 | |
| Y0000439 | Didanosine CRS | 10 mg | 69655-05-6 | |
| Y0000441 | Didanosine impurity A CRS | 20 mg | 68-94-0 | |
| Y0000442 | Didanosine impurity G CRS | 10 mg | 4097-22-7 | |
| Y0000440 | Didanosine for system suitability CRS | 10 mg | 69655-05-6 | |
| D1200000 | Dienestrol CRS | 150 mg | 84-17-3 | |
| Y0001785 | Dienogest CRS | 80 mg | 65928-58-7 | |
| Y0001782 | Dienogest for system suitability CRS | 10 mg | 65928-58-7 | |
| D1410000 | Diethyl phthalate CRS | 1 mL | 84-66-2 | |
| D1300000 | Diethylcarbamazine citrate CRS | 250 mg | 1642-54-2 | |
| Y0000217 | Diethylene glycol (monoethyl ether) - reference spectrum | n/a | n/a | |
| D1500000 | Diethylstilbestrol CRS | 100 mg | 56-53-1 | |
| D1600000 | Diethylstilbestrol dimethyl ether CRS | 10 mg | 7773-34-4 | |
| D1700000 | Diethylstilbestrol monomethyl ether CRS | 10 mg | 7773-60-6 | |
| Y0001423 | Difloxacin hydrochloride CRS | 60 mg | 91296-86-5 | |
| Y0001429 | Difloxacin impurity G CRS | 15 mg | n/a | |
| D1750000 | Diflunisal CRS | 30 mg | 22494-42-4 | |
| D1800000 | Digitoxin CRS | 200 mg | 71-63-6 | |
| Y0002036 | Digitoxin for LC assay CRS | 25 mg | 71-63-6 | |
| Y0000640 | Digoxigenin CRS | 10 mg | 1672-46-4 | |
| D1900000 | Digoxin CRS | 30 mg | 20830-75-5 | |
| Y0000554 | Digoxin for peak identification CRS | 10 mg | 20830-75-5 | |
| D1940001 | Dihydralazine sulfate (hydrated) - reference spectrum | n/a | n/a | |
| Y0000232 | Dihydralazine for system suitability CRS | 10 mg | 7327-87-9 | |
| Y0000216 | Dihydrocodeine hydrogen tartrate - reference spectrum | n/a | n/a | |
| Y0000053 | 17 alpha-dihydroequilin CRS | 10 mg | 651-55-8 | |
| D1945000 | Dihydroergocristine mesilate CRS | 250 mg | 24730-10-7 | |
| D1950000 | Dihydroergotamine mesilate CRS | 50 mg | 6190-39-2 | |
| Y0000831 | Dihydroergotamine for peak identification CRS | 10 mg | 6190-39-2 | |
| D1954000 | Dihydrostreptomycin sulfate CRS | 25 mg | 5490-27-7 | |
| Y0000544 | Dihydrotachysterol CRS | 30 mg | 67-96-9 | |
| Y0000482 | Dihydrotachysterol for system suitability CRS | 5 mg | 67-96-9 | |
| D1980000 | Diltiazem hydrochloride CRS | 300 mg | 33286-22-5 | |
| Y0001439 | Diltiazem impurity F CRS | 15 mg | n/a | |
| Y0001141 | Diltiazem for system suitability CRS | 10 mg | 33286-22-5 | |
| D2000000 | Dimenhydrinate CRS | 100 mg | 523-87-5 | |
| Y0001103 | Dimenhydrinate for peak identification CRS | 1 mg | 523-87-5 | |
| Y0000234 | N,N-Dimethylacetamide - reference spectrum | n/a | n/a | |
| D2050000 | Dimethyl sulfoxide CRS | 1 mL | 67-68-5 | |
| Y0001489 | 2-(Dimethylamino)ethyl methacrylate CRS | 50 mg | 2867-47-2 | |
| Y0001879 | (25R)-Spirost-5-en-3-one CRS | 10 mg | 20817-62-3 | |
| D2200000 | Dimeticone CRS | 450 mg | 9006-65-9 | |
| D2205000 | Dimetindene maleate CRS | 10 mg | 3614-69-5 | |
| D2255000 | Dinoprost trometamol CRS | 60 mg | 38562-01-5 | |
| D2250000 | Dinoprostone CRS | 60 mg | 363-24-6 | |
| D2250015 | Dinoprostone impurity C CRS | 10 mg | 36150-00-2 | |
| Y0001871 | Diosgenin CRS | 15 mg | 512-04-9 | |
| Y0000094 | Diosmin CRS | 70 mg | 520-27-4 | |
| Y0000095 | Diosmin for system suitability CRS | 5 mg | 520-27-4 | |
| D2600000 | Diphenhydramine hydrochloride CRS | 100 mg | 147-24-0 | |
| Y0000135 | Diphenhydramine impurity A CRS | 10 mg | n/a | |
| Y0001415 | Diphenoxylate hydrochloride CRS - * narc | 15 mg | 3810-80-8 | |
| D2630000 | Diphenoxylate hydrochloride - reference spectrum | n/a | n/a | |
| Y0001430 | Diphenoxylate for system suitability CRS - * narc | 10 mg | 3810-80-8 | |
| Y0000258 | Diphtheria toxin BRP | 1 ml | n/a | |
| D2700000 | Diphtheria vaccine (adsorbed) BRP | 32 mg | n/a | |
| Y0000376 | Dipivefrine hydrochloride CRS | 100 mg | 64019-93-8 | |
| Y0000394 | Dipivefrine for system suitability CRS | 10 mg | 64019-93-8 | |
| D2750100 | Dipotassium clorazepate - reference spectrum | n/a | n/a | |
| Y0002289 | Dipotassium clorazepate monohydrate - reference spectrum | 1 uc | n/a | |
| D2800000 | Diprophylline CRS | 100 mg | 479-18-5 | |
| D2850000 | Dipyridamole CRS | 50 mg | 58-32-2 | |
| Y0000802 | Dipyridamole for peak identification CRS | 2 mg | 58-32-2 | |
| D2880000 | Dirithromycin CRS | 100 mg | 62013-04-1 | |
| D2900000 | Disodium edetate CRS | 100 mg | 6381-92-6 | |
| D2920000 | Disopyramide CRS | 100 mg | 3737-09-5 | |
| D2922000 | Disopyramide phosphate CRS | 100 mg | 22059-60-5 | |
| D2950000 | Disulfiram CRS | 100 mg | 97-77-8 | |
| D2953000 | Dithranol CRS | 55 mg | 1143-38-0 | |
| D2953025 | Dithranol impurity C CRS | 15 mg | n/a | |
| D2953050 | Dithranol impurity D CRS | 20 mg | n/a | |
| Y0002212 | DL-lysine acetylsalicylate impurity C | 5 mg | | |
| Y0002213 | DL-lysine acetylsalicylate impurity G | 15 mg | 35436-74-9 | |
| M0950000 | DL-Methionine CRS | 50 mg | 59-51-8 | |
| D2954000 | Dobutamine hydrochloride CRS | 100 mg | 49745-95-1 | |
| Y0001239 | Dobutamine impurity mixture CRS | 0.1 mg | n/a | |
| Y0001133 | Docetaxel trihydrate CRS | 160 mg | 148408-66-6 | |
| Y0001155 | Docetaxel for system suitability CRS | 10 mg | 148408-66-6 | |
| Y0001452 | Docetaxel impurity E CRS | 15 mg | 32981-86-5 | |
| D2954600 | Docosahexaenoic acid ethyl ester CRS | 150 mg | 81926-94-5 | |
| Y0001567 | Docusate sodium CRS | 10 mg | 577-11-7 | |
| Y0000365 | Dodecyl gallate CRS | 30 mg | 1166-52-5 | |
| D2955000 | Domperidone CRS | 120 mg | 57808-66-9 | |
| D2957000 | Domperidone maleate CRS | 150 mg | 83898-65-1 | |
| Y0002165 | Donepezil for system suitability CRS | 10 mg | n/a | |
| Y0002160 | Donepezil hydrochloride CRS | 50 mg | 120011-70-3 | |
| Y0002166 | Donepezil hydrochloride monohydrate CRS | 20 mg | | |
| D2960000 | Dopamine hydrochloride CRS | 20 mg | 62-31-7 | |
| Y0000612 | Dopexamine dihydrochloride CRS | 10 mg | 86484-91-5 | |
| Y0000613 | Dopexamine impurity B CRS | 10 mg | n/a | |
| Y0000614 | Dopexamine impurity F CRS | 10 mg | n/a | |
| Y0000726 | Dorzolamide hydrochloride CRS | 50 mg | 130693-82-2 | |
| Y0000727 | Dorzolamide impurity A CRS | 5 mg | 120279-95-0 | |
| Y0000750 | Dorzolamide for system suitability CRS | 5 mg | 130693-82-2 | |
| Y0001965 | Dosulepin for system suitability CRS | 15 mg | N/A | |
| D2962000 | Dosulepin hydrochloride CRS | 100 mg | 897-15-4 | |
| D2962005 | Dosulepin impurity A CRS | 30 mg | n/a | |
| D2963000 | Doxapram hydrochloride CRS | 50 mg | 7081-53-0 | |
| Y0000208 | Doxapram impurity B CRS | 10 mg | n/a | |
| Y0000553 | Doxazosin mesilate CRS | 60 mg | 77883-43-3 | |
| Y0000551 | Doxazosin impurity D CRS | 10 mg | n/a | |
| Y0000552 | Doxazosin impurity F CRS | 15 mg | 23680-84-4 | |
| Y0000838 | Doxepin hydrochloride CRS | 5 mg | 1229-29-4 | |
| Y0000851 | Doxepin for system suitability CRS | 1 mg | 1229-29-4 | |
| D2975000 | Doxorubicin hydrochloride CRS | 150 mg | 25316-40-9 | |
| D3000000 | Doxycycline hyclate CRS | 50 mg | 24390-14-5 | |
| Y0001714 | Doxycycline for system suitability CRS | 10 mg | 24390-14-5 | |
| Y0001562 | Doxylamine hydrogen succinate CRS | 60 mg | 562-10-7 | |
| Y0002121 | Dronedarone hydrochloride CRS | 120 mg | 141625-93-6 | |
| Y0001492 | Doxylamine for system suitability CRS | 110 mg | 562-10-7 | |
| Y0002186 | Dronedarone impurity A CRS | 10 mg | | |
| Y0002112 | Dronedarone impurity B CRS | 10 mg | | |
| D3100000 | Droperidol CRS | 150 mg | 548-73-2 | |
| Y0001105 | Drospirenone CRS | 80 mg | 67392-87-4 | |
| Y0001115 | Drospirenone impurity E CRS | 0.06 mg | n/a | |
| Y0001718 | Drospirenone for peak identification CRS | 10 mg | 266-679-2 | |
| Y0001453 | Duloxetine hydrochloride CRS | 120 mg | 136434-34-9 | |
| Y0001455 | Duloxetine impurity A CRS | 10 mg | n/a | |
| Y0001454 | Duloxetine for system suitability CRS | 40 mg | 136434-34-9 | |
| Y0001598 | Dutasteride CRS | 150 mg | 164656-23-9 | |
| Y0001603 | Dutasteride for system suitability CRS | 10 mg | 164656-23-9 | |
| Y0001004 | Dydrogesterone CRS | 60 mg | 152-62-5 | |
| Y0001005 | Dydrogesterone impurity A CRS | 6 mg | 23035-53-2 | |
| Y0001006 | Dydrogesterone impurity B CRS | 5 mg | 1162-56-7 | |
| Y0001887 | E1 Colistimethate sodium for peak identification CRS | 5 mg | 8068-28-8 | |
| Y0002031 | Ebastine CRS | 25 mg | 90729-43-4 | |
| Y0001886 | E2 Colistimethate sodium for peak identification CRS | 5 mg | 8068-28-8 | |
| Y0001236 | Econazole CRS | 10 mg | 27220-47-9 | |
| Y0000254 | Econazole for system suitability CRS | 20 mg | 24169-02-6 | |
| E0050000 | Econazole nitrate CRS | 100 mg | 24169-02-6 | |
| Y0001738 | Edrophonium chloride CRS | 10 mg | 116-38-1 | |
| E0085000 | Eicosapentaenoic acid ethyl ester CRS | 200 mg | 86227-47-6 | |
| Y0000537 | Emedastine difumarate CRS | 10 mg | 87233-62-3 | |
| Y0000512 | Emedastine impurity E CRS | 10 mg | n/a | |
| E0100000 | Emetine hydrochloride CRS | 15 mg | 316-42-7 | |
| Y0001837 | Emodin CRS | 15 mg | 518-82-1 | |
| E0109000 | Enalapril maleate CRS | 15 mg | 76095-16-4 | |
| E0110000 | Enalapril for system suitability CRS | 10 mg | 76095-16-4 | |
| Y0001853 | Enalapril impurity mixture A CRS | 0.024 mg | N/A | |
| Y0001829 | Enalapril impurity G CRS | 15 mg | N/A | |
| Y0000615 | Enalaprilat dihydrate CRS | 100 mg | 84680-54-6 | |
| Y0000678 | Enalaprilat impurity G CRS | 0.005 mg | n/a | |
| Y0000629 | Enalaprilat for system suitability CRS | 10 mg | 84680-54-6 | |
| E0150000 | Endotoxin standard BRP | 10 mg | 67924-63-4 | |
| Y0000136 | Enilconazole CRS | 60 mg | 35554-44-0 | |
| Y0000137 | Enilconazole impurity E CRS | 20 mg | 24155-42-8 | |
| E0180000 | Enoxaparin sodium CRS | 120 mg | 679809-58-6 | |
| E0180500 | Enoxolone CRS | 220 mg | 471-53-4 | |
| Y0001259 | Enrofloxacin CRS | 5 mg | 93106-60-6 | |
| Y0001160 | Enrofloxacin for system suitability CRS | 15 mg | 93106-60-6 | |
| Y0001249 | Entacapone CRS | 160 mg | 130929-57-6 | |
| Y0001250 | Entacapone impurity A CRS | 10 mg | n/a | |
| Y0001800 | Entecavir monohydrate CRS | 110 mg | 209216-23-9 | |
| Y0001802 | Entecavir impurity F CRS | 10 mg | N/A | |
| Y0001801 | Entecavir for system suitability CRS | 1 mg | 209216-23-9 | |
| E0200000 | Enterokinase BRP | 200 mg | 9014-74-8 | |
| E0300000 | Ephedrine hydrochloride CRS - * Drug Precursor | 150 mg | 50-98-6 | |
| E0305000 | Ephedrine hydrochloride (racemic) CRS - * Drug Precursor | 50 mg | 134-71-4 | |
| E0400000 | 4-Epianhydrotetracycline hydrochloride CRS | 25 mg | 4465-65-0 | |
| Y0001128 | Epinastine for system suitability CRS | 10 mg | 108929-04-0 | |
| Y0002208 | Epinastine for system suitability A CRS | 10 mg | 108929-04-0 | |
| Y0001139 | Epinastine hydrochloride CRS | 20 mg | 108929-04-0 | |
| E0550000 | Epirubicin hydrochloride CRS | 100 mg | 56390-09-1 | |
| E0600000 | 4-Epitetracycline hydrochloride CRS | 30 mg | 23313-80-6 | |
| Y0001704 | Eplerenone CRS | 75 mg | 107724-20-9 | |
| Y0001706 | Eplerenone for peak identification CRS | 10 mg | 107724-20-9 | |
| Y0001705 | Eplerenone for system suitability CRS | 10 mg | 107724-20-9 | |
| P1609010 | trans-Epoxyphytomenadione CRS | 5 mg | n/a | |
| E0850010 | Equine influenza subtype 1 strain A/eq/ Newmarket/ 77 h a BRP | 1 mg | n/a | |
| E0850021 | Equine influenza subtype 2 American-like/Newmarket/1/93 h a BRP | 1 mg | n/a | |
| Y0000712 | Equine influenza subtype 2 American-like/South Africa/4/03 h a BRP | 1 mg | n/a | |
| E0850022 | Equine influenza subtype 2 European-like/Newmarket/2/93 h a BRP | 1 mg | n/a | |
| Y0000052 | Equilin CRS | 15 mg | 474-86-2 | |
| Y0001874 | Equine influenza subtype 2 American-like strain A/Eq/Richmond/1/2007 h | 1 mg | N/A | |
| Y0001325 | Equisetum palustre HRS | 200 mg | n/a | |
| E0900000 | Ergocalciferol CRS | 150 mg | 50-14-6 | |
| Y0001375 | Ergocalciferol for system suitability CRS | 10 mg | 50-14-6 | |
| Y0002170 | Ergometrine impurity mixture CRS | 0.002 mg | n/a | |
| E1000000 | Ergometrine maleate CRS - * Drug Precursor | 50 mg | 129-51-1 | |
| E1100000 | Ergosterol CRS | 20 mg | 57-87-4 | |
| Y0001851 | Ergotamine for system suitability CRS - * Drug Prec (see Add info) | 10 mg | 379-79-3 | |
| E1200000 | Ergotamine tartrate CRS - * Drug Precursor | 100 mg | 379-79-3 | |
| Y0000051 | Erysipelas ELISA coating antigen BRP | 0.4 mg | n/a | |
| Y0000177 | Erythritol CRS | 1020 mg | 149-32-6 | |
| E1400000 | Erythromycin estolate CRS | 100 mg | 3521-62-8 | |
| E1500000 | Erythromycin ethylsuccinate CRS | 10 mg | 1264-62-6 | |
| E1500800 | Erythromycin stearate CRS | 50 mg | 643-22-1 | |
| Y0001848 | Erythromycin lactobionate CRS | 15 mg | 3847-29-8 | |
| Y0001912 | Erythromycin A CRS | 250 mg | 114-07-8 | |
| E1310000 | Erythromycin B CRS | 25 mg | 527-75-3 | |
| Y0001849 | Erythromycin stearate for impurity S identification CRS | 15 mg | 643-22-1 | |
| E1320000 | Erythromycin C CRS | 25 mg | 1675-02-1 | |
| Y0001845 | Erythromycin ethylsuccinate for impurity P identification CRS | 15 mg | 1264-62-6 | |
| Y0001846 | Erythromycin for impurity M identification CRS | 10 mg | 114-07-8 | |
| E1300000 | Erythromycin for microbiological assay CRS | 100 mg | 114-07-8 | |
| Y0001847 | Erythromycin for system suitability CRS | 15 mg | 114-07-8 | |
| Y0001725 | Erythropoietin for physicochemical tests CRS | 0.1 mg | 11096-26-7 | |
| Y0001844 | Escitalopram CRS | 10 mg | 128196-01-0 | |
| Y0001797 | Escitalopram for system suitability CRS | 15 mg | 219861-08-2 | |
| Y0001796 | Escitalopram oxalate CRS | 10 mg | 219861-08-2 | |
| Y0001611 | Esculetin CRS | 25 mg | 305-01-1 | |
| Y0002009 | Erythropoietin for SEC system suitability CRS | 15 mg | 11096-26-7 | |
| Y0001612 | Esculin CRS | 25 mg | 531-75-9 | |
| Y0000324 | Esketamine hydrochloride - reference spectrum | n/a | n/a | |
| Y0000338 | Esketamine impurity D CRS - * narc (R-Ketamine hydrochloride) | 10 mg | 6740-88-1 | |
| Y0001660 | Esomeprazole magnesium dihydrate CRS | 15 mg | 217087-10-0 | |
| Y0002075 | Esomeprazole sodium CRS | 60 mg | 161796-78-7 | |
| Y0001028 | Esomeprazole magnesium trihydrate CRS | 5 mg | 217087-09-7 | |
| Y0000749 | Essential oil CRS | 1000 mg | n/a | |
| E1600000 | Estradiol benzoate CRS | 250 mg | 50-50-0 | |
| Y0000852 | Estradiol benzoate for system suitability CRS | 10 mg | 50-50-0 | |
| E1620000 | Estradiol hemihydrate CRS | 100 mg | 50-28-2 | |
| Y0000314 | Estradiol for peak identification CRS | 15 mg | 50-28-2 | |
| Y0000046 | Estradiol valerate CRS | 120 mg | 979-32-8 | |
| Y0001823 | Estradiol valerate for system suitability CRS | 10 mg | 979-32-8 | |
| E1680000 | Estriol CRS | 70 mg | 50-27-1 | |
| Y0001971 | Estriol for system suitability CRS | 10 mg | 50-27-1 | |
| E1700000 | Estrone CRS | 20 mg | 53-16-7 | |
| E1800000 | Etacrynic acid CRS | 100 mg | 58-54-8 | |
| Y0001263 | Etacrynic acid for system suitability CRS | 10 mg | 58-54-8 | |
| E1830000 | Etamsylate CRS | 10 mg | 2624-44-4 | |
| Y0001969 | Etanercept CRS | 25 mg | 185243-69-0 | |
| Y0002042 | Etanercept BRP | 50 mg | 185243-69-0 | |
| E1840000 | Ethacridine lactate monohydrate CRS | 50 mg | 6402-23-9 | |
| E1850000 | Ethambutol hydrochloride CRS | 250 mg | 1070-11-7 | |
| Y0000803 | Ethambutol for system suitability CRS | 10 mg | 1070-11-7 | |
| A1202800 | Ethanol (anhydrous) - reference spectrum | n/a | n/a | |
| E1860100 | Ethanol 96% - reference spectrum | n/a | n/a | |
| Y0002267 | Ethanolamine CRS | 30 mg | 141-43-5 | |
| E1900000 | Ethinylestradiol CRS | 200 mg | 57-63-6 | |
| Y0001124 | Ethinylestradiol for system suitability CRS | 1.01 mg | 57-63-6 | |
| E2000000 | Ethionamide CRS | 100 mg | 536-33-4 | |
| Y0001686 | Ethionamide for system suitability CRS | 10 mg | 536-33-4 | |
| E2150000 | Ethosuximide CRS | 55 mg | 77-67-8 | |
| E2250000 | Ethosuximide impurity A CRS | 30 mg | n/a | |
| E2195000 | Ethyl acetate - reference spectrum | n/a | n/a | |
| Y0000617 | Ethyl indole-3-carboxylate CRS | 10 mg | 776-41-0 | |
| E2425000 | Ethyl parahydroxybenzoate CRS | 150 mg | 120-47-8 | |
| Y0001633 | Ethylcellulose CRS | 100 mg | 9004-57-3 | |
| E2202000 | 1-N-Ethylgaramine sulfate CRS | 60 mg | n/a | |
| E2205500 | 1,1'-Ethylidenebistryptophan CRS | 0.002 mg | 132685-02-0 | |
| E2300000 | Ethylmorphine hydrochloride - reference spectrum | n/a | n/a | |
| E2400000 | Ethylnicotinamide CRS | 100 mg | n/a | |
| Y0000572 | Etidronate disodium CRS | 10 mg | 7414-83-7 | |
| E2450000 | Etifenin CRS | 25 mg | 63245-28-3 | |
| E2451000 | Etilefrine hydrochloride CRS | 75 mg | 943-17-9 | |
| E2451010 | Etilefrine impurity A CRS | 20 mg | n/a | |
| E2470000 | Etodolac CRS | 60 mg | 41340-25-4 | |
| E2470050 | Etodolac impurity H CRS | 10 mg | 41340-36-7 | |
| Y0000768 | Etodolac for peak identification CRS | 0.41 mg | 41340-25-4 | |
| E2499900 | Etofenamate CRS | 50 mg | 30544-47-9 | |
| E2499914 | Etofenamate impurity G CRS | 25 mg | n/a | |
| E2499901 | Etofenamate for peak identification CRS | 20 mg | 30544-47-9 | |
| E2500000 | Etofylline CRS | 100 mg | 519-37-9 | |
| E2503000 | Etomidate CRS | 50 mg | 33125-97-2 | |
| E2503004 | Etomidate impurity B CRS | 25 mg | 5377-20-8 | |
| E2600000 | Etoposide CRS | 150 mg | 33419-42-0 | |
| Y0001365 | Etoposide for system suitability CRS | 10 mg | 33419-42-0 | |
| Y0001747 | Exemestane CRS | 70 mg | 107868-30-4 | |
| Y0002156 | Exemestane for peak identification CRS | 10 mg | n/a | |
| Y0001605 | Eucommia bark HRS | 2100 mg | N/Ap | |
| E5000000 | Eugenol CRS | 500 µl | 97-53-0 | |
| Y0001756 | Exemestane for system suitability CRS | 10 mg | 107868-30-4 | |
| Y0002048 | Everolimus CRS | 70 mg | 159351-69-6 | |
| Y0002063 | Everolimus for impurity C identification CRS | 10 mg | n/a | |
| Y0002061 | Everolimus for system suitability CRS | 10 mg | 159351-69-6 | |
| Y0001908 | Evodiamine CRS | 15 mg | 518-17-2 | |
| F0005000 | Famotidine CRS | 110 mg | 76824-35-6 | |
| Y0000409 | Famotidine impurity D CRS | 10 mg | n/a | |
| Y0000382 | Famotidine for system suitability CRS | 15 mg | 76824-35-6 | |
| Y0000556 | Febantel CRS | 150 mg | 58306-30-2 | |
| Y0000660 | Febantel for system suitability CRS | 10 mg | 58306-30-2 | |
| Y0000731 | Felbinac CRS | 10 mg | 5728-52-9 | |
| Y0000732 | Felbinac impurity A CRS | 20 mg | 92-91-1 | |
| F0030000 | Felodipine CRS | 100 mg | 72509-76-3 | |
| Y0000415 | Felypressin CRS | 0.994 mg | 56-59-7 | |
| F0040000 | Fenbendazole CRS | 150 mg | 43210-67-9 | |
| F0040010 | Fenbendazole impurity A CRS | 20 mg | n/a | |
| F0040020 | Fenbendazole impurity B CRS | 25 mg | n/a | |
| F0041000 | Fenbufen CRS | 100 mg | 36330-85-5 | |
| F0048000 | Fenofibrate CRS | 100 mg | 49562-28-9 | |
| F0048005 | Fenofibrate impurity A CRS | 15 mg | 42019-78-3 | |
| F0048010 | Fenofibrate impurity B CRS | 10 mg | 42017-89-0 | |
| F0048035 | Fenofibrate impurity G CRS | 25 mg | 217636-48-1 | |
| Y0002102 | Fenoterol for system suitability CRS | 0.13 mg | | |
| F0050000 | Fenoterol hydrobromide CRS | 20 mg | 1944-12-3 | |
| Y0001985 | Fentanyl CRS - * narc | 30 mg | 437-38-7 | |
| Y0001963 | Fentanyl citrate CRS - * narc | 15 mg | 990-73-8 | |
| Y0001967 | Fentanyl impurity mixture - * narc CRS | 0.02 mg | | |
| F0060000 | Fenticonazole nitrate CRS | 50 mg | 73151-29-8 | |
| F0060040 | Fenticonazole impurity D CRS | 0.01 mg | N/A | |
| F0100000 | Ferrous gluconate CRS | 100 mg | 299-29-6 | |
| Y0001013 | Ferulic acid CRS | 20 mg | 537-98-4 | |
| Y0000789 | Fexofenadine hydrochloride CRS | 60 mg | 153439-40-8 | |
| Y0000751 | Fexofenadine impurity A CRS | 5 mg | N/A | |
| Y0000752 | Fexofenadine impurity B CRS | 0.01 mg | N/A | |
| Y0000753 | Fexofenadine impurity C CRS | 5 mg | N/A | |
| Y0001173 | Filgrastim CRS | 0.3 mL | 143011-72-7 | |
| Y0000090 | Finasteride CRS | 130 mg | 98319-26-7 | |
| Y0001604 | Finasteride for peak identification CRS | 15 mg | n/a | |
| Y0002055 | Fingolimod hydrochloride CRS | 110 mg | 162359-56-0 | |
| Y0002058 | Fingolimod for system suitability CRS | 10 mg | N/A | |
| Y0001968 | Fipronil CRS | 170 mg | 120068-37-3 | |
| Y0001990 | Fipronil for system suitability CRS | 5 mg | 120068-37-3 | |
| Y0000736 | Flavoxate hydrochloride CRS | 10 mg | 3717-88-2 | |
| Y0000737 | Flavoxate impurity A CRS | 15 mg | N/A | |
| Y0000738 | Flavoxate impurity B CRS | 10 mg | N/A | |
| F0120000 | Flecainide acetate CRS | 10 mg | 54143-56-5 | |
| F0120005 | Flecainide impurity A CRS | 20 mg | n/a | |
| F0120010 | Flecainide impurity B CRS | 35 mg | n/a | |
| Y0001274 | Flecainide for system suitability CRS | 10 mg | 54143-56-5 | |
| Y0001606 | Fleeceflower root HRS | 300 mg | n/a | |
| Y0000138 | Flubendazole CRS | 25 mg | 31430-15-6 | |
| Y0000139 | Flubendazole for system suitability CRS | 20 mg | 31430-15-6 | |
| Y0000892 | Flucloxacillin magnesium octahydrate CRS | 5 mg | 58486-36-5 | |
| Y0000889 | Flucloxacillin impurity C CRS | 5 mg | 551-16-6 | |
| Y0000890 | Flucloxacillin impurity D CRS | 5 mg | 3919-74-2 | |
| Y0000891 | Flucloxacillin impurity E CRS | 5 mg | n/a | |
| F0150000 | Flucloxacillin sodium CRS | 250 mg | 1847-24-1 | |
| Y0000557 | Fluconazole CRS | 50 mg | 86386-73-4 | |
| Y0000573 | Fluconazole impurity B CRS | 15 mg | n/a | |
| Y0000574 | Fluconazole impurity C CRS | 20 mg | n/a | |
| Y0000558 | Fluconazole for peak identification CRS | 10 mg | 86386-73-4 | |
| F0175000 | Flucytosine CRS | 50 mg | 2022-85-7 | |
| Y0001262 | Flucytosine for system suitability CRS | 0.3 mg | 2022-85-7 | |
| Y0002256 | Fludarabine for peak identification | 15 mg | 75607-67-9 | |
| Y0001536 | Fludarabine for system suitability CRS | 20 mg | 75607-67-9 | |
| Y0000419 | Fludarabine phosphate CRS | 120 mg | 75607-67-9 | |
| F0180000 | Fludrocortisone acetate CRS | 100 mg | 514-36-3 | |
| F0188000 | Flumazenil - reference spectrum | n/a | n/a | |
| Y0000335 | Flumazenil impurity B CRS | 5 mg | 131666-45-0 | |
| F0189000 | Flumequine CRS | 60 mg | 42835-25-6 | |
| F0189020 | Flumequine impurity B CRS | 0.1 mg | n/a | |
| F0188500 | Flumetasone pivalate CRS | 100 mg | 2002-29-1 | |
| F0189900 | Flunarizine dihydrochloride CRS | 50 mg | 30484-77-6 | |
| Y0000265 | Flunarizine dihydrochloride - reference spectrum | n/a | n/a | |
| Y0000266 | Flunarizine dihydrochloride for system suitability CRS | 20 mg | 30484-77-6 | |
| F0190000 | Flunitrazepam CRS - * psy | 100 mg | 1622-62-4 | |
| Y0000169 | Flunitrazepam - reference spectrum | n/a | n/a | |
| Y0000443 | Flunixin meglumine CRS | 10 mg | 42461-84-7 | |
| Y0000444 | Flunixin impurity B CRS | 10 mg | 54396-44-0 | |
| Y0000445 | Flunixin impurity C CRS | 55 mg | 1452-94-4 | |
| F0200000 | Fluocinolone acetonide CRS | 110 mg | 67-73-2 | |
| Y0001711 | Fluocinolone acetonide for peak identification CRS | 10 mg | | |
| Y0001710 | Fluocinolone acetonide for system suitability CRS | 10 mg | 67-73-2 | |
| Y0002141 | Fluocortolone pivalate for ID and assay CRS | 110 mg | n/a | |
| Y0002157 | Fluocortolone pivalate for system suitability CRS | 10 mg | | |
| Y0000796 | Fluorescein CRS | 120 mg | 2321-07-5 | |
| Y0000804 | Fluorescein impurity C CRS | 0.01 mg | 2513-33-9 | |
| F0245000 | Fluoresceine sodium - reference spectrum | n/a | n/a | |
| F0250000 | Fluorouracil CRS | 40 mg | 51-21-8 | |
| Y0000762 | Fluorouracil impurity A CRS | 10 mg | 67-52-7 | |
| Y0000763 | Fluorouracil impurity B CRS | 15 mg | 496-76-4 | |
| Y0000764 | Fluorouracil impurity C CRS | 20 mg | 66-22-8 | |
| Y0000765 | Fluorouracil impurity F CRS | 10 mg | 56177-80-1 | |
| Y0000791 | Fluorouracil impurity mixture CRS | 0.0002 mg | N/A | |
| F0253000 | Fluoxetine hydrochloride CRS | 250 mg | 56296-78-7 | |
| Y0002219 | Fluoxetine hydrochloride for ID and assay CRS | 250 mg | 56296-78-7 | |
| Y0002201 | Fluoxetine impurity A CRS | 15 mg | | |
| F0253020 | Fluoxetine impurity B CRS | 5 mg | 23580-89-4 | |
| F0253030 | Fluoxetine impurity C CRS | 5 mg | 79088-29-2 | |
| Y0000064 | Flupentixol dihydrochloride CRS | 100 mg | 2413-38-9 | |
| Y0002094 | Flupentixol for system suitability CRS | 1.01 mg | n/a | |
| F0260000 | Fluphenazine decanoate CRS | 100 mg | 5002-47-1 | |
| F0280000 | Fluphenazine dihydrochloride CRS | 50 mg | 146-56-5 | |
| Y0000708 | Fluphenazine impurity mixture CRS | 0.07 mg | N/A | |
| Y0000009 | Fluphenazine enantate CRS | 100 mg | 2746-81-8 | |
| Y0000298 | Fluphenazine octanoate CRS | 20 mg | 5002-47-1 | |
| Y0000299 | Fluphenazine sulfoxide CRS | 15 mg | 1674-76-6 | |
| Y0000211 | Flurazepam monohydrochloride - reference spectrum | n/a | n/a | |
| F0285200 | Flurbiprofen CRS | 50 mg | 5104-49-4 | |
| F0285202 | Flurbiprofen impurity A CRS | 25 mg | 6341-72-6 | |
| Y0000236 | Fluspirilene CRS | 20 mg | 1841-19-6 | |
| Y0000375 | Fluspirilene impurity C CRS | 10 mg | n/a | |
| F0285600 | Flutamide CRS | 100 mg | 13311-84-7 | |
| Y0001591 | Flutamide for system suitability CRS | 10 mg | N/Ap. | |
| Y0000284 | Fluticasone propionate CRS | 100 mg | 80474-14-2 | |
| Y0001754 | Fluticasone propionate for impurity C identification CRS | 5 mg | 80474-14-2 | |
| Y0000221 | Fluticasone impurity D CRS | 5 mg | N/A | |
| Y0001755 | Fluticasone propionate for impurity G identification CRS | 5 mg | 80474-14-2 | |
| Y0002249 | Fluticasone propionate for system suitability CRS | 15 mg | n/a | |
| F0290000 | Flutrimazole CRS | 100 mg | 119006-77-8 | |
| F0290010 | Flutrimazole impurity B CRS | 60 mg | n/a | |
| Y0001090 | Fluvastatin sodium CRS | 110 mg | 93957-55-2 | |
| Y0001082 | Fluvastatin for system suitability CRS | 0.5 mg | 93957-55-2 | |
| Y0000854 | Fluvoxamine maleate CRS | 5 mg | 61718-82-9 | |
| Y0000853 | Fluvoxamine for system suitability CRS | 1 mg | 61718-82-9 | |
| Y0000916 | Fluvoxamine impurity D CRS | 10 mg | n/a | |
| Y0000386 | Foeniculin for peak identification CRS | 100 mg | 68952-43-2 | |
| F0300000 | Folic acid CRS | 310 mg | 59-30-3 | |
| Y0001980 | Folic acid for impurity I identification CRS | 10 mg | 293629 | |
| Y0001979 | Folic acid for system suitability CRS | 10 mg | n/a | |
| Y0001242 | Folic acid impurity A CRS | 25 mg | 4271-30-1 | |
| Y0001243 | Folic acid impurity D CRS | 15 mg | 119-24-4 | |
| Y0001629 | Follitropin CRS | 0.2 mg | N/A | |
| Y0001627 | Follitropin for peptide mapping and glycan analysis CRS | 0.5 mL | N/A | |
| F0372000 | Formoterol fumarate dihydrate CRS | 10 mg | 183814-30-4 | |
| Y0001970 | Formic acid CRS | 0.5 mL | 64-18-6 | |
| Y0000339 | Formoterol for impurity I identification CRS | 10 mg | 43229-80-7 | |
| Y0000340 | Formoterol fumarate for system suitability CRS | 10 mg | 43229-80-7 | |
| Y0002226 | Forsythoside A CRS | 20 mg | 79916-77-1 | |
| F0389000 | Foscarnet sodium hexahydrate CRS | 50 mg | 34156-56-4 | |
| F0389004 | Foscarnet impurity B CRS | 10 mg | n/a | |
| Y0001222 | Foscarnet impurity D CRS | 50 mg | 1474-78-8 | |
| Y0001213 | Foscarnet impurity mixture CRS | 0.012 mg | n/a | |
| Y0000782 | Fosfomycin calcium CRS | 10 mg | 26469-67-0 | |
| F0399950 | Fosfomycin sodium - reference spectrum | n/a | n/a | |
| F0400000 | Fosfomycin trometamol CRS | 1500 mg | 78964-85-9 | |
| Y0001227 | Fosinopril sodium CRS | 60 mg | 88889-14-9 | |
| Y0001228 | Fosinopril impurity A CRS | 5 mg | n/a | |
| Y0001229 | Fosinopril impurity B CRS | 5 mg | n/a | |
| Y0001230 | Fosinopril impurity C CRS | 10 mg | n/a | |
| Y0001231 | Fosinopril impurity D CRS | 10 mg | n/a | |
| Y0001232 | Fosinopril impurity I CRS | 5 mg | 123599-82-6 | |
| Y0001233 | Fosinopril impurity K CRS | 5 mg | n/a | |
| Y0001212 | Fosinopril impurity mixture CRS | 0.02 mg | n/a | |
| F0450000 | Framycetin sulfate CRS | 25 mg | 4146-30-9 | |
| F0550000 | Fructose CRS | 100 mg | 57-48-7 | |
| Y0001399 | Fulvestrant CRS | 130 mg | 129453-61-8 | |
| Y0001413 | Fulvestrant for system suitability CRS | 40 mg | 129453-61-8 | |
| F0600000 | Fumaric acid CRS | 120 mg | 110-17-8 | |
| F0700000 | Furosemide CRS | 100 mg | 54-31-9 | |
| F0702000 | Furosemide impurity A CRS | 5 mg | 4818-59-1 | |
| Y0001493 | Furosemide for peak identification CRS | 10 mg | 54-31-9 | |
| Y0001411 | Fusidic acid CRS | 10 mg | 6990-06-3 | |
| Y0001394 | Fusidic acid for peak identification CRS | 5 mg | 6990-06-3 | |
| Y0001384 | Fusidic acid impurity mixture CRS | 0.048 mg | n/a | |
| Y0001280 | Gabapentin CRS | 400 mg | 60142-96-3 | |
| Y0001281 | Gabapentin impurity A CRS | 20 mg | 64744-50-9 | |
| Y0001348 | Gabapentin impurity B CRS | 20 mg | 133481-09-1 | |
| Y0001349 | Gabapentin impurity D CRS | 20 mg | n/a | |
| Y0001803 | Gadobutrol monohydrate CRS | 210 mg | 198637-52-4 | |
| Y0001804 | Gadobutrol for peak identification CRS | 20 mg | 198637-52-4 | |
| Y0001875 | Gadodiamide CRS | 300 mg | 131410-48-5 | |
| Y0001876 | Gadodiamide impurity A CRS | 15 mg | N/A | |
| Y0001877 | Gadodiamide impurity B CRS | 15 mg | N/A | |
| G0049000 | Galactitol CRS | 50 mg | 608-66-2 | |
| G0050000 | Galactose CRS | 100 mg | 59-23-4 | |
| Y0001279 | Galantamine hydrobromide CRS | 10 mg | 1953-04-4 | |
| Y0001190 | Galantamine natural for system suitability CRS | 10 mg | 1953-04-4 | |
| Y0001201 | Galantamine racemic mixture CRS | 10 mg | 193146-85-9 | |
| Y0001191 | Galantamine synthetic for system suitability CRS | 5 mg | 1953-04-4 | |
| Y0001936 | (-)-Epigallocatechin-3-O-gallate CRS | 50 mg | 989-51-5 | |
| G0150000 | Gammacyclodextrin CRS | 120 mg | 17465-86-0 | |
| Y0001129 | Ganciclovir CRS | 120 mg | 82410-32-0 | |
| Y0001144 | Ganciclovir impurity mixture CRS | 0.005 mg | n/a | |
| Y0002190 | Ganoderic acid A CRS | 20 mg | 81907-62-2 | |
| Y0002209 | Ganoderma dry extract for system suitability HRS | 210 mg | | |
| Y0001834 | Gastrodin CRS | 15 mg | 62499-27-8 | |
| Y0001813 | Gefitinib CRS | 110 mg | 184475-35-2 | |
| Y0001809 | Gefitinib for system suitability CRS | 0.351 mg | 184475-35-2 | |
| Y0000675 | Gemcitabine hydrochloride CRS | 50 mg | 122111-03-9 | |
| Y0000676 | Gemcitabine impurity A CRS | 20 mg | 71-30-7 | |
| Y0001682 | Gemcitabine impurity C CRS | 25 mg | N/A | |
| Y0000513 | Gemfibrozil CRS | 5 mg | 25812-30-0 | |
| Y0000514 | Gemfibrozil for system suitability CRS | 0.196 mg | 25812-30-0 | |
| Y0001835 | Geniposide CRS | 15 mg | 24512-63-8 | |
| G0200000 | Gentamicin sulfate CRS | 25 mg | 1405-41-0 | |
| Y0001363 | Gentamicin for peak identification CRS | 10 mg | 1405-41-0 | |
| Y0001112 | Gestodene CRS | 130 mg | 60282-87-3 | |
| Y0001116 | Gestodene impurity I CRS | 0.01 mg | n/a | |
| Y0001110 | Gestodene for system suitability CRS | 10 mg | 60282-87-3 | |
| Y0001012 | Ginkgo dry extract for peak identification CRS | 150 mg | n/a | |
| Y0001010 | Ginkgolic acids CRS | 50 mg | n/a | |
| Y0001029 | Ginseng dry extract HRS | 500 mg | N/A | |
| Y0001347 | Ginsenoside Rb1 CRS | 30 mg | 41753-43-9 | |
| Y0002096 | Ginsenoside Rg1 CRS | 15 mg | 22427-39-0 | |
| G0300000 | Gitoxin CRS | 30 mg | 4562-36-1 | |
| G0325000 | Glibenclamide CRS | 50 mg | 10238-21-8 | |
| G0325010 | Glibenclamide impurity A CRS | 10 mg | 16673-34-0 | |
| Y0000242 | Glibenclamide impurity B CRS | 10 mg | n/a | |
| Y0001511 | Glibenclamide for peak identification CRS | 30 mg | 10238-21-8 | |
| Y0001406 | Glucosamine hydrochloride CRS | 15 mg | 66-84-2 | |
| G0326000 | Gliclazide CRS | 20 mg | 21187-98-4 | |
| G0326004 | Gliclazide impurity B CRS | 50 mg | n/a | |
| G0326012 | Gliclazide impurity F CRS | 50 mg | n/a | |
| Y0001685 | Glucosamine sulfate potassium chloride CRS | 10 mg | | |
| Y0000515 | Glimepiride CRS | 110 mg | 93479-97-1 | |
| Y0001742 | Glimepiride for impurity A identification CRS | 5 mg | N/A | |
| Y0000516 | Glimepiride for system suitability CRS | 0.012 mg | 93479-97-1 | |
| G0340000 | Glipizide CRS | 50 mg | 29094-61-9 | |
| G0342000 | Glipizide impurity A CRS | 15 mg | n/a | |
| Y0000523 | Glipizide impurity C CRS | 10 mg | n/a | |
| Y0000643 | Glipizide impurity D CRS | 10 mg | n/a | |
| Y0001407 | Glucosamine sulfate sodium chloride CRS | 15 mg | 38899-05-7 | |
| Y0001381 | Glucosamine for system suitability CRS | 3 mg | 66-84-2 | |
| Y0001745 | Glucose monohydrate CRS | 750 mg | 5996-10-1 | |
| G0355000 | Glutamic acid CRS | 50 mg | 56-86-0 | |
| Y0000517 | Glutathione CRS | 10 mg | 70-18-8 | |
| G0360000 | Glutethimide CRS - * psy | 50 mg | 77-21-4 | |
| G0400000 | Glycerol (85 per cent) - reference spectrum | n/a | n/a | |
| Y0001391 | Glycerol formal CRS | 20 mg | 4740-78-7 | |
| Y0000794 | Glycerol monocaprylate CRS | 400 mg | N/A | |
| Y0000795 | Glycerol monocaprylocaprate CRS | 500 | N/A | |
| G0400006 | Glycerol monolinoleate CRS | 2000 mg | 26545-74-4 | |
| G0400007 | Glycerol mono-oleate CRS | 2500 mg | 25496-72-4 | |
| G0400008 | Glycerol monostearate 40-55 CRS | 2000 mg | 31566-31-1 | |
| Y0001786 | Glyceryl trinitrate for system suitability CRS | 0.5 mL | n/a | |
| G0400100 | Glyceryl trinitrate solution CRS | 0.5 mL | 55-63-0 | |
| G0400101 | Glyceryl trinitrate - reference spectrum | n/a | n/a | |
| G0450000 | Glycine CRS | 50 mg | 56-40-6 | |
| Y0001308 | Glycopyrronium bromide CRS | 10 mg | 51186-83-5 | |
| Y0001358 | Glycopyrronium impurity N CRS | 10 mg | N/A | |
| Y0000433 | Ammonium glycyrrhizate CRS | 70 mg | 53956-04-0 | |
| Y0001309 | Glycopyrronium for peak identification CRS | 10 mg | 51186-83-5 | |
| G0525000 | Gonadorelin CRS | 5 mg | 499785-55-6 | |
| Y0001546 | Gonadorelin for NMR identification CRS | 6 mg | 33515-09-2 | |
| Y0001942 | Gonadorelin for system suitability CRS | 1 mg | N/A | |
| Y0000125 | Goserelin CRS | 2 mg | 65807-02-5 | |
| Y0000126 | Gosereline - reference spectrum | n/a | n/a | |
| Y0001473 | Goserelin for NMR identification CRS | 14 mg | 65807-02-5 | |
| Y0000194 | Goserelin validation mixture CRS | 1 mg | n/a | |
| Y0000019 | 4-D-Ser-goserelin CRS | 0.1 mg | N/A | |
| G0550000 | Gramicidin CRS | 250 mg | 1405-97-6 | |
| Y0000396 | Granisetron hydrochloride CRS | 120 mg | 107007-99-8 | |
| Y0000477 | Granisetron impurity A CRS | 1 mg | n/a | |
| Y0000478 | Granisetron impurity B CRS | 1 mg | n/a | |
| Y0000395 | Granisetron impurity E CRS | 15 mg | 135906-03-5 | |
| Y0001935 | Green tea dry extract HRS | 110 mg | N/A | |
| Y0002044 | Griseofulvin for system suitability CRS | 10 mg | | |
| Y0002046 | Griseofulvin for LC assay and identification CRS | 110 mg | | |
| Y0000619 | Guaiacol CRS | 1500 mg | 90-05-1 | |
| G0700000 | Guaifenesin CRS | 120 mg | 93-14-1 | |
| Y0001956 | Guaifenesin for peak identification CRS | 10 mg | N/A | |
| Y0000117 | Halofantrine hydrochloride CRS | 125 mg | 36167-63-2 | |
| Y0000118 | Halofantrine impurity C CRS | 10 mg | 38492-81-8 | |
| H0100000 | Haloperidol CRS | 60 mg | 52-86-8 | |
| Y0001518 | Haloperidol for peak identification CRS | 20 mg | 52-86-8 | |
| Y0001517 | Haloperidol for system suitability CRS | 25 mg | 52-86-8 | |
| H0100100 | Haloperidol decanoate CRS | 60 mg | 74050-97-8 | |
| H0150000 | Halothane - reference spectrum | n/a | n/a | |
| Y0000673 | Harpagoside CRS | 1 mg | 19210-12-9 | |
| Y0002210 | Hawthorn dry extract for system suitability HRS | 110 mg | N/A | |
| H0200000 | Heparin sodium BRP | 1.1 mL | 9041-08-1 | |
| Y0001283 | Heparin sodium for NMR identification CRS | 50 mg | 9041-08-1 | |
| Y0001287 | Heparin calcium for NMR identification CRS | 30 mg | 37270-89-6 | |
| Y0001282 | Heparin for physico-chemical analysis CRS | 300 mg | 01/08/9041 | |
| H0185000 | Heparin Low-Molecular-Mass for assay BRP | 1 mL | n/a | |
| H0190000 | Heparin Low-Molecular-Mass for calibration CRS | 10 mg | n/a | |
| H0205010 | Hepatitis A vaccine (inactivated, adsorbed) Type B BRP | 0.5 ml | n/a | |
| Y0001192 | Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP | 1 mL | n/a | |
| Y0001624 | Hepatitis A virus Coating Reagent for ELISA - BRR | 1 mL | n/a | |
| Y0001623 | Hepatitis A vaccine ELISA detection antibodies set - BRR | 295 µL | N/A | |
| Y0001872 | Hepatitis A virus RNA for NAT testing BRP | 45 mg | N/A | |
| Y0000389 | Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) | 0.5 ml | N/Ap | |
| H0210010 | Hepatitis B vaccine (rDNA) BRP method B | 1 ml | n/a | |
| H0215000 | Hepatitis C Virus RNA for NAT testing BRP | 40 mg | N/A | |
| Y0001873 | Hepatitis E virus RNA for NAT testing BRP | 45 mg | N/A | |
| Y0000063 | Heptaminol hydrochloride CRS | 120 mg | 543-15-7 | |
| Y0000057 | Heptaminol impurity A CRS | 20 mg | n/a | |
| Y0001203 | Hesperidin CRS | 20 mg | 520-26-3 | |
| H0330000 | Hexamidine diisetionate CRS | 20 mg | 659-40-5 | |
| H0325000 | Hexetidine CRS | 100 mg | 141-94-6 | |
| H0420000 | Hexylresorcinol CRS | 100 mg | 136-77-6 | |
| Y0001746 | Hexylresorcinol for system suitability CRS | 1 mg | 136-77-6 | |
| Y0002130 | Hibifolin CRS | 15 mg | 55366-56-8 | |
| H0500000 | Hide powder CRS | 500 mg | n/a | |
| Y0001779 | Histamine CRS | 15 mg | 51-45-6 | |
| H0600000 | Histamine dihydrochloride CRS | 250 mg | 56-92-8 | |
| H0750000 | Histidine CRS | 25 mg | 71-00-1 | |
| H0755000 | Histidine hydrochloride monohydrate CRS | 100 mg | 5934-29-2 | |
| H0800000 | Homatropine hydrobromide CRS | 100 mg | 51-56-9 | |
| H0830000 | Homatropine methylbromide CRS | 25 mg | 80-49-9 | |
| H0837000 | L-Homocysteine thiolactone hydrochloride - reference spectrum | n/a | n/a | |
| Y0001383 | Homatropine methylbromide for system suitability CRS | 5 mg | 80-49-9 | |
| Y0001290 | Honokiol CRS | 20 mg | 35354-74-6 | |
| H0900000 | Human albumin for electrophoresis BRP | 50 mg | 70024-90-7 | |
| Y0001913 | Human albumin (molecular size) BRP | 50 mg | 70024-90-7 | |
| Y0000219 | Human anti-D immunoglobulin BRP | 40 mg | n/a | |
| Y0000667 | Human coagulation factor VII concentrate BRP | 25 mg | 9001-25-6 | |
| Y0001663 | Human coagulation factor VIIa (rDNA) CRS | 42 mg | 102786-61-8 | |
| H0920000 | Human coagulation factor VIII concentrate BRP | 40 mg | 9001-27-8 | |
| H0920500 | Human coagulation factor IX concentrate BRP | 30 mg | 9001-28-4 | |
| Y0001659 | Human coagulation factor IX (rDNA) CRS | 10 mg | N/A | |
| Y0000191 | Human glucagon CRS | 2.94 mg | 9007-92-5 | |
| H0950000 | Human hepatitis A immunoglobulin BRP | 10 mg | n/a | |
| Y0001414 | Human Hepatitis B immunoglobulin BRP | 100 mg | n/a | |
| Y0000488 | Human immunoglobulin (molecular size) BRP | 10 mL | 9007-83-4 | |
| Y0001994 | Human immunoglobulin for anticomplementary activity BRP | 10 g | N/A | |
| H1000000 | Human immunoglobulin for electrophoresis BRP | 50 mg | 9007-83-4 | |
| Y0001966 | Human immunoglobulin for Fc function BRP | 10 mL | N/A | |
| H1005000 | Human Plasma Pools for NAT validation CRS | 3502 mg | n/a | |
| H1100000 | Human rabies immunoglobulin BRP | 170 mg | n/a | |
| H1110000 | Human tetanus immunoglobulin BRP | 50 mg | n/a | |
| Y0000502 | Human vaccinia immunoglobulin BRP | 1 ml | N/A | |
| H1115000 | Hyaluronidase BRP | 50 mg | 9001-54-1 | |
| H1120000 | Hydralazine hydrochloride CRS | 20 mg | 304-20-1 | |
| Y0001151 | Hydrastine hydrochloride CRS | 25 mg | 5936-28-7 | |
| H1200000 | Hydrochlorothiazide CRS | 300 mg | 58-93-5 | |
| Y0001494 | Hydrochlorothiazide for peak identification CRS | 10 mg | 58-93-5 | |
| Y0000646 | Hydrocodone hydrogen tartrate 2.5-hydrate CRS - * narc | 10 mg | 34195-34-1 | |
| Y0000710 | Hydrocodone for peak identification CRS - * narc | 10 mg | | |
| H1300000 | Hydrocortisone CRS | 100 mg | 50-23-7 | |
| Y0001092 | Hydrocortisone for peak identification CRS | 5 mg | 50-23-7 | |
| H1400000 | Hydrocortisone acetate CRS | 125 mg | 50-03-3 | |
| Y0001482 | Hydrocortisone acetate for peak identification CRS | 15 mg | 50-03-3 | |
| H1425000 | Hydrocortisone hydrogen succinate CRS | 100 mg | 2203-97-6 | |
| H1426000 | Hydrogenated wool fat CRS | 250 mg | 8031-44-5 | |
| Y0000446 | Hydromorphone hydrochloride CRS - * narc | 10 mg | 71-68-1 | |
| B0650000 | Hydrous benzoyl peroxide - reference spectrum | n/a | n/a | |
| H1428000 | Hydroxocobalamin CRS | 10 mg | 13422-51-0 | |
| Y0000119 | Hydroxycarbamide CRS | 360 mg | 127-07-1 | |
| Y0001841 | Hydroxychloroquine for system suitability CRS | 15 mg | 747-36-4 | |
| Y0001839 | Hydroxychloroquine sulfate CRS | 70 mg | 747-36-4 | |
| H1429400 | Hydroxyethyl salicylate CRS | 125 mg | 87-28-5 | |
| Y0001322 | Hydroxyethyl starch (high Mw) CRS | 800 mg | 9005-27-0 | |
| Y0001277 | Hydroxyethyl starch (medium MW) CRS | 1200 mg | 9005-27-0 | |
| H1430000 | D-alpha-(4-hydroxyphenyl)glycine CRS | 25 mg | 22818-40-2 | |
| Y0001951 | Hydroxyethylcellulose CRS | 60 mg | 9004-62-0 | |
| Y0000186 | Hydroxypropylbetadex CRS | 200 mg | 128446-35-5 | |
| Y0001720 | Hydroxypropylcellulose CRS | 20 mg | 9004-64-2 | |
| Y0001798 | Low-substituted hydroxypropylcellulose CRS | 50 mg | 9004-64-2 | |
| H1435000 | Hydroxyzine hydrochloride CRS | 600 mg | 2192-20-3 | |
| Y0000011 | Hymecromone CRS | 100 mg | 90-33-5 | |
| Y0000012 | Hymecromone impurity A CRS | 25 mg | 108-46-3 | |
| Y0000013 | Hymecromone impurity B CRS | 25 mg | n/a | |
| Y0000483 | Hyoscine CRS | 10 mg | 51-34-3 | |
| Y0000484 | Hyoscine impurity A CRS | 15 mg | n/a | |
| H1450000 | Hyoscine butylbromide CRS | 20 mg | 149-64-4 | |
| Y0001983 | Hyoscine butylbromide for system suitability CRS | 10 mg | N/A | |
| H1500000 | Hyoscine hydrobromide CRS | 50 mg | 6533-68-2 | |
| Y0000448 | Hyoscine hydrobromide impurity B CRS | 10 mg | n/a | |
| H1600000 | Hyoscyamine sulfate CRS | 100 mg | 620-61-1 | |
| Y0000449 | Hyoscyamine impurity E CRS | 10 mg | n/a | |
| Y0000915 | Hypromellose phthalate CRS | 10 mg | 9050-31-1 | |
| Y0002248 | Ibandronate sodium monohydrate CRS | 15 mg | | |
| I0020000 | Ibuprofen CRS | 150 mg | 15687-27-1 | |
| B1220000 | Ibuprofen impurity B CRS | 1.15 mL | N/A | |
| Y0000140 | Ibuprofen impurity F CRS | 5 mg | n/a | |
| Y0000881 | Ibuprofen for peak identification CRS | 0.09 mg | 15687-27-1 | |
| I0050000 | Idoxuridine CRS | 50 mg | 54-42-2 | |
| I0060000 | Ifosfamide CRS | 50 mg | 3778-73-2 | |
| I0060100 | Ifosfamide - reference spectrum | n/a | n/a | |
| I0060002 | Ifosfamide impurity A CRS | 100 mg | n/a | |
| I0060004 | Ifosfamide impurity B CRS | 40 mg | n/a | |
| I0060010 | Ifosfamide impurity E CRS | 40 mg | N/A | |
| I0060012 | Ifosfamide impurity F CRS | 10 mg | 40722-73-4 | |
| Y0001691 | Imatinib mesilate CRS | 120 mg | 220127-57-1 | |
| Y0002028 | Imidacloprid CRS | 150 mg | 138261-41-3 | |
| Y0001695 | Imatinib impurity A CRS | 0.03 mg | N/A | |
| Y0002030 | Imidacloprid for system suitability CRS | 15 mg | | |
| Y0001693 | Imatinib impurity F CRS | 10 mg | N/A | |
| Y0001694 | Imatinib impurity H CRS | 130 mg | 350-03-8 | |
| Y0001692 | Imatinib for system suitability CRS | 5 mg | 220127-57-1 | |
| I0086000 | Imidazole CRS | 60 mg | 288-32-4 | |
| I0090000 | Imipenem CRS | 70 mg | 74431-23-5 | |
| I0100000 | Imipramine hydrochloride CRS | 50 mg | 113-52-0 | |
| Y0001689 | Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP | 50 mg | N/A | |
| Y0001688 | Immunoglobulin (anti-A, anti-B antibodies test Positive control) BRP | 46 mg | N/A | |
| Y0000893 | Imipramine for system suitability CRS | 10 mg | 113-52-0 | |
| Y0001153 | Immunoglobulin for anti-A, anti-B antibodies limit test BRP | 45 mg | n/a | |
| Y0000540 | Immunoglobulin panel for anti-D antibodies test BRP | 2000 mg | 9007-83-4 | |
| Y0001205 | Imperatorin CRS | 20 mg | 482-44-0 | |
| I0150000 | Indapamide CRS | 150 mg | 26807-65-8 | |
| Y0001828 | Indapamide Impurity C CRS | 25 mg | 85392-00-3 | |
| I0150020 | Indapamide impurity B CRS | 10 mg | 63968-75-2 | |
| Y0001752 | Indigo CRS | 15 mg | 482-89-3 | |
| Y0000788 | Indinavir CRS | 100 mg | 157810-81-6 | |
| Y0000880 | Indinavir sulfate - reference spectrum | n/a | n/a | |
| Y0000746 | Indinavir for system suitability CRS | 20 mg | 157810-81-6 | |
| I0200000 | Indometacin CRS | 70 mg | 53-86-1 | |
| Y0001640 | Indometacin impurity mixture CRS | 0.002 mg | 53-86-1 | |
| Y0002047 | Infliximab CRS | 100 mg | 170277-31-3 | |
| Y0000349 | Insulin aspart CRS | 8 mg | 116094-23-6 | |
| Y0002110 | Infliximab BRP | 25 mg | | |
| I0305000 | Insulin (bovine) CRS | 7.99 mg | 11070-73-8 | |
| Y0001542 | Insulin glargine CRS | 15 mg | 160337-95-1 | |
| Y0001544 | Insulin glargine for peak identification CRS | 3.2 mg | 160337-95-1 | |
| I0310000 | Insulin (human) CRS | 8 mg | 11061-68-0 | |
| Y0000348 | Insulin lispro CRS | 6 mg | 133107-64-9 | |
| I0320000 | Insulin (porcine) CRS | 9.2 mg | 12584-58-6 | |
| Y0001717 | Insulin porcine for system suitability CRS | 9 mg | 12584-58-6 | |
| I0320301 | Interferon alfa-2b CRS | 200 µL | 99210-65-8 | |
| Y0001101 | Interferon beta-1a CRS | 0.6 mL | 145258-61-3 | |
| I0320330 | Interferon gamma-1b CRS | 0.5 mL | 98059-61-1 | |
| Y0001664 | Interferon gamma-1b for system suitability CRS | 0.6 mg | 98059-61-1 | |
| I0328000 | Iobenguane sulfate CRS | 25 mg | 87862-25-7 | |
| Y0000839 | Iobenguane sulfate - reference spectrum | n/a | n/a | |
| Y0001294 | Iodixanol CRS | 60 mg | 92339-11-2 | |
| Y0001292 | Iodixanol impurity C CRS | 10 mg | n/a | |
| Y0001291 | Iodixanol impurity E CRS | 10 mg | n/a | |
| Y0001293 | Iodixanol impurity H CRS | 10 mg | n/a | |
| I0320800 | Iohexol CRS | 150 mg | 66108-95-0 | |
| I0320810 | Iohexol impurity A CRS | 50 mg | N/A | |
| I0320820 | Iohexol impurity J CRS | 125 mg | N/A | |
| Y0000672 | Iohexol for peak identification CRS | 10 mg | 66108-95-0 | |
| I0329000 | Iopamidol CRS | 50 mg | 60166-93-0 | |
| I0329010 | Iopamidol impurity A CRS | 15 mg | n/a | |
| Y0000406 | Iopamidol impurity H CRS | 15 mg | n/a | |
| I0330000 | Iopanoic acid CRS | 100 mg | 96-83-3 | |
| Y0001297 | Iopentol CRS | 10 mg | 89797-00-2 | |
| Y0001020 | Iopromide CRS | 100 mg | 73334-07-3 | |
| Y0001077 | Iopromide impurity A CRS | 0.125 mg | n/a | |
| Y0001021 | Iopromide for system suitability 1 CRS | 5 mg | 73334-07-3 | |
| Y0001022 | Iopromide for system suitability 2 CRS | 5 mg | 73334-07-3 | |
| Y0000555 | Iotrolan CRS | 100 mg | 79770-24-4 | |
| Y0000658 | Iotrolan for system suitability CRS | 5 mg | 79770-24-4 | |
| Y0000141 | Ioxaglic acid CRS | 125 mg | 59017-64-0 | |
| Y0000142 | Ioxaglic acid impurity A CRS | 20 mg | 22871-58-5 | |
| I0360000 | Ipratropium bromide CRS | 100 mg | 66985-17-9 | |
| I0361000 | Ipratropium impurity B CRS | 10 mg | 58073-59-9 | |
| Y0000276 | Ipratropium impurity A CRS | 15 mg | 58005-18-8 | |
| Y0001166 | Irbesartan CRS | 60 mg | 138402-11-6 | |
| Y0001156 | Irbesartan impurity A CRS | 10 mg | n/a | |
| Y0001831 | Irinotecan for peak identification CRS | 1 mg | 136572-09-3 | |
| Y0001830 | Irinotecan for system suitability 1 CRS | 1.5 mg | 136572-09-3 | |
| Y0001833 | Irinotecan for system suitability 2 CRS | 10 mg | 136572-09-3 | |
| Y0001832 | Irinotecan hydrochloride trihydrate CRS | 170 mg | 136572-09-3 | |
| Y0001616 | Irisflorentin CRS | 15 mg | 41743-73-1 | |
| I0375000 | Isoconazole CRS | 150 mg | 27523-40-6 | |
| I0380000 | Isoconazole nitrate CRS | 150 mg | 24168-96-5 | |
| Y0000858 | Isoflurane CRS | 1.4 mL | 26675-46-7 | |
| Y0000037 | Isoflurane - reference spectrum | n/a | n/a | |
| I0460000 | Isoleucine CRS | 30 mg | 73-32-5 | |
| I0465000 | Isomalt CRS | 3000 mg | 64519-82-0 | |
| Y0000070 | Isomaltooligosaccharide CRS | 0.9 mg | n/a | |
| I0500000 | Isoniazid CRS | 100 mg | 54-85-3 | |
| I0599990 | Isoprenaline hydrochloride CRS | 50 mg | 51-30-9 | |
| Y0001577 | Isoprenaline impurity A CRS | 15 mg | 16899-81-3 | |
| I0600000 | Isoprenaline sulfate CRS | 510 mg | 6700-39-6 | |
| Y0001728 | Isopropyl alcohol CRS | 100 mg | 67-63-0 | |
| I0725000 | Isopropyl hexadecanoate CRS | 100 mg | 142-91-6 | |
| Y0001907 | Isopropyl isostearate CRS | 0.5 mL | 68171-33-5 | |
| I0750000 | Isopropyl tetradecanoate CRS | 2 mL | 110-27-0 | |
| Y0001568 | Isoquercitroside CRS | 20 mg | 482-35-9 | |
| Y0001836 | Isorhynchophylline CRS | 15 mg | 6859-01-4 | |
| I0775000 | Isosorbide dinitrate CRS | 350 mg | 87-33-2 | |
| I0775010 | Isosorbide mononitrate CRS | 150 mg | 16051-77-7 | |
| I0775020 | Isosorbide-2-nitrate CRS | 50 mg | 16106-20-0 | |
| I0800000 | Isotretinoin CRS | 20 mg | 4759-48-2 | |
| Y0002183 | Isovitexin HRS | 15 mg | 29702-25-8 | |
| I0900000 | Isoxsuprine hydrochloride CRS | 50 mg | 579-56-6 | |
| Y0000366 | Isradipine CRS | 125 mg | 75695-93-1 | |
| Y0000367 | Isradipine impurity D CRS | 5 mg | n/a | |
| I7000000 | Itraconazole CRS | 20 mg | 84625-61-6 | |
| Y0001100 | Itraconazole for system suitability CRS | 25 mg | 84625-61-6 | |
| I8000010 | Ivermectin CRS | 150 mg | 70288-86-7 | |
| Y0001592 | Ivy leaf dry extract HRS | 70 mg | N/A | |
| Y0000041 | Josamycin CRS | 150 mg | 16846-24-5 | |
| Y0001315 | Josamycin for peak identification CRS | 25 mg | 16846-24-5 | |
| Y0000042 | Josamycin propionate CRS | 150 mg | 31674-19-8 | |
| K0100000 | Kanamycin B sulfate CRS | 20 mg | 29701-07-3 | |
| K0200000 | Kanamycin monosulfate CRS | 150 mg | 25389-94-0 | |
| Y0000450 | Ketamine hydrochloride CRS - * narc | 10 mg | 1867-66-9 | |
| K0551000 | Ketamine impurity A CRS | 20 mg | n/a | |
| Y0000246 | Ketobemidone hydrochloride - reference spectrum | n/a | n/a | |
| Y0000244 | Ketobemidone impurity B CRS | 5 mg | n/a | |
| Y0000245 | Ketobemidone impurity C CRS | 5 mg | n/a | |
| K0600000 | Ketoconazole CRS | 150 mg | 65277-42-1 | |
| Y0002185 | Ketoconazole impurity mixture CRS | 0.03 mg | | |
| K2000000 | Ketoprofen CRS | 50 mg | 22071-15-4 | |
| K2000010 | Ketoprofen impurity A CRS | 10 mg | 66067-44-5 | |
| K2000015 | Ketoprofen impurity C CRS | 15 mg | 68432-95-1 | |
| Y0000486 | Ketorolac trometamol CRS | 10 mg | 74103-07-4 | |
| Y0000626 | Ketorolac trometamol for peak identification CRS | 5 mg | 74103-07-4 | |
| Y0001619 | Ketotifen hydrogen fumarate CRS | 10 mg | 34580-14-8 | |
| Y0000161 | Ketotifen impurity G CRS | 0.0225 mg | n/a | |
| Y0001617 | Ketotifen for peak identification CRS | 15 mg | N/Ap. | |
| Y0001200 | Kudzuvine root dry extract HRS | 200 mg | n/a | |
| L0050000 | Labetalol hydrochloride CRS | 120 mg | 32780-64-6 | |
| Y0001548 | Labetalol impurity A CRS | 10 mg | n/a | |
| Y0001982 | Lacosamide CRS | 150 mg | 175481-36-4 | |
| Y0001972 | Lacosamide impurity A CRS | 5 mg | N/A | |
| Y0002065 | Lacosamide impurity D CRS | 10 mg | N/A | |
| Y0001989 | Lacosamide impurity F CRS | 5 mg | n/a | |
| Y0001973 | Lacosamide for system suitability CRS | 10 mg | 175481-36-4 | |
| L0129000 | Lactitol monohydrate CRS | 60 mg | 81025-04-9 | |
| Y0000257 | Lactobionic acid CRS | 100 mg | 96-82-2 | |
| A1206000 | Lactose (anhydrous) CRS | 30 mg | 63-42-3 | |
| Y0001750 | Lactose monohydrate CRS | 100 mg | 64044-51-5 | |
| L0130000 | Lactulose CRS | 4120 mg | 4618-18-2 | |
| Y0001510 | Lactulose for peak identification CRS | 1900 mg | 4618-18-2 | |
| Y0000425 | Lamivudine CRS | 150 mg | 134678-17-4 | |
| Y0000518 | Lamivudine for system suitability 1 CRS | 10 mg | 134678-17-4 | |
| Y0000426 | Lamivudine for system suitability 2 CRS | 10.3 mg | N/A | |
| Y0001030 | Lamotrigine CRS | 10 mg | 84057-84-1 | |
| Y0001032 | Lamotrigine impurity E CRS | 15 mg | 50-45-3 | |
| Y0001031 | Lamotrigine for peak identification CRS | 20 mg | 84057-84-1 | |
| Y0001085 | Lamotrigine for system suitability CRS | 10 mg | 84057-84-1 | |
| Y0000773 | Lansoprazole CRS | 60 mg | 103577-45-3 | |
| Y0000774 | Lansoprazole for peak identification CRS | 1.01 mg | 103577-45-3 | |
| Y0002218 | Latanoprost CRS | 100 mg | 130209-82-4 | |
| Y0002243 | Latanoprost - reference spectrum | 1 uc | n/a | |
| Y0002189 | Latanoprost for system suitability CRS | 2 mg | n/a | |
| Y0002205 | Latanoprost impurity H CRS | 0.002 mg | 41639-83-2 | |
| Y0001765 | Laudanosine CRS | 15 mg | 1699-51-0 | |
| Y0001474 | Lauric acid CRS | 1500 mg | 143-07-7 | |
| Y0001992 | Lavender oil for peak identification HRS | 500 µL | N/A | |
| Y0001996 | Lead solution CRS | 10 mL | n/a | |
| Y0000654 | Leflunomide CRS | 100 mg | 75706-12-6 | |
| Y0000487 | Leflunomide impurity A CRS | 30 mg | 455-14-1 | |
| Y0000674 | Leflunomide for peak identification CRS | 1 mg | 75706-12-6 | |
| Y0000685 | Letrozole CRS | 80 mg | 112809-51-5 | |
| Y0002184 | Letrozole impurity A CRS | 0.0005 mg | | |
| L0375000 | Leucine CRS | 50 mg | 61-90-5 | |
| L0376000 | Leuprorelin CRS | 1 mg | 53714-56-0 | |
| L0376001 | Leuprorelin - reference spectrum | n/a | n/a | |
| Y0000048 | Levamisole - reference spectrum | n/a | n/a | |
| L0380000 | Levamisole hydrochloride CRS | 20 mg | 16595-80-5 | |
| Y0000047 | Levamisole hydrochloride for system suitability CRS | 15 mg | 16595-80-5 | |
| Y0001253 | Levetiracetam CRS | 120 mg | 102767-28-2 | |
| Y0001254 | Levetiracetam impurity A CRS | 10 mg | n/a | |
| Y0001256 | Levetiracetam impurity C CRS | 15 mg | 142-08-5 | |
| Y0001257 | Levetiracetam impurity D CRS | 15 mg | 103765-01-1 | |
| L0390000 | Levocabastine hydrochloride CRS | 125 mg | 79547-78-7 | |
| Y0001962 | Levetiracetam impurity E CRS | 10 mg | 3886-69-9 | |
| Y0001948 | Levetiracetam impurity G CRS | 10 mg | 7682-20-4 | |
| Y0001636 | Levocabastine for system suitability 1 CRS | 5.028 mg | 79547-78-7 | |
| Y0001637 | Levocabastine for system suitability 2 CRS | 5.005 mg | 79547-78-7 | |
| L0399900 | Levocarnitine CRS | 15 mg | 541-15-1 | |
| L0399905 | Levocarnitine impurity A CRS | 50 mg | n/a | |
| L0400000 | Levodopa CRS | 20 mg | 59-92-7 | |
| L0420000 | Levodropropizine CRS | 60 mg | 99291-25-5 | |
| L0420002 | Levodropropizine impurity A CRS | 25 mg | n/a | |
| Y0001033 | Levodropropizine impurity B CRS | 50 mg | 92-54-6 | |
| Y0001048 | Levodropropizine impurity C CRS | 420 mg | 556-52-5 | |
| Y0002089 | Levofloxacin for system suitability CRS | 1.01 mg | n/a | |
| Y0002085 | Levofloxacin hemihydrate CRS | 10 mg | 138199-71-0 | |
| Y0002084 | Levofloxacin impurity F CRS | 15 mg | | |
| L0500000 | Levomepromazine hydrochloride CRS | 30 mg | 1236-99-3 | |
| L0505000 | Levomepromazine maleate CRS | 50 mg | 7104-38-3 | |
| L0551000 | Levonorgestrel CRS | 30 mg | 797-63-7 | |
| Y0001379 | Levonorgestrel impurity B CRS | 15 mg | n/a | |
| Y0001431 | Levonorgestrel for system suitability 1 CRS | 10 mg | 797-63-7 | |
| Y0001618 | Levonorgestrel for system suitability 2 CRS | 10 mg | 797-63-7 | |
| L0570000 | Levothyroxine sodium CRS | 100 mg | 25416-65-3 | |
| Y0001382 | Levothyroxine for peak identification CRS | 10 mg | 25416-65-3 | |
| L0595000 | Lidocaine CRS | 10 mg | 137-58-6 | |
| L0600000 | Lidocaine hydrochloride CRS | 40 mg | 6108-05-0 | |
| L0650000 | Lincomycin hydrochloride CRS | 100 mg | 7179-49-9 | |
| Y0001393 | Lincomycin hydrochloride for system suitability CRS | 10 mg | 7179-49-9 | |
| L0700000 | Liothyronine sodium CRS | 60 mg | 55-06-1 | |
| Y0000860 | Liothyronine for peak identification CRS | 0.0046 mg | 55-06-1 | |
| L0702000 | Lisinopril dihydrate CRS | 50 mg | 83915-83-7 | |
| Y0001234 | Lisinopril impurity F CRS | 0.01 mg | n/a | |
| Y0001701 | Lisinopril for peak identification CRS | 10 mg | 83915-83-7 | |
| Y0001709 | Lisinopril for system suitability A CRS | 15 mg | 83915-83-7 | |
| L0720000 | Lithium clavulanate CRS | 125 mg | 61177-44-4 | |
| L0720800 | Lithocholic acid CRS | 60 mg | 434-13-9 | |
| Y0000112 | Lobeline hydrochloride CRS | 50 mg | 134-63-4 | |
| L0745000 | Lomustine CRS | 50 mg | 13010-47-4 | |
| Y0001438 | Long pepper for system suitability HRS | 600 mg | N/A | |
| Y0002087 | Loperamide for system suitability CRS | 15 mg | 34552-83-5 | |
| L0750000 | Loperamide hydrochloride CRS | 50 mg | 34552-83-5 | |
| Y0000341 | Loperamide oxide monohydrate CRS | 20 mg | 106900-12-3 | |
| Y0001498 | Lopinavir CRS | 170 mg | 192725-17-0 | |
| Y0001506 | Lopinavir for peak identification CRS | 10 mg | 192725-17-0 | |
| Y0001505 | Lopinavir for system suitability CRS | 10 mg | 192725-17-0 | |
| Y0000688 | Loratadine CRS | 60 mg | 79794-75-5 | |
| Y0000604 | Loratadine impurity F CRS | 10 mg | n/a | |
| Y0000605 | Loratadine impurity H CRS | 50 mg | 29976-53-2 | |
| Y0000603 | Loratadine for system suitability CRS | 15 mg | 79794-75-5 | |
| L0750500 | Lorazepam CRS - * psy | 15 mg | 846-49-1 | |
| Y0000718 | Lorazepam impurity D CRS | 15 mg | n/a | |
| Y0000576 | Lorazepam for system suitability CRS - * psy (Lorazepam) | 0.8 mg | 846-49-1 | |
| Y0001062 | Losartan potassium CRS | 50 mg | 124750-99-8 | |
| Y0001072 | Losartan impurity D CRS | 10 mg | 83857-96-9 | |
| Y0001076 | Losartan for system suitability CRS | 0.002 mg | n/a | |
| L0790000 | Lovastatin CRS | 60 mg | 75330-75-5 | |
| Y0001136 | Lovastatin for peak identification CRS | 20 mg | 75330-75-5 | |
| Y0001284 | Lufenuron CRS | 140 mg | 103055-07-8 | |
| Y0001261 | Lufenuron for peak identification CRS | 0.4028 mg | 103055-07-8 | |
| Y0001265 | Lufenuron impurity G CRS | 15 mg | n/a | |
| L0800000 | Lynestrenol CRS | 50 mg | 52-76-6 | |
| Y0001034 | Lynestrenol for peak identification CRS | 20 mg | 52-76-6 | |
| Y0000397 | Lysine acetate CRS | 60 mg | 57282-49-2 | |
| Y0002211 | DL-Lysine acetylsalicylate CRS | 15 mg | 62952-06-1 | |
| L0900000 | Lysine hydrochloride CRS | 50 mg | 657-27-2 | |
| Y0001904 | Lysophosphatidylcholine from egg yolk CRS | 200 mg | 9008-30-4 | |
| Y0001952 | Lysophosphatidylcholine from soya bean CRS | 200 mg | 9008-30-4 | |
| Y0001369 | Macrogol 30 dipolyhydroxystearate CRS | 100 mg | n/a | |
| Y0000745 | Macrogol 40 sorbitol heptaoleate CRS | 20 mg | N/A | |
| Y0001684 | High-molecular-mass macrogol CRS | 10 mg | 25322-68-3 | |
| Y0001157 | Macrogol polyvinyl alcohol grafted copolymer CRS | 400 mg | 96734-39-3 | |
| M0088000 | Magnesium aspartate dihydrate CRS | 40 mg | 2068-80-6 | |
| Y0001923 | Magnolia biondii flower for system suitability HRS | 260 mg | n/a | |
| Y0001918 | Magnolin CRS | 15 mg | 31008-18-1 | |
| Y0001289 | Magnolol CRS | 20 mg | 528-43-8 | |
| M0120000 | Malathion CRS | 250 mg | 121-75-5 | |
| M0120005 | Malathion impurity A CRS | 15 mg | 05/12/3344 | |
| M0120010 | Malathion impurity B CRS | 15 mg | 1634-78-2 | |
| M0100000 | Maleic acid CRS | 100 mg | 110-16-7 | |
| Y0000143 | Malic acid - reference spectrum | n/a | n/a | |
| M0160000 | Maltitol CRS | 1200 mg | 585-88-6 | |
| Y0001751 | Mangiferin CRS | 15 mg | 4773-96-0 | |
| M0200000 | Mannitol CRS | 1200 mg | 69-65-8 | |
| M0206000 | Maprotiline hydrochloride CRS | 100 mg | 10347-81-6 | |
| M0206040 | Maprotiline impurity D CRS | 25 mg | n/a | |
| Y0000819 | Marbofloxacin CRS | 10 mg | 115550-35-1 | |
| Y0000820 | Marbofloxacin for peak identification CRS | 20 mg | 115550-35-1 | |
| Y0002038 | Marrubiin CRS | 15 mg | 465-92-9 | |
| Y0002013 | Matrine CRS | 15 mg | 519-02-8 | |
| M0210000 | Measles vaccine (live) BRP | 400 mg | n/a | |
| M0215000 | Mebendazole CRS | 20 mg | 31431-39-7 | |
| Y0000144 | Mebendazole for system suitability CRS | 20 mg | 31431-39-7 | |
| Y0002107 | Mebeverine for system suitability CRS | 1.02 mg | n/a | |
| Y0002079 | Mebeverine hydrochloride CRS | 10 mg | 2753-45-9 | |
| Y0001086 | Mebrofenin CRS | 120 mg | 78266-06-5 | |
| M0220000 | Meclozine dihydrochloride CRS | 150 mg | 1104-22-9 | |
| Y0001310 | Meclozine impurity B CRS | 15 mg | 119-56-2 | |
| Y0001311 | Meclozine impurity H CRS | 15 mg | 303-26-4 | |
| Y0001770 | Medronate for radiochemical purity testing CRS | 5 mg | N/A | |
| M0240000 | Medronic acid CRS | 20 mg | 1984-15-2 | |
| Y0001107 | Medronic acid impurity A CRS | 60 µL | 116-17-6 | |
| Y0001106 | Medronic acid impurity B CRS | 40 µL | 1660-95-3 | |
| M0250000 | Medroxyprogesterone acetate CRS | 100 mg | 71-58-9 | |
| Y0001484 | Medroxyprogesterone acetate for peak identification CRS | 25 mg | 71-58-9 | |
| Y0000598 | Medroxyprogesterone acetate for system suitability CRS | 10 mg | 71-58-9 | |
| M0252600 | Mefenamic acid CRS | 50 mg | 61-68-7 | |
| Y0001081 | Mefenamic acid impurity A CRS | 100 mg | 87-59-2 | |
| M0253000 | Mefloquine hydrochloride CRS | 100 mg | 51773-92-3 | |
| Y0001514 | Megestrol acetate CRS | 120 mg | 595-33-5 | |
| Y0001594 | Megestrol acetate for impurity K identification CRS | 0.01 mg | n/a | |
| Y0001507 | Megestrol acetate for peak identification CRS | 20 mg | 595-33-5 | |
| Y0001524 | Megestrol acetate for system suitability CRS | 50 mg | 595-33-5 | |
| Y0001209 | Meglumine CRS | 10 mg | 6284-40-8 | |
| Y0001670 | Meldonium dihydrate CRS | 10 mg | 86426-17-7 | |
| Y0001671 | Meldonium impurity A CRS | 25 mg | 2840-24-6 | |
| Y0001672 | Meldonium impurity B CRS | 25 mg | 34810-18-9 | |
| Y0001673 | Meldonium impurity C CRS | 25 mg | 106966-25-0 | |
| Y0001674 | Meldonium impurity D CRS | 25 mg | 76144-84-8 | |
| Y0001675 | Meldonium impurity E CRS | 25 mg | n/a | |
| Y0001676 | Meldonium impurity F CRS | 25 mg | N/Ap. | |
| Y0001080 | Meloxicam CRS | 50 mg | 71125-38-7 | |
| Y0001035 | Meloxicam impurity A CRS | 5 mg | n/a | |
| Y0001036 | Meloxicam impurity B CRS | 5 mg | 7305-71-7 | |
| Y0001037 | Meloxicam impurity C CRS | 10 mg | 1262333-25-4 | |
| Y0001039 | Meloxicam impurity D CRS | 5 mg | n/a | |
| Y0001158 | Melphalan hydrochloride CRS | 100 mg | 3223-07-2 | |
| Y0001513 | Melphalan - reference spectrum | 1 uc | n/a | |
| Y0001457 | Melphalan for system suitability CRS | 10 mg | 148-82-3 | |
| M0300000 | Menadione CRS | 100 mg | 58-27-5 | |
| M0350000 | Menthol CRS | 150 mg | 89-78-1 | |
| M0370000 | Mepivacaine hydrochloride CRS | 100 mg | 1722-62-9 | |
| M0370020 | Mepivacaine impurity B CRS | 40 mg | n/a | |
| M0400000 | Meprobamate CRS - * psy | 100 mg | 57-53-4 | |
| M0500000 | Mepyramine maleate CRS | 600 mg | 59-33-6 | |
| Y0002147 | Mercaptopurine impurity A CRS | 15 mg | | |
| Y0000679 | Mepyramine impurity A CRS | 10 mg | n/a | |
| Y0002148 | Mercaptopurine impurity B | 15 mg | | |
| Y0002152 | Mercaptopurine impurity D CRS | 15 mg | | |
| Y0002003 | Mercury solution CRS | 10 mL | 7697-37-2 | |
| Y0000680 | Mepyramine impurity C CRS | 10 mg | 504-29-0 | |
| Y0001252 | Meropenem trihydrate CRS | 110 mg | 119478-56-7 | |
| Y0000297 | Mesalazine CRS | 50 mg | 89-57-6 | |
| Y0001563 | Mesalazine impurity A CRS | 15 mg | 123-30-8 | |
| Y0001569 | Mesalazine impurity C CRS | 15 mg | 95-55-6 | |
| Y0001574 | Mesalazine for system suitability CRS | 10 mg | 89-57-6 | |
| Y0001040 | Mesityl oxide CRS | 100 mg | 141-79-7 | |
| Y0000337 | Mesna - reference spectrum | n/a | n/a | |
| Y0000316 | Mesna impurity C CRS | 15 mg | n/a | |
| Y0000317 | Mesna impurity D CRS | 10 mg | n/a | |
| Y0000227 | Meso-rich exametazime CRS | 0.5 mg | 105613-48-7 | |
| Y0000097 | Mesterolone CRS | 120 mg | 1424-00-6 | |
| Y0002127 | Mesterolone for system suitability CRS | 15 mg | n/a | |
| Y0000096 | Mesterolone impurity A CRS | 30 mg | 604-26-2 | |
| M0600000 | Mestranol CRS | 100 mg | 72-33-3 | |
| Y0000301 | Metacresol - reference spectrum | n/a | n/a | |
| M0600900 | Metamizole sodium CRS | 10 mg | 5907-38-0 | |
| M0600905 | Metamizole impurity A CRS | 15 mg | 1672-58-8 | |
| Y0001481 | Metamizole impurity E CRS | 0.01 mg | n/a | |
| M0605000 | Metformin hydrochloride CRS | 50 mg | 1115-70-4 | |
| Y0001590 | Metformin impurity A CRS | 25 mg | n/a | |
| Y0001600 | Metformin impurity F CRS | 2 mL | N/A | |
| Y0001820 | Methacrylic acid - methylmethacrylate copolymer (1:1) CRS | 120 mg | 25086-15-1 | |
| Y0001821 | Methacrylic acid - methylmethacrylate copolymer (1:2) CRS | 120 mg | 25086-15-1 | |
| Y0000770 | Methacrylic acid-ethyl acrylate copolymer (1:1) - type A CRS | 200 mg | n/a | |
| Y0000323 | Methacrylic acid-ethyl acrylate copolymer (1:1) - type B CRS | 200 mg | n/a | |
| M0610030 | Methacrylic acid-ethyl acrylate copolymer (1:1), dispersion 30%-ref.sp | n/a | n/a | |
| M0800000 | Methadone hydrochloride - reference spectrum | n/a | n/a | |
| Y0000428 | Methanol - reference spectrum | n/a | n/a | |
| Y0000754 | Methenamine CRS | 10 mg | 100-97-0 | |
| M0960000 | Methionine CRS | 50 mg | 63-68-3 | |
| M1000000 | Methotrexate CRS | 100 mg | 59-05-2 | |
| Y0000663 | Methotrexate impurity C CRS | 10 mg | n/a | |
| M1000008 | Methotrexate impurity D CRS | 10 mg | n/a | |
| Y0000664 | Methotrexate impurity E CRS | 10 mg | n/a | |
| Y0000602 | Methotrexate for peak identification CRS | 20 mg | 59-05-2 | |
| Y0001668 | Methotrexate for system suitability CRS | 100 mg | N/Ap | |
| M1470000 | Methyl 2-(4-chlorophenoxy)-2-methylpropionate CRS | 0.5 ml | n/a | |
| M1556000 | Methyl 12-hydroxystearate CRS | 100 mg | 141-23-1 | |
| Y0001488 | Methyl methacrylate CRS | 50 mg | 80-62-6 | |
| Y0000398 | Methyl nicotinate CRS | 25 mg | 93-60-7 | |
| M1650000 | Methyl parahydroxybenzoate CRS | 150 mg | 99-76-3 | |
| M1770180 | Methyl ricinoleate CRS | 125 mg | 141-24-2 | |
| M1770200 | Methyl stearate CRS | 100 mg | 112-61-8 | |
| M1300000 | Methylatropine bromide CRS | 30 mg | 2870-71-5 | |
| M1500000 | Methyldopa CRS | 50 mg | 41372-08-1 | |
| Y0001083 | Methyldopa for system suitability CRS | 0.024 mg | 41372-08-1 | |
| Y0001374 | Racemic methyldopa CRS | 5 mg | 41372-08-1 | |
| M1550000 | Methylene chloride CRS | 1.5 mL | 75-09-02 | |
| Y0002012 | Racemic rotigotine CRS | 5 mg | | |
| Y0000776 | Methylergometrine maleate CRS | 10 mg | 57432-61-8 | |
| Y0000777 | Methylergometrine for system suitability | 0.53 mg | 57432-61-8 | |
| M1625000 | Methylnitrosoindoline CRS | 110 mg | 85440-79-5 | |
| Y0001017 | Methylphenidate hydrochloride CRS - * narc | 40 mg | 298-59-9 | |
| Y0001490 | Methylphenidate impurity C CRS | 10 mg | n/a | |
| Y0000910 | Methylphenidate impurity mixture CRS | 0.04 mg | n/a | |
| M1700000 | Methylphenobarbital CRS - * psy | 500 mg | 115-38-8 | |
| M1750000 | Methylprednisolone CRS | 240 mg | 83-43-2 | |
| Y0001799 | Methylprednisolone for system suitability A CRS | 10 mg | 83-43-2 | |
| M1755000 | Methylprednisolone acetate CRS | 110 mg | 53-36-1 | |
| Y0001736 | Methylprednisolone acetate for peak identification CRS | 0.01 mg | 53-36-1 | |
| Y0001760 | Methylprednisolone acetate for system suitability CRS | 10 mg | 53-36-41 | |
| M1755200 | Methylprednisolone hydrogen succinate CRS | 60 mg | 2921-57-5 | |
| Y0001759 | Methylprednisolone hydrogen succinate for peak identification CRS | 10 mg | 2921-57-5 | |
| M1755220 | Methylprednisolone hydrogen succinate for performance test CRS | 10 mg | 2921-57-5 | |
| Y0001376 | 2-methylpyrazine CRS | 100 mg | 109-08-0 | |
| Y0000190 | N-Methylpyrrolidone - reference spectrum | n/a | n/a | |
| Y0000418 | Methylrosanilinium chloride CRS | 40 mg | 548-62-9 | |
| Y0002083 | Methyl salicylate CRS | 15 mg | 119-36-8 | |
| Y0002261 | N-Nitroso-dibutylamine | 1 mL | 924-16-3 | |
| Y0000407 | Methylrosanilinium chloride for system suitability CRS | 10 mg | 548-62-9 | |
| Y0002258 | N-Nitroso-diethylamine | 1 mL | 55-18-5 | |
| Y0002263 | N-nitroso-diisopropylamine | 1 mL | | |
| Y0002259 | N-nitroso-dimethylamine | 1 mL | 62-75-9 | |
| Y0002264 | N-Nitroso-dipropylamine | 1 mL | | |
| M1800000 | Methyltestosterone CRS | 10 mg | 58-18-4 | |
| Y0000861 | Methyltestosterone for system suitability CRS | 10 mg | 58-18-4 | |
| M1800900 | Methylthioninium chloride CRS | 130 mg | 61-73-4 | |
| Y0001744 | Methylthioninium for system suitability CRS | 15 mg | 61-73-4 | |
| M1808000 | Metixene hydrochloride CRS | 75 mg | 7081-40-5 | |
| M1824990 | Metoclopramide CRS | 100 mg | 364-62-5 | |
| M1825000 | Metoclopramide hydrochloride CRS | 50 mg | 54143-57-6 | |
| M1824995 | Metoclopramide impurity A CRS | 25 mg | n/a | |
| M1825010 | Metoclopramide impurity E CRS | 40 mg | 100-36-7 | |
| Y0000701 | Metolazone CRS | 80 mg | 17560-51-9 | |
| Y0000702 | Metolazone for system suitability CRS | 10 mg | 17560-51-9 | |
| Y0000171 | Metoprolol succinate - reference spectrum | n/a | n/a | |
| M1830000 | Metoprolol tartrate CRS | 60 mg | 56392-17-7 | |
| Y0000145 | Metoprolol impurity A CRS | 15 mg | n/a | |
| Y0002262 | N-nitroso-ethyl-isopropylamine | 1 mL | | |
| Y0002260 | N-nitroso-N-methyl-4-aminobutyric acid | 1 mL | | |
| M1845000 | Metrifonate CRS | 100 mg | 52-68-6 | |
| M1850000 | Metronidazole CRS | 20 mg | 443-48-1 | |
| Y0000087 | Metronidazole impurity A CRS | 10 mg | 696-23-1 | |
| M1851000 | Metronidazole benzoate CRS | 50 mg | 13182-89-3 | |
| Y0000069 | Metronidazole benzoate - reference spectrum | n/a | n/a | |
| M1860000 | Mexiletine hydrochloride CRS | 100 mg | 5370-01-4 | |
| Y0002176 | Mexiletine impurity A CRS | 40 mg | 576-26-1 | |
| Y0000202 | Mexiletine impurity C CRS | 10 mg | n/a | |
| Y0000203 | Mexiletine impurity D CRS | 15 mg | n/a | |
| M1875000 | Mianserin hydrochloride CRS | 100 mg | 21535-47-7 | |
| Y0001041 | Mianserin impurity B CRS | 10 mg | n/a | |
| Y0000862 | Mianserin for system suitability CRS | 1.01 mg | 21535-47-7 | |
| M1880000 | Miconazole CRS | 50 mg | 22916-47-8 | |
| M1900000 | Miconazole nitrate CRS | 100 mg | 22832-87-7 | |
| Y0002021 | Microcrystalline cellulose CRS | 50 mg | 9004-34-6 | |
| M2200000 | Midazolam CRS - * psy | 50 mg | 59467-70-8 | |
| Y0000562 | Midazolam impurity C CRS | 0.08 mg | N/A | |
| Y0000599 | Midazolam for system suitability CRS - * psy (Midazolam) | 1 mg | 59467-70-8 | |
| Y0001882 | Milbemycin oxime for system suitability CRS | 10 mg | 129496-10-2 | |
| Y0001893 | Milbemycin oxime CRS | 100 mg | 129496-10-2 | |
| Y0001687 | Milk thistle dry extract HRS | 120 mg | 84604-20-6 | |
| Y0001878 | Minocycline for system suitability CRS | 10 mg | 13614-98-7 | |
| Y0001930 | Minocycline hydrochloride CRS | 100 mg | 13614-98-7 | |
| M2300000 | Minoxidil CRS | 50 mg | 38304-91-5 | |
| Y0001432 | Minoxidil for system suitability CRS | 10 mg | 38304-91-5 | |
| Y0000705 | Mirtazapine CRS | 10 mg | 61337-67-5 | |
| Y0000721 | Mirtazapine for system suitability CRS | 10 mg | 61337-67-5 | |
| Y0000490 | Misoprostol CRS | 60 mg | 59122-46-2 | |
| Y0001162 | Misoprostol for system suitability CRS | 5 mg | 59122-46-2 | |
| Y0000378 | Mitomycin CRS | 70 mg | 50-07-7 | |
| M2305000 | Mitoxantrone hydrochloride CRS | 60 mg | 70476-82-3 | |
| M2305005 | Mitoxantrone impurity A CRS | 5 mg | n/a | |
| Y0000635 | Modafinil CRS | 130 mg | 68693-11-8 | |
| Y0000636 | Modafinil for system suitability CRS | 0.1 mg | 68693-11-8 | |
| Y0000251 | Molgramostim CRS | 0.3 ml | 99283-10-0 | |
| Y0000821 | Molsidomine CRS | 5 mg | 25717-80-0 | |
| Y0000822 | Molsidomine impurity B CRS | 10 mg | 59-89-2 | |
| Y0000823 | Molsidomine impurity D CRS | 10 mg | 4394-85-8 | |
| M2900000 | Mometasone furoate CRS | 60 mg | 83919-23-7 | |
| Y0001977 | Mometasone furoate for system suitability CRS | 10 mg | N/A | |
| Y0001981 | Mometasone furoate monohydrate CRS | 70 mg | 141646-00-6 | |
| G0460000 | Monoammonium glycyrrhizate CRS | 300 mg | 53956-04-0 | |
| Y0002220 | Monotropein CRS | 10 mg | 5945-50-6 | |
| Y0001436 | Montelukast dicyclohexylamine CRS | 150 mg | n/a | |
| Y0001433 | Montelukast racemate CRS | 0.1 mg | 577953-88-9 | |
| Y0001434 | Montelukast sodium CRS | 20 mg | 151767-02-1 | |
| Y0001435 | Montelukast for peak identification CRS | 20 mg | 151767-02-1 | |
| Y0000028 | Morantel hydrogen tartrate CRS | 50 mg | 26155-31-7 | |
| Y0002230 | Morinda root for system suitabillity HRS | 520 mg | | |
| Y0000451 | Morphine hydrochloride trihydrate CRS - * narc | 30 mg | 07/06/6055 | |
| Y0000452 | Morphine sulfate CRS - * narc (Morphine hemisulfate pentahydrate) | 40 mg | 6211-15-0 | |
| Y0000830 | Morphine for system suitability CRS - * narc (Morphine sulfate) | 10 mg | 6211-15-0 | |
| Y0000772 | Moxidectin CRS | 70 mg | 113507-06-5 | |
| Y0000747 | Moxidectin for system suitability CRS | 10 mg | 113507-06-5 | |
| Y0002099 | Moxifloxacin for peak identification A CRS | 10 mg | n/a | |
| Y0002081 | Moxifloxacin for peak identification B CRS | 10 mg | n/a | |
| Y0002078 | moxifloxacin for system suitability CRS | 10 mg | n/a | |
| Y0000703 | Moxifloxacin hydrochloride CRS | 120 mg | 186826-86-8 | |
| Y0000226 | Moxonidine CRS | 50 mg | 75438-57-2 | |
| Y0000222 | Moxonidine impurity A CRS | 15 mg | N/A | |
| M3600000 | Mumps vaccine (live) BRP | 165 mg | n/a | |
| M3805000 | Mupirocin - reference spectrum | n/a | n/a | |
| M3805500 | Mupirocin calcium - reference spectrum | n/a | n/a | |
| M3806000 | Mupirocin lithium CRS | 110 mg | 73346-79-9 | |
| Y0002200 | Mycophenolate for system suitability CRS | 10 mg | n/a | |
| Y0000489 | Mycophenolate mofetil CRS | 30 mg | 128794-94-5 | |
| Y0000519 | Mycophenolate mofetil for peak identification CRS | 10 mg | 128794-94-5 | |
| Y0001810 | Mycophenolate sodium CRS | 200 mg | 37415-62-6 | |
| Y0000692 | Mycoplasma fermentans BRP | 1 ml | n/a | |
| Y0000690 | Mycoplasma hyorhinis BRP | 1 ml | n/a | |
| Y0000691 | Mycoplasma orale BRP | 1 ml | n/a | |
| Y0000689 | Mycoplasma synoviae BRP | 1 ml | n/a | |
| Y0000485 | Myo-inositol CRS | 1020 mg | 87-89-8 | |
| N0020000 | Nabumetone CRS | 60 mg | 42924-53-8 | |
| N0020020 | Nabumetone impurity D CRS | 10 mg | n/a | |
| N0020030 | Nabumetone impurity F CRS | 10 mg | 29619-45-2 | |
| Y0000146 | Nadolol CRS | 100 mg | 42200-33-9 | |
| Y0001215 | Nadolol impurity mixture CRS | 0.01 mg | n/a | |
| N0025000 | Nadroparin calcium CRS | 450 mg | 37270-89-6 | |
| Y0000077 | Naftidrofuryl - reference spectrum | n/a | n/a | |
| Y0000120 | Naftidrofuryl impurity A CRS | 10 mg | n/a | |
| Y0000121 | Naftidrofuryl impurity B CRS | 25 mg | n/a | |
| Y0000331 | Naftidrofuryl impurity F CRS | 10 mg | n/a | |
| N0050000 | Nalidixic acid CRS | 100 mg | 389-08-2 | |
| Y0001792 | Nalidixic acid impurity C CRS | 20 mg | 87-13-8 | |
| N0075000 | Naloxone hydrochloride dihydrate CRS | 100 mg | 51481-60-8 | |
| Y0001571 | Naloxone impurity D CRS | 25 mg | n/a | |
| Y0000695 | Naloxone for peak identification CRS | 5.1 mg | 51481-60-8 | |
| Y0000400 | Naltrexone hydrochloride CRS | 50 mg | 16676-29-2 | |
| Y0000410 | Naltrexone impurity C CRS | 15 mg | N/A | |
| Y0000542 | Nandrolone decanoate CRS | 5 mg | 360-70-3 | |
| Y0000547 | Nandrolone decanoate for peak identification CRS | 10 mg | 360-70-3 | |
| Y0000548 | Nandrolone decanoate for system suitability CRS | 10 mg | 360-70-3 | |
| N0080000 | Naphazoline hydrochloride CRS | 50 mg | 550-99-2 | |
| N0100000 | Naphazoline nitrate CRS | 10 mg | 5144-52-5 | |
| N0200000 | Naphazoline impurity A CRS | 15 mg | 36321-43-4 | |
| N0250000 | Naproxen CRS | 50 mg | 22204-53-1 | |
| Y0000399 | Naproxen (racemic) CRS | 10 mg | 23981-80-8 | |
| Y0000631 | Naproxen impurity L CRS | 15 mg | 3900-45-6 | |
| Y0001378 | Naringin CRS | 20 mg | 10236-47-2 | |
| Y0001437 | Nateglinide CRS | 200 mg | 105816-04-4 | |
| Y0001440 | Nateglinide impurity A CRS | 10 mg | 7077-05-6 | |
| Y0001441 | Nateglinide impurity B CRS | 15 mg | n/a | |
| Y0001442 | Nateglinide impurity C CRS | 10 mg | n/a | |
| N0300000 | Neamine CRS | 0.5 mg | 3947-65-7 | |
| N0399000 | Neohesperidin-dihydrochalcone CRS | 125 mg | 20702-77-6 | |
| N0399004 | Neohesperidin-dihydrochalcone impurity B CRS | 10 mg | n/a | |
| N0400000 | Neomycin sulfate CRS | 50 mg | 1405-10-3 | |
| N0401000 | Neomycin sulfate for microbiological assay CRS | 25 mg | 1405-10-3 | |
| N0500000 | Neostigmine bromide CRS | 50 mg | 114-80-7 | |
| N0550000 | Neostigmine metilsulfate CRS | 50 mg | 51-60-5 | |
| Y0001639 | Neostigmine impurity A CRS | 0.0025 mg | N/Ap | |
| Y0001890 | Netilmicin for peak identification CRS | 15 mg | 56391-57-2 | |
| N0559000 | Netilmicin sulfate CRS | 25 mg | 56391-57-2 | |
| Y0001894 | Netilmicin sulfate for LC assay CRS | 25 mg | 56391-57-2 | |
| Y0000520 | Nevirapine (anhydrous) CRS | 30 mg | 129618-40-2 | |
| Y0001499 | Nevirapine hemihydrate CRS | 15 mg | 220988-26-1 | |
| Y0000521 | Nevirapine for peak identification CRS | 0.058 mg | 129618-40-2 | |
| Y0000388 | Newcastle Disease Vaccine (inactivated) BRP | 40 mg | n/a | |
| Y0001917 | Nicardipine for system suitability CRS | 10 mg | 54527-84-3 | |
| Y0001924 | Nicardipine hydrochloride CRS | 20 mg | 54527-84-3 | |
| Y0001373 | Nicergoline CRS | 50 mg | 27848-84-6 | |
| Y0001362 | Nicergoline for peak identification CRS | 1 mg | 27848-84-6 | |
| Y0001352 | Nicergoline for system suitability CRS | 10 mg | 27848-84-6 | |
| Y0001356 | Nicergoline impurity D CRS | 20 mg | 20826-04-4 | |
| Y0002250 | Nickel solution CRS | 10 mL | n/a | |
| N0560000 | Niclosamide (anhydrous) CRS | 50 mg | 50-65-7 | |
| Y0001761 | Nicorandil CRS | 5 mg | 65141-46-0 | |
| Y0001762 | Nicorandil impurity A CRS | 5 mg | N/A | |
| N0600000 | Nicotinamide CRS | 50 mg | 98-92-0 | |
| N0590000 | Nicotine - reference spectrum | n/a | n/a | |
| N0590200 | Nicotine ditartrate CRS | 120 mg | 65-31-6 | |
| Y0001425 | Nicotine ditartrate dihydrate CRS | 15 mg | 6019-06-3 | |
| Y0001023 | Nicotine for system suitability CRS | 1 mg | 6019-06-3 | |
| N0700000 | Nicotinic acid CRS | 100 mg | 59-67-6 | |
| Y0001268 | Nicotinic acid impurity mixture CRS | 0.12 mg | N/A | |
| Y0001995 | Nicotinic acid for equipment qualification CRS | 250 mg | | |
| N0750000 | Nifedipine CRS | 50 mg | 21829-25-4 | |
| N0750010 | Nifedipine impurity A CRS | 25 mg | 67035-22-7 | |
| N0750015 | Nifedipine impurity B CRS | 25 mg | 50428-14-3 | |
| Y0000824 | Niflumic acid CRS | 10 mg | 4394-00-7 | |
| Y0000825 | Niflumic acid impurity A CRS | 10 mg | 2942-59-8 | |
| Y0000826 | Niflumic acid impurity B CRS | 10 mg | n/a | |
| Y0000827 | Niflumic acid impurity E CRS | 15 mg | n/a | |
| Y0000836 | Nifuroxazide CRS | 10 mg | 965-52-6 | |
| N0800000 | Nikethamide CRS | 1 mL | 59-26-7 | |
| Y0002100 | Nilotinib for system suitability CRS | 5 mg | | |
| Y0002097 | Nilotinib hydrochloride monohydrate CRS | 100 mg | 641571-10-0 | |
| Y0002103 | Nilotinib impurity A CRS | 20 mg | 641571-11-1 | |
| Y0002111 | Nilotinib impurity B CRS | 25 mg | 18595-18-1 | |
| Y0002108 | Nilotinib impurity C CRS | 20 mg | 2458-12-0 | |
| Y0000829 | Nilutamide CRS | 110 mg | 63612-50-0 | |
| Y0000894 | Nilutamide impurity B CRS | 5 mg | 393-11-3 | |
| N0845000 | Nimesulide CRS | 100 mg | 51803-78-2 | |
| N0845008 | Nimesulide impurity D CRS | 0.004 mg | n/a | |
| Y0001237 | Nimesulide for peak identification CRS | 10 mg | 51803-78-2 | |
| N0850000 | Nimodipine CRS | 50 mg | 66085-59-4 | |
| Y0001784 | Nimodipine for peak identification CRS | 15 mg | 14255-61-9 | |
| N0850010 | Nimodipine impurity A CRS | 1 mL | n/a | |
| N0900000 | Nitrazepam CRS - * psy | 100 mg | 146-22-5 | |
| N0905000 | Nitrendipine CRS | 60 mg | 39562-70-4 | |
| N0905005 | Nitrendipine impurity A CRS | 30 mg | n/a | |
| Y0001456 | Nitrendipine for peak identification CRS | 10 mg | 39562-70-4 | |
| N0930000 | Nitric oxide - reference spectrum | n/a | n/a | |
| N0950000 | Nitrofural CRS | 150 mg | 59-87-0 | |
| Y0001570 | Nitrofural impurity B CRS | 30 mg | 92-55-7 | |
| Y0001377 | Nitrofural for peak identification CRS | 0.11 mg | N/A | |
| N1000000 | Nitrosotriaminopyrimidine CRS | 20 mg | 1006-23-1 | |
| N1090000 | Nizatidine CRS | 250 mg | 76963-41-2 | |
| N1090060 | Nizatidine impurity F CRS | 10 mg | n/a | |
| Y0001278 | Nizatidine for system suitability CRS | 10 mg | 76963-41-2 | |
| Y0002161 | Nomegestrol acetate for ID and assay CRS | 70 mg | n/a | |
| N1080005 | Nomegestrol acetate impurity A CRS | 50 mg | n/a | |
| Y0002169 | Nomegestrol acetate impurity B CRS | 0.0008 mg | 58691-88-6 | |
| Y0001314 | 1-nonadecanol CRS | 425 mg | 1454-84-8 | |
| Y0000670 | Nonivamide CRS | 10 mg | 2444-46-4 | |
| Y0000755 | Nonoxinol 9 CRS | 10 mg | 26027-38-3 | |
| N1100000 | Noradrenaline tartrate CRS | 200 mg | 108341-18-0 | |
| Y0000681 | Noradrenaline impurity D CRS | 15 mg | n/a | |
| Y0000682 | Noradrenaline impurity E CRS | 10 mg | 99-40-1 | |
| Y0000686 | Noradrenaline impurity F CRS | 10 mg | 20455-68-9 | |
| N1130000 | Norcyclobenzaprine CRS | 25 mg | 303-50-4 | |
| N1200000 | Norethisterone CRS | 25 mg | 68-22-4 | |
| Y0000522 | Norethisterone for system suitability CRS | 10 mg | 68-22-4 | |
| N1225000 | Norethisterone acetate CRS | 110 mg | 51-98-9 | |
| Y0001532 | Norethisterone acetate for system suitability CRS | 2.6 mg | 51-98-9 | |
| N1230000 | Norfloxacin CRS | 20 mg | 70458-96-7 | |
| N1230010 | Norfloxacin impurity A CRS | 20 mg | n/a | |
| Y0001301 | Norfloxacin for peak identification CRS | 10 mg | 70458-96-7 | |
| Y0001015 | Norfloxacin for system suitability CRS | 10 mg | 70458-96-7 | |
| Y0001609 | Norflurane - reference spectrum | n/a | n/a | |
| Y0000724 | Norgestimate CRS | 10 mg | 35189-28-7 | |
| Y0000725 | Norgestimate for system suitability CRS | 5 mg | 35189-28-7 | |
| N1250000 | Norgestrel CRS | 30 mg | 6533-00-2 | |
| N1280000 | Nortriptyline hydrochloride CRS | 10 mg | 894-71-3 | |
| Y0001296 | Nortriptyline for system suitability CRS | 20 mg | 894-71-3 | |
| N1300000 | Noscapine CRS | 100 mg | 128-62-1 | |
| N1400000 | Nystatin CRS | 100 mg | 1400-61-9 | |
| O0100900 | Octoxinol 10 CRS | 310 mg | 9002-93-1 | |
| Y0002104 | Octreotide CRS | 11 mg | 79517-01-4 | |
| Y0002105 | Octreotide for NMR identification CRS | 2 mg | | |
| Y0002106 | Octreotide impurity mixture CRS | 0.01 mg | n/a | |
| Y0000368 | Octyl gallate CRS | 30 mg | 1034-01-1 | |
| O0101000 | Octyldodecanol CRS | 500 mg | 5333-42-6 | |
| O0120000 | Ofloxacin CRS | 50 mg | 82419-36-1 | |
| O0120010 | Ofloxacin impurity A CRS | 20 mg | n/a | |
| Y0002202 | Ofloxacin impurity D CRS | 20 mg | | |
| O0120050 | Ofloxacin impurity E CRS | 20 mg | n/a | |
| Y0001370 | Olanzapine CRS | 200 mg | 132539-06-1 | |
| Y0001392 | Olanzapine impurity A CRS | 5 mg | 138564-59-7 | |
| Y0002177 | Olanzapine embonate for peak identification CRS | 10 mg | n/a | |
| Y0002175 | Olanzapine embonate monohydrate CRS | 10 mg | 221373-18-8 | |
| Y0001380 | Olanzapine for system suitability CRS | 10 mg | 132539-06-1 | |
| Y0001204 | Oleanolic acid CRS | 20 mg | 508-02-1 | |
| Y0001479 | Oleic Acid CRS | 2000 mg | 112-80-1 | |
| Y0000805 | Oleuropein CRS | 25 mg | 32619-42-4 | |
| Y0001405 | Olmesartan medoxomil CRS | 100 mg | 144689-63-4 | |
| Y0001424 | Olmesartan medoxomil for system suitability CRS | 10 mg | 144689-63-4 | |
| O0146000 | Olsalazine sodium CRS | 70 mg | 6054-98-4 | |
| O0146010 | Olsalazine sodium for performance test CRS | 60 mg | 6054-98-4 | |
| O0150000 | Omeprazole CRS | 50 mg | 73590-58-6 | |
| Y0001043 | Omeprazole magnesium CRS | 10 mg | 95382-33-5 | |
| O0151000 | Omeprazole impurity D CRS | 15 mg | 88546-55-8 | |
| Y0000218 | Ondansetron hydrochloride dihydrate CRS | 220 mg | 103639-04-9 | |
| Y0001042 | Omeprazole for peak identification CRS | 10 mg | 73590-58-6 | |
| Y0001345 | Ondansetron impurity A CRS | 10 mg | 153139-56-1 | |
| Y0000195 | Ondansetron impurity D CRS | 15 mg | 99614-64-9 | |
| Y0001326 | Ondansetron impurity E CRS | 10 mg | 288-32-4 | |
| Y0001320 | Ondansetron impurity F CRS | 10 mg | 693-98-1 | |
| Y0001346 | Ondansetron impurity G CRS | 10 mg | N/A | |
| Y0000197 | Ondansetron for LC system suitability CRS | 10 mg | 103639-04-9 | |
| Y0000196 | Ondansetron for TLC system suitability CRS | 20 mg | 103639-04-9 | |
| Y0001125 | Orbifloxacin CRS | 200 mg | 113617-63-3 | |
| Y0001147 | Orbifloxacin impurity mixture CRS | 0.0008 mg | 113617-63-3 | |
| O0180000 | Orciprenaline sulfate CRS | 100 mg | 5874-97-5 | |
| Y0000895 | Orciprenaline for system suitability CRS | 5 mg | 5874-97-5 | |
| Y0001501 | Orientvine stem HRS | 600 mg | 115-53-7 | |
| Y0000101 | Orphenadrine citrate CRS | 100 mg | 4682-36-4 | |
| Y0000100 | Orphenadrine hydrochloride CRS | 100 mg | 341-69-5 | |
| Y0000102 | Orphenadrine impurity E CRS | 60 mg | n/a | |
| Y0001181 | Orphenadrine for peak identification CRS | 0.44 mg | 341-69-5 | |
| Y0001337 | Oseltamivir phosphate (impurity B-free) CRS | 300 mg | 204255-11-8 | |
| Y0001338 | Oseltamivir impurity A CRS | 10 mg | n/a | |
| Y0001339 | Oseltamivir impurity B CRS | 10 mg | n/a | |
| Y0001340 | Oseltamivir impurity C CRS | 10 mg | n/a | |
| Y0001341 | Oseltamivir impurity H CRS | 30 mg | 814-29-9 | |
| Y0001207 | Osthole CRS | 20 mg | 484-12-8 | |
| O0200000 | Ouabain CRS | 150 mg | 11018-89-6 | |
| Y0000638 | Oxacillin sodium monohydrate CRS | 110 mg | 7240-38-2 | |
| Y0000560 | Oxacillin for peak identification CRS | 10 mg | 7240-38-2 | |
| Y0000271 | Oxaliplatin CRS | 250 mg | 61825-94-3 | |
| Y0000272 | Oxaliplatin impurity B CRS | 22 mg | n/a | |
| Y0000273 | Oxaliplatin impurity C CRS | 25 mg | n/a | |
| Y0000274 | Oxaliplatin impurity D CRS | 15 mg | n/a | |
| O0225000 | Oxazepam CRS - * psy | 50 mg | 604-75-1 | |
| Y0000543 | Oxazepam for peak identification CRS | 0.008 mg | n/a | |
| Y0001576 | Oxcarbazepine CRS | 120 mg | 28721-07-5 | |
| Y0001549 | Oxcarbazepine impurity mixture CRS | 0.008 mg | n/a | |
| Y0000350 | Oxeladin hydrogen citrate CRS | 50 mg | 52432-72-1 | |
| Y0000404 | Oxeladin impurity C CRS | 10 mg | n/a | |
| Y0000390 | Oxeladin impurity D CRS | 20 mg | n/a | |
| O0225800 | Oxfendazole CRS | 50 mg | 53716-50-0 | |
| Y0000224 | Oxfendazole impurity B CRS | 10 mg | n/a | |
| Y0000225 | Oxfendazole with impurity D CRS | 10 mg | 53716-50-0 | |
| Y0001771 | Oxidronate for radiochemical purity testing CRS | 34 mg | 14255-61-9 | |
| Y0000709 | Oxitropium bromide CRS | 50 mg | 30286-75-0 | |
| Y0000715 | Oxitropium bromide impurity B CRS | 15 mg | 155-41-9 | |
| Y0000713 | Oxitropium bromide impurity D CRS | 10 mg | 95778-01-1 | |
| O0240000 | Oxolinic acid CRS | 50 mg | 14698-29-4 | |
| O0240005 | Oxolinic acid impurity A CRS | 20 mg | n/a | |
| O0240010 | Oxolinic acid impurity B CRS | 20 mg | n/a | |
| O0250000 | Oxprenolol hydrochloride CRS | 50 mg | 6452-73-9 | |
| O0270000 | Oxybuprocaine hydrochloride CRS | 100 mg | 5987-82-6 | |
| O0288000 | Oxybutynin hydrochloride CRS | 50 mg | 1508-65-2 | |
| Y0002275 | Oxybutynin hydrochloride for system suitability CRS | 15 mg | | |
| O0288005 | Oxybutynin impurity A CRS | 20 mg | n/a | |
| Y0000492 | Oxycodone hydrochloride CRS - * narc | 70 mg | 124-90-3 | |
| Y0000453 | Oxycodone impurity D CRS | 50 mg | 508-54-3 | |
| Y0002015 | Oxymatrine CRS | 15 mg | 16837-52-8 | |
| O0290000 | Oxymetazoline hydrochloride CRS | 80 mg | 2315-02-8 | |
| Y0001044 | Oxymetazoline impurity A CRS | 15 mg | n/a | |
| Y0001896 | Oxytetracycline CRS | 100 mg | 79-57-2 | |
| Y0001850 | Oxytetracycline for system suitability CRS | 15 mg | 2058-46-0 | |
| Y0002136 | Oxytetracycline for system suitability A CRS | 20 mg | | |
| O0500000 | Oxytetracycline hydrochloride CRS | 20 mg | 2058-46-0 | |
| O0700000 | Oxytocin CRS | 41 mg | 6233-83-6 | |
| O0770000 | Oxytocin/Desmopressin validation mixture CRS | 20 mg | N/A | |
| Y0000698 | Paclitaxel CRS | 40 mg | 33069-62-4 | |
| Y0000699 | Paclitaxel impurity C CRS | 10 mg | 153415-45-3 | |
| Y0000700 | Paclitaxel natural for peak identification CRS | 10 mg | 33069-62-4 | |
| Y0000719 | Paclitaxel semi-synthetic for peak identification CRS | 10 mg | 33069-62-4 | |
| Y0000739 | Paclitaxel semi-synthetic for system suitability CRS | 1.01 mg | 33069-62-4 | |
| Y0001856 | Paeoniflorin CRS | 15 mg | 23180-57-6 | |
| Y0001947 | Paeonol CRS | 20 mg | 552-41-0 | |
| P0090000 | Palmitic acid CRS | 70 mg | 57-10-3 | |
| Y0000524 | Pamidronate disodium pentahydrate CRS | 10 mg | 109552-15-0 | |
| Y0001632 | Pancreas powder (amylase) BRP | 2000 mg | 8049-47-6 | |
| Y0001631 | Pancreas powder (lipase) BRP | 2000 mg | 8049-47-6 | |
| P0200000 | Pancreas powder (protease) BRP | 2000 mg | 8049-47-6 | |
| P0250000 | Pancuronium bromide CRS | 20 mg | 15500-66-0 | |
| Y0000577 | Pancuronium bromide for system suitability CRS | 15 mg | 15500-66-0 | |
| Y0002109 | Pantolactone CRS | 10 mg | 599-04-2 | |
| Y0000835 | Pantoprazole sodium sesquihydrate CRS | 20 mg | 164579-32-2 | |
| Y0001001 | Pantoprazole for system suitability CRS | 5 mg | 164579-32-2 | |
| Y0002101 | Pantothenate for peak identification CRS | 10 mg | n/a | |
| P0270000 | Papaverine hydrochloride CRS | 25 mg | 61-25-6 | |
| P0300000 | Paracetamol CRS | 50 mg | 103-90-2 | |
| Y0001781 | Paracetamol for equipment qualification CRS | 250 mg | 103-90-2 | |
| Y0001955 | Paracetamol impurity K CRS | 15 mg | 123-30-8 | |
| Y0001945 | Paracetamol impurity J CRS | 15 mg | 539-03-7 | |
| Y0000780 | Paraffin (hard) CRS | 10 mg | 8002-74-2 | |
| Y0000058 | Paraffin (liquid) - reference spectrum | n/a | n/a | |
| Y0000913 | Paraffin (White soft) CRS | 10 mg | 8002-74-2 | |
| Y0000912 | Paraffin (Yellow soft) CRS | 10 mg | 8002-74-2 | |
| P0305000 | Parnaparin sodium CRS | 200 mg | 9041-08-1 | |
| Y0000578 | Paroxetine hydrochloride (anhydrous) CRS | 100 mg | 78246-49-8 | |
| Y0000579 | Paroxetine hydrochloride (anhydrous) impurity C CRS | 10 mg | n/a | |
| Y0000581 | Paroxetine hydrochloride (anhydrous) impurity H CRS | 15 mg | n/a | |
| Y0000281 | Paroxetine hydrochloride hemihydrate CRS | 200 mg | 110429-35-1 | |
| Y0000233 | Paroxetine impurity A CRS | 15 mg | n/a | |
| Y0000256 | Paroxetine impurity D CRS | 10 mg | 130855-30-0 | |
| Y0000580 | Paroxetine impurity E CRS | 5 mg | n/a | |
| Y0000630 | Paroxetine for system suitability CRS | 0.02 mg | 110429-35-1 | |
| P0309000 | Pefloxacin mesilate dihydrate CRS | 200 mg | 149676-40-4 | |
| Y0001838 | Parthenolide CRS | 15 mg | 20554-84-1 | |
| P0309020 | Pefloxacin impurity B CRS | 10 mg | n/a | |
| P0309030 | Pefloxacin impurity C CRS | 0.01 mg | n/a | |
| Y0002257 | Pemetrexed disodium 2.5-hydrate CRS | 15 mg | | |
| Y0001539 | Pemetrexed disodium heptahydrate CRS | 200 mg | 357166-29-1 | |
| Y0001538 | Pemetrexed for system suitability CRS | 20 mg | 357166-29-1 | |
| Y0001535 | Pemetrexed impurity mixture CRS | 0.002 mg | n/a | |
| P0307000 | Penbutolol sulfate CRS | 100 mg | 38363-32-5 | |
| P0307005 | Penbutolol impurity A CRS | 20 mg | n/a | |
| P0310000 | Penicillamine CRS | 100 mg | 52-67-5 | |
| P0320000 | Penicillamine disulfide CRS | 100 mg | 20902-45-8 | |
| P0400100 | Pentaerythrityl tetranitrate diluted CRS | 600 mg | N/A | |
| P0405000 | Pentamidine diisetionate CRS | 30 mg | 140-64-7 | |
| P0405500 | Pentazocine - reference spectrum | n/a | n/a | |
| P0405510 | Pentazocine hydrochloride - reference spectrum | n/a | n/a | |
| Y0000417 | Pentazocine lactate - reference spectrum | n/a | n/a | |
| Y0001051 | Pentetate sodium calcium CRS | 100 mg | 12111-24-9 | |
| P0500000 | Pentobarbital CRS - * psy | 100 mg | 76-74-4 | |
| Y0002194 | Pentobarbital sodium CRS - * psy | 40 mg | 57-33-0 | |
| Y0002026 | Pentobarbital impurity E CRS | 5 mg | N/A | |
| P0510000 | Pentoxifylline CRS | 100 mg | 6493-05-6 | |
| Y0000076 | Pentoxyverine hydrogen citrate - reference spectrum | n/a | n/a | |
| Y0000098 | Pentoxyverine impurity A CRS | 10 mg | 77-55-4 | |
| Y0000099 | Pentoxyverine impurity B CRS | 10 mg | 77-22-5 | |
| P0525000 | Pepsin powder BRP | 2000 mg | 9001-75-6 | |
| Y0000010 | Pergolide mesilate CRS | 150 mg | 66104-23-2 | |
| Y0000238 | Perindopril tert-butylamine CRS | 40 mg | 107133-36-8 | |
| Y0000237 | Perindopril impurity A CRS | 15 mg | 80875-98-5 | |
| Y0000771 | Perindopril for peak identification CRS | 5 mg | 107133-36-8 | |
| Y0000207 | Perindopril for stereochemical purity CRS | 40 mg | 107133-36-8 | |
| Y0001733 | Permethrin (25:75) CRS | 350 mg | 52645-53-1 | |
| Y0001741 | Permethrin for system suitability CRS | 60 mg | 52645-53-1 | |
| P0550000 | Perphenazine CRS | 100 mg | 58-39-9 | |
| Y0001045 | Perphenazine for system suitability CRS | 5 mg | 58-39-9 | |
| Y0000021 | Pertussis toxin BRP | 0.05 mg | 70323-44-3 | |
| P0600000 | Pethidine hydrochloride - reference spectrum | n/a | n/a | |
| P0600002 | Pethidine impurity A CRS | 20 mg | N/A | |
| P0800000 | Phenazone CRS | 20 mg | 60-80-0 | |
| Y0001138 | Phenazone impurity A CRS | 20 mg | 89-25-8 | |
| P0850000 | Pheniramine maleate CRS | 250 mg | 132-20-7 | |
| Y0001428 | Pheniramine impurity A CRS | 20 mg | 101-82-6 | |
| P0900000 | Phenobarbital CRS - * psy | 200 mg | 50-06-6 | |
| Y0001350 | Phenobarbital impurity A CRS | 15 mg | n/a | |
| Y0001351 | Phenobarbital impurity B CRS | 15 mg | n/a | |
| P0950000 | Phenoxyethanol CRS | 1 mL | 122-99-6 | |
| P1000000 | Phenoxymethylpenicillin CRS | 250 mg | 87-08-1 | |
| Y0001868 | Phenoxymethylpenicillin for system suitability CRS | 25 mg | 87-08-1 | |
| P1100000 | Phenoxymethylpenicillin potassium CRS | 260 mg | 132-98-9 | |
| Y0001127 | Phentolamine mesilate CRS | 10 mg | 65-28-1 | |
| P1109000 | Phentolamine mesilate - reference spectrum | n/a | n/a | |
| Y0001251 | Phentolamine for system suitability CRS | 10 mg | 65-28-1 | |
| P1150000 | Phenylalanine CRS | 60 mg | 63-91-2 | |
| P1200000 | Phenylbutazone CRS | 100 mg | 50-33-9 | |
| Y0000147 | Phenylbutazone impurity B CRS | 20 mg | n/a | |
| P1240000 | Phenylephrine CRS | 50 mg | 59-42-7 | |
| P1250000 | Phenylephrine hydrochloride CRS | 20 mg | 61-76-7 | |
| Y0000683 | Phenylephrine hydrochloride for peak identification CRS | 2 mg | 61-76-7 | |
| Y0000229 | Phenylmercuric acetate - reference spectrum | n/a | n/a | |
| P1255100 | Phenylmercuric borate - reference spectrum | n/a | n/a | |
| P1260000 | Phenylpropanolamine hydrochloride CRS - * Drug Precursor | 50 mg | 154-41-6 | |
| P1290000 | Phenytoin CRS | 120 mg | 57-41-0 | |
| P1300000 | Phenytoin sodium CRS | 250 mg | 630-93-3 | |
| Y0001167 | Phenytoin for system suitability CRS | 20 mg | 57-41-0 | |
| Y0000493 | Phloroglucinol (anhydrous) CRS | 220 mg | 108-73-6 | |
| Y0000761 | Pholcodine CRS - * narc | 10 mg | 509-67-1 | |
| Y0001865 | Pholcodine for impurity G identification CRS - * narc (see Add info) | 15 mg | N/A | |
| Y0001905 | Phosphatidylcholine from egg yolk CRS | 250 mg | 97281-44-2 | |
| Y0000798 | Pholcodine for peak identification CRS - * narc (see Add info) | 10 mg | 509-67-1 | |
| Y0001950 | Phosphatidylcholine from soya bean CRS | 250 mg | 97281-47-5 | |
| Y0001903 | Phosphatidylethanolamine from egg yolk CRS | 200 mg | 97281-50-0 | |
| Y0001953 | Phosphatidylethanolamine from soya bean CRS | 200 mg | 39382-08-6 | |
| Y0000766 | Phthalic acid CRS | 20 mg | 88-99-3 | |
| P1500000 | Phthalylsulfathiazole CRS | 100 mg | 85-73-4 | |
| P1600000 | Physostigmine salicylate CRS | 100 mg | 57-64-7 | |
| P1609000 | Phytomenadione CRS | 150 mg | 84-80-0 | |
| Y0001104 | Picosulfate for system suitability CRS | 0.5 mg | 10040-45-6 | |
| P1645000 | Picotamide monohydrate CRS | 125 mg | 80530-63-8 | |
| P1645005 | Picotamide impurity A CRS | 25 mg | 2206-43-1 | |
| Y0001508 | Picrotin CRS | 40 mg | 21416-53-5 | |
| Y0001528 | Picrotoxinin CRS | 40 mg | 17617-45-7 | |
| Y0000124 | Pidolate impurity B CRS | 110 mg | n/a | |
| Y0000123 | Pidolic acid CRS | 125 mg | 98-79-3 | |
| P1650000 | Pilocarpine hydrochloride CRS | 50 mg | 54-71-7 | |
| P1700000 | Pilocarpine nitrate CRS | 50 mg | 148-72-1 | |
| Y0000106 | Pilocarpine nitrate for system suitability CRS | 20 mg | 148-72-1 | |
| Y0000525 | Pimobendan CRS | 10 mg | 74150-27-9 | |
| Y0000401 | Pimobendan for system suitability CRS | 0.1 mg | N/A | |
| P1750000 | Pimozide CRS | 150 mg | 2062-78-4 | |
| P1800000 | Pindolol CRS | 100 mg | 13523-86-9 | |
| Y0001520 | Pioglitazone hydrochloride CRS | 120 mg | 112529-15-4 | |
| Y0001519 | Pioglitazone for system suitability CRS | 15 mg | 112529-15-4 | |
| Y0001476 | Pipemidic acid trihydrate CRS | 15 mg | 72571-82-5 | |
| Y0000061 | Pipemidic acid trihydrate - reference spectrum | n/a | n/a | |
| P1890000 | Piperacillin CRS | 100 mg | 66258-76-2 | |
| Y0002235 | Piperacillin for peak identification CRS | 15 mg | n/a | |
| Y0002237 | Piperacillin impurity I CRS | 15 mg | 158411-82-6 | |
| Y0002241 | Piperacillin impurity N CRS | 15 mg | | |
| P1900000 | Piperazine adipate CRS | 250 mg | 142-88-1 | |
| P2000000 | Piperazine citrate CRS | 250 mg | 144-29-6 | |
| P2100000 | Piperazine hydrate CRS | 250 mg | 142-63-2 | |
| Y0001217 | Piperine CRS | 30 mg | 94-62-2 | |
| Y0000288 | Piracetam CRS | 150 mg | 7491-74-9 | |
| Y0000038 | Pirenzepine dihydrochloride monohydrate CRS | 250 mg | 29868-97-1 | |
| P2120000 | Piretanide CRS | 100 mg | 55837-27-9 | |
| Y0001458 | Piretanide for system suitability CRS | 10 mg | 55837-27-9 | |
| Y0001769 | Pirfenidone CRS | 120 mg | 53179-13-8 | |
| P2130000 | Piroxicam CRS | 50 mg | 36322-90-4 | |
| Y0001475 | Piroxicam for system suitability CRS | 15 mg | 36322-90-4 | |
| P2150000 | Pivampicillin CRS | 125 mg | 33817-20-8 | |
| P2152000 | Pivmecillinam hydrochloride CRS | 100 mg | 32887-03-9 | |
| P2152015 | Pivmecillinam impurity C CRS | 20 mg | n/a | |
| P2155001 | Plastic additive 01 CRS | 2 mL | 117-81-7 | |
| P2155003 | Plastic additive 03 CRS | 100 mg | 110-30-5 | |
| E0800000 | Plastic additive 04 CRS | 500 mg | 8013-07-8 | |
| P2155005 | Plastic additive 05 CRS | 500 mg | 8016-11-3 | |
| P2155008 | Plastic additive 08 CRS | 500 mg | 32509-66-3 | |
| P2155009 | Plastic additive 09 CRS | 250 mg | 6683-19-8 | |
| P2155010 | Plastic additive 10 CRS | 250 mg | 1709-70-2 | |
| P2155011 | Plastic additive 11 CRS | 300 mg | 2082-79-3 | |
| P2155012 | Plastic additive 12 CRS | 250 mg | 31570-04-4 | |
| P2155013 | Plastic additive 13 CRS | 180 mg | 27676-62-6 | |
| P2155014 | Plastic additive 14 CRS | 250 mg | 3806-34-6 | |
| P2155015 | Plastic additive 15 CRS | 500 mg | 2500-88-1 | |
| P2155016 | Plastic additive 16 CRS | 250 mg | 123-28-4 | |
| P2155017 | Plastic additive 17 CRS | 250 mg | 693-36-7 | |
| P2155018 | Plastic additive 18 CRS | 50 mg | N/Ap. | |
| O0140000 | Plastic additive 20 CRS | 100 mg | 301-02-0 | |
| E1260000 | Plastic additive 21 CRS | 100 mg | 112-84-5 | |
| P2155022 | Plastic additive 22 CRS | 100 mg | 65447-77-0 | |
| P2155023 | Plastic additive 23 CRS | 200 mg | | |
| Y0002022 | Plastic additive 24 CRS | 500 mg | 166412-78-8 | |
| Y0002025 | Plastic additive 25 CRS | 50 mg | 82469-79-2 | |
| Y0002023 | Plastic additive 26 CRS | 50 mg | 3319-31-1 | |
| Y0002024 | Plastic additive 27 CRS | 50 mg | 6422-86-2 | |
| Y0001946 | Platycodin D CRS | 20 mg | 58479-68-8 | |
| Y0001957 | Platycodon root dry extract for system suitability HRS | 10 mg | N/A | |
| Y0002002 | Podophyllotoxin CRS | 100 mg | 518-28-5 | |
| Y0002034 | Podophyllotoxin for system suitability CRS | 10 mg | n/a | |
| P2160000 | Poliomyelitis vaccine (inactivated) BRP | 0.6 mL | n/a | |
| P2163920 | Poloxamer 124 CRS | 500 mg | 9003-11-6 | |
| P2164009 | Poloxamer 188 CRS | 20 mg | 106392-12-5 | |
| P2164020 | Poloxamer 237 CRS | 100 mg | 9003-11-6 | |
| P2164021 | Poloxamer 338 CRS | 100 mg | 9003-11-6 | |
| P2164030 | Poloxamer 407 CRS | 100 mg | 9003-11-6 | |
| Y0001557 | Poly(vinyl acetate) CRS | 100 mg | 9003-20-7 | |
| Y0000792 | Poly(vinyl acetate) dispersion 30 per cent CRS | 1500 mg | 9003-20-7 | |
| Y0001550 | Poly(vinyl alcohol) CRS | 100 mg | 9002-89-5 | |
| P2600000 | Poly(vinyl chloride) CRS | 100 mg | 9002-86-2 | |
| P2170000 | Polyacrylate - reference spectrum | n/a | n/a | |
| Y0001855 | Polydatin CRS | 15 mg | 65914-17-2 | |
| Y0001860 | Polygonum orientale fruit for system suitability HRS | 510 mg | N/A | |
| P2400000 | Polymyxin B sulfate CRS | 25 mg | 1405-20-5 | |
| Y0000355 | Polymyxin B sulfate for microbiological assay CRS | 25 mg | 1405-20-5 | |
| Y0001712 | Polyoxypropylene stearyl ether CRS | 250 mg | 25231-21-4 | |
| Y0000289 | Polysorbate 20 - reference spectrum | n/a | n/a | |
| Y0000290 | Polysorbate 40 - reference spectrum | n/a | n/a | |
| Y0000291 | Polysorbate 60 - reference spectrum | n/a | n/a | |
| Y0000007 | Polysorbate 80 - reference spectrum | n/a | n/a | |
| P2649610 | Potassium clavulanate - reference spectrum | n/a | n/a | |
| Y0001168 | Potassium clavulanate impurity G CRS | 5 mg | 374816-32-7 | |
| Y0000315 | Potassium hydrogen aspartate hemihydrate CRS | 50 mg | 1115-63-5 | |
| P2650000 | Potassium sorbate CRS | 100 mg | 590-00-1 | |
| Y0001275 | Potassium sucrose octasulfate CRS | 100 mg | 73264-44-5 | |
| P2660000 | Povidone CRS | 50 mg | 9003-39-8 | |
| Y0000466 | Povidone (iodinated) CRS | 10 mg | 25655-41-8 | |
| Y0001266 | Pramipexole dihydrochloride monohydrate CRS | 5 mg | 191217-81-9 | |
| Y0001267 | Pramipexole impurity D CRS | 5 mg | 104632-27-1 | |
| Y0001187 | Pramipexole for system suitability CRS | 15 mg | 191217-81-9 | |
| Y0002119 | Prasugrel for system suitability CRS | 10 mg | n/a | |
| Y0000215 | Pravastatin sodium - reference spectrum | n/a | n/a | |
| Y0002122 | Prasugrel hydrochloride CRS | 70 mg | 389574-19-0 | |
| Y0000223 | Pravastatin impurity A CRS | 0.1 mg | 250737-12-3 | |
| Y0000204 | Pravastatin 1,1,3,3-tetramethylbutylamine CRS | 30 mg | 151006-14-3 | |
| P2669000 | Prazepam CRS - * psy | 15 mg | 2955-38-6 | |
| P2670000 | Praziquantel CRS | 200 mg | 55268-74-1 | |
| Y0001533 | Praziquantel for system suitability CRS | 10 mg | 55268-74-1 | |
| Y0002095 | Prazosin impurity A CRS | 0.002 mg | 23680-84-4 | |
| P2680000 | Prazosin hydrochloride CRS | 30 mg | 19237-84-4 | |
| P2698000 | Prednicarbate CRS | 110 mg | 73771-04-7 | |
| Y0002231 | Prednicarbate for peak identification CRS | 15 mg | | |
| Y0001630 | Prednicarbate for system suitability A CRS | 10 mg | 73771-04-7 | |
| P2700000 | Prednisolone CRS | 110 mg | 50-24-8 | |
| Y0001359 | Prednisolone for peak identification CRS | 10 mg | 50-24-8 | |
| Y0001355 | Prednisolone for system suitability CRS | 10 mg | 50-24-8 | |
| P2800000 | Prednisolone acetate CRS | 50 mg | 52-21-1 | |
| Y0000582 | Prednisolone acetate for peak identification CRS | 10 mg | 52-21-1 | |
| P2805000 | Prednisolone pivalate CRS | 120 mg | 1107-99-9 | |
| P2810000 | Prednisolone sodium phosphate CRS | 100 mg | 125-02-0 | |
| P2900000 | Prednisone CRS | 110 mg | 53-03-2 | |
| Y0001921 | Prednisone for peak identification CRS | 15 mg | n/a | |
| Y0001920 | Prednisone impurity B CRS | 20 mg | | |
| Y0001805 | Pregabalin CRS | 260 mg | 148553-50-8 | |
| Y0001806 | Pregabalin impurity A CRS | 0.25 mg | N/A | |
| Y0001808 | Pregabalin impurity D CRS | 10 mg | N/A | |
| P2920000 | Pregnenolone isobutyrate CRS | 260 mg | n/a | |
| Y0000263 | Prekallikrein activator in albumin BRP | 200 mg | 70024-90-7 human alb | |
| P2939000 | Prilocaine CRS | 150 mg | 721-50-6 | |
| P2939060 | Prilocaine hydrochloride CRS | 100 mg | 1786-81-8 | |
| Y0001408 | Prilocaine impurity B CRS | 80 mg | 636-21-5 | |
| P2939025 | Prilocaine impurity E CRS | 25 mg | n/a | |
| Y0001681 | Prilocaine for peak identification CRS | 20 mg | 1786-81-8 | |
| P2940000 | Primaquine diphosphate CRS | 500 mg | 63-45-6 | |
| Y0002035 | Primaquine for system suitability CRS | 10 mg | n/a | |
| P2950000 | Primidone CRS | 150 mg | 125-33-7 | |
| Y0000369 | Primidone for peak identification CRS | 10 mg | 125-33-7 | |
| Y0002215 | Primidone for system suitability CRS | 10 mg | n/a | |
| P3000000 | Probenecid CRS | 100 mg | 57-66-9 | |
| P3050000 | Procainamide hydrochloride CRS | 100 mg | 614-39-1 | |
| P3090000 | Procaine benzylpenicillin CRS | 250 mg | 6130-64-9 | |
| Y0002077 | Procaine benzylpenicillin for peak identification CRS | 15 mg | 6130-64-9 | |
| Y0002265 | Procaine benzylpenicillin for peak identification A | 15 mg | n/a | |
| Y0002171 | Procaine benzylpenicillin impurity F CRS | 0.025 mg | | |
| P3100000 | Procaine hydrochloride CRS | 100 mg | 51-05-8 | |
| Y0001941 | Raltegravir for peak identification CRS | 10 mg | 871038-72-1 | |
| Y0002082 | Prochlorperazine for system suitability CRS | 10 mg | | |
| P3200000 | Prochlorperazine maleate CRS | 100 mg | 84-02-6 | |
| Y0001949 | Raltegravir impurity E CRS | 10 mg | N/A | |
| P3300000 | Progesterone CRS | 120 mg | 57-83-0 | |
| Y0001667 | Progesterone for impurity H identification CRS | 20 mg | N/A | |
| Y0001666 | Progesterone for peak identification CRS | 5 mg | N/A | |
| Y0001665 | Progesterone for system suitability CRS | 5 mg | N/A | |
| Y0001885 | Proguanil for system suitability CRS | 15 mg | 637-32-1 | |
| Y0001901 | Proguanil hydrochloride CRS | 10 mg | 637-32-1 | |
| Y0000179 | Proguanil hydrochloride - reference spectrum | n/a | n/a | |
| Y0001909 | Proguanil impurity B CRS | 15 mg | 106-47-8 | |
| P3350000 | Proline CRS | 60 mg | 147-85-3 | |
| P3390000 | Promazine hydrochloride CRS | 40 mg | 53-60-1 | |
| P3400000 | Promethazine hydrochloride CRS | 50 mg | 58-33-3 | |
| Y0000769 | Promethazine impurity D CRS | 35 mg | n/a | |
| Y0000797 | Promethazine for peak identification CRS | 5 mg | 58-33-3 | |
| P3490000 | Propacetamol hydrochloride - reference spectrum | n/a | n/a | |
| Y0000455 | Propafenone hydrochloride CRS | 10 mg | 34183-22-7 | |
| Y0000456 | Propafenone impurity B CRS | 10 mg | n/a | |
| Y0000278 | Propanol - reference spectrum | n/a | n/a | |
| Y0000016 | Propofol CRS | 650 mg | 2078-54-8 | |
| Y0000018 | Propofol impurity J CRS | 20 mg | n/a | |
| Y0000017 | Propofol for peak identification CRS | 0.1 ml | 2078-54-8 | |
| Y0002135 | Propranolol for system suitability CRS | 15 mg | n/a | |
| P3500000 | Propranolol hydrochloride CRS | 30 mg | 318-98-9 | |
| Y0001547 | Propylene glycol CRS | 150 mg | 57-55-6 | |
| Y0000318 | Propylene glycol dilaurate CRS | 100 mg | 22788-19-8 | |
| Y0000319 | Propylene glycol monolaurate CRS | 100 mg | 27194-74-7 | |
| Y0002116 | Propyl gallate for ID and assay CRS | 80 mg | 121-79-9 | |
| P3650000 | Propyl parahydroxybenzoate CRS | 150 mg | 94-13-3 | |
| P3700000 | Propylthiouracil CRS | 30 mg | 51-52-5 | |
| P3750000 | Propyphenazone CRS | 200 mg | 479-92-5 | |
| Y0002179 | Protamine sulfate CRS | 3 mg | 9009-65-8 | |
| P3760000 | Protirelin CRS | 5.03 mg | 24305-27-9 | |
| P3760020 | D-His-Protirelin CRS | 0.1 mg | n/a | |
| P3800000 | Proxyphylline CRS | 100 mg | 603-00-9 | |
| P3850000 | Pseudoephedrine hydrochloride CRS - * Drug Precursor | 50 mg | 345-78-8 | |
| Y0000387 | Pseudoisoeugenyl 2-methylbutyrate for peak identification CRS | 100 mg | 8007-70-3 | |
| Y0001537 | Purified quillaia saponins HRS | 30 mg | 68990-67-0 | |
| P3900000 | Purpureaglycoside A CRS | 25 mg | 19855-40-4 | |
| P4000000 | Purpureaglycoside B CRS | 25 mg | 19855-39-1 | |
| Y0000402 | Pyrantel embonate CRS | 10 mg | 22204-24-6 | |
| Y0000403 | Pyrantel impurity A CRS | 20 mg | n/a | |
| Y0002158 | Pyrantel impurity C CRS | 30 mg | 98-03-3 | |
| Y0001817 | Pyrantel impurity D CRS | 20 mg | 4271-96-9 | |
| P4050000 | Pyrazinamide CRS | 30 mg | 98-96-4 | |
| P4099900 | Pyridostigmine bromide CRS | 30 mg | 101-26-8 | |
| P4099910 | Pyridostigmine impurity A CRS | 20 mg | 51581-32-9 | |
| Y0001486 | Pyridostigmine impurity B CRS | 10 mg | n/a | |
| P4100000 | Pyridoxine hydrochloride CRS | 100 mg | 58-56-0 | |
| Y0001226 | Pyridoxine impurity A CRS | 5 mg | 5196-20-3 | |
| P4200000 | Pyrimethamine CRS | 250 mg | 58-14-0 | |
| Y0002066 | Pyrimethamine impurity B CRS | 20 mg | 3275-44-3 | |
| Y0000659 | Pyrrolidone CRS | 20 mg | 616-45-5 | |
| Y0001009 | Quercetin dihydrate CRS | 25 mg | 6151-25-3 | |
| Y0001657 | Quetiapine fumarate CRS | 50 mg | 111974-72-2 | |
| Y0001931 | Quercitrin CRS | 15 mg | 522-12-3 | |
| Y0001419 | Quetiapine for system suitability CRS | 2 mg | 111974-72-2 | |
| Y0001564 | Quillaia saponin for assay CRS | 30 mg | 53956-04-0 | |
| Y0001491 | Quinapril hydrochloride CRS | 30 mg | 82586-55-8 | |
| Y0001502 | Quinapril for peak identification CRS | 5.075 mg | 82586-55-8 | |
| Y0001503 | Quinapril for system suitability CRS | 5.125 mg | 82586-55-8 | |
| Q0100000 | Quinidine sulfate CRS | 300 mg | 6591-63-5 | |
| Q0200000 | Quinine sulfate CRS | 300 mg | 6119-70-6 | |
| Y0001783 | Rabeprazole sodium hydrate CRS | 150 mg | 891191-56-3 | |
| R0100000 | Rabies vaccine (inactivated) for veterinary use BRP | 86 mg | n/a | |
| Y0000896 | Racecadotril CRS | 120 mg | 81110-73-8 | |
| Y0000897 | Racecadotril impurity A CRS | 1.5 mL | 507-09-5 | |
| Y0000898 | Racecadotril impurity G CRS | 10 mg | n/a | |
| Y0000902 | Racecadotril for peak identification CRS | 5 mg | 81110-73-8 | |
| Y0001134 | Raloxifene hydrochloride CRS | 110 mg | 82640-04-8 | |
| Y0001135 | Raloxifene for peak identification CRS | 10 mg | 82640-04-8 | |
| Y0001943 | Raltegravir potassium CRS | 100 mg | 871038-72-1 | |
| R0145000 | Ramipril CRS | 20 mg | 87333-19-5 | |
| R0145005 | Ramipril impurity A CRS | 10 mg | 108313-11-7 | |
| R0145010 | Ramipril impurity B CRS | 10 mg | 295328-72-2 | |
| R0145015 | Ramipril impurity C CRS | 10 mg | 885516-61-0 | |
| Y0002227 | Regorafenib impurity FP-B CRS | 15 mg | | |
| R0145020 | Ramipril impurity D CRS | 10 mg | 108731-95-9 | |
| R0150000 | Ranitidine hydrochloride CRS | 100 mg | 66357-59-3 | |
| Y0000416 | Ranitidine impurity J CRS | 0.00025 mg | n/a | |
| Y0001787 | Ranitidine for impurity A identification CRS | 15 mg | 66357-59-3 | |
| Y0001565 | Recombinant Major Allergen rBet v 1 CRS | 0.01025 mg | n/a | |
| Y0001566 | Recombinant Major Allergen rPhl p 5a CRS | 0.00856 mg | n/a | |
| Y0002225 | Regorafenib for FP system suitability CRS | 10 mg | n/a | |
| Y0002093 | Regorafenib impurity A CRS | 15 mg | 757251-39-1 | |
| Y0002091 | Regorafenib impurity C CRS | 10 mg | | |
| Y0002092 | Regorafenib impurity D CRS | 10 mg | | |
| Y0002228 | Regorafenib impurity FP-C CRS | 20 mg | | |
| Y0002090 | Regorafenib monohydrate CRS | 120 mg | 1019206-88-2 | |
| Y0001892 | Remifentanil hydrochloride CRS - * narc | 100 mg | 132539-07-2 | |
| Y0001884 | Remifentanil impurity mixture - * narc CRS | 15 mg | 132539-07-2 | |
| Y0000457 | Repaglinide CRS | 20 mg | 135062-02-1 | |
| Y0000459 | Repaglinide impurity E CRS | 10 mg | N/A | |
| Y0000458 | Repaglinide for system suitability CRS | 6 mg | 135062-02-1 | |
| R0200000 | Reserpine CRS | 100 mg | 50-55-5 | |
| R0250000 | Class 1 residual solvent solution CRS - * ODS | 1.4 mL | n/a | |
| Y0000767 | Resorcinol CRS | 30 mg | 108-46-3 | |
| Y0001194 | Resveratrol CRS | 25 mg | 501-36-0 | |
| R0300000 | Retinol acetate CRS | 500 mg | 127-47-9 | |
| R0290000 | Retinol esters CRS | 100 mg | n/a | |
| Y0002159 | Rhein CRS | 25 mg | 478-43-3 | |
| Y0000377 | Ribavirin CRS | 150 mg | 36791-04-5 | |
| R0600000 | Riboflavin CRS | 130 mg | 83-88-5 | |
| Y0000757 | Riboflavin for peak identification CRS | 0.12 mg | 83-88-5 | |
| R0630000 | Riboflavin sodium phosphate CRS | 250 mg | 130-40-5 | |
| Y0000662 | Ribonucleic acid CRS | 100 mg | 63231-63-0 | |
| Y0000149 | Rifabutin CRS | 150 mg | 72559-06-9 | |
| Y0000184 | Rifabutin impurity A CRS | 20 mg | n/a | |
| R0700000 | Rifampicin CRS | 100 mg | 13292-46-1 | |
| R0800000 | Rifampicin quinone CRS | 50 mg | 13983-13-6 | |
| R1000000 | Rifamycin sodium CRS | 150 mg | 14897-39-3 | |
| R0900000 | Rifamycin B CRS | 25 mg | 13929-35-6 | |
| R0950000 | Rifamycin S CRS | 100 mg | 13553-79-2 | |
| Y0001074 | Rifaximin CRS | 160 mg | 80621-81-4 | |
| Y0001075 | Rifaximin for system suitability CRS | 10 mg | 80621-81-4 | |
| Y0000250 | Rilmenidine dihydrogenophosphate - reference spectrum | n/a | n/a | |
| Y0000187 | Rilmenidine for system suitability CRS | 30 mg | 85409-38-7 | |
| Y0002238 | Riociguat CRS | 130 mg | 625115-55-1 | |
| Y0002240 | Riociguat for FP system suitability CRS | 15 mg | | |
| Y0002239 | Riociguat for system suitability CRS | 15 mg | | |
| Y0001541 | Risedronate sodium 2.5-hydrate CRS | 15 mg | 329003-65-8 | |
| Y0001558 | Risedronate impurity A CRS | 15 mg | n/a | |
| Y0001540 | Risedronate impurity E CRS | 15 mg | 75755-10-1 | |
| R1000600 | Risperidone CRS | 50 mg | 106266-06-2 | |
| Y0001276 | Risperidone impurity K CRS | 0.015 mg | n/a | |
| Y0000370 | Risperidone for system suitability CRS | 20 mg | 106266-06-2 | |
| Y0000714 | Ritonavir CRS | 80 mg | 155213-67-5 | |
| Y0000706 | Ritonavir for peak identification CRS | 10 mg | 155213-67-5 | |
| Y0002187 | Rivaroxaban CRS | 100 mg | 366789-02-8 | |
| Y0002193 | Rivaroxaban for system suitability CRS | 5 mg | n/a | |
| Y0002188 | Rivaroxaban impurity A CRS | 5 mg | | |
| Y0001485 | Rivastigmine for system suitability CRS | 1.0114 mg | 129101-54-8 | |
| Y0001516 | Rivastigmine hydrogen tartrate CRS | 350 mg | 129101-54-8 | |
| Y0001515 | Rivastigmine impurity D CRS | 10 mg | 415973-05-6 | |
| Y0001302 | Rizatriptan benzoate CRS | 200 mg | 145202-66-0 | |
| Y0001303 | Rizatriptan for system suitability CRS | 15 mg | 145202-66-0 | |
| R1300000 | RK 13 cell line | 1 ml | n/a | |
| Y0001580 | Rocuronium bromide CRS | 20 mg | 119302-91-9 | |
| Y0000527 | Rocuronium for peak identification CRS | 10 mg | 119302-91-9 | |
| Y0001773 | Ropinirole hydrochloride CRS | 125 mg | 91374-20-8 | |
| Y0001774 | Ropinirole impurity A CRS | 25 mg | | |
| Y0001775 | Ropinirole for peak identification 1 CRS | 15 mg | 91374-20-8 | |
| Y0001776 | Ropinirole for peak identification 2 CRS | 15 mg | 91374-20-8 | |
| Y0002019 | Ropinirole for peak identification 3 CRS | 10 mg | 91374-20-8 | |
| Y0000742 | Ropivacaine hydrochloride monohydrate CRS | 10 mg | 132112-35-7 | |
| Y0000743 | Ropivacaine impurity G CRS | 5 mg | N/A | |
| Y0000786 | Rosmarinic acid CRS | 50 mg | 20283-92-5 | |
| Y0001719 | Rosuvastatin Calcium CRS | 100 mg | 147098-20-2 | |
| Y0002146 | Rosuvastatin for impurity L identification CRS | 10 mg | | |
| Y0002150 | Rosuvastatin for peak identification CRS | 15 mg | n/a | |
| Y0001721 | Rosuvastatin for system suitability CRS | 15 mg | 147098-20-2 | |
| Y0001722 | Rosuvastatin impurity G CRS | 0.004 mg | 1242184-42-4 | |
| Y0002167 | Rosuvastatin impurity mixture CRS | 0.002 mg | n/a | |
| Y0002010 | Rotigotine CRS | 50 mg | 99755-59-6 | |
| R1500000 | Roxithromycin CRS | 125 mg | 80214-83-1 | |
| Y0002005 | Rotigotine hydrochloride CRS | 70 mg | 125572-93-2 | |
| Y0002016 | Rotigotine impurity C CRS | 10 mg | | |
| Y0000220 | Roxithromycin for system suitability CRS | 10 mg | 80214-83-1 | |
| Y0002017 | Rotigotine impurity G CRS | 10 mg | | |
| R2000000 | Rubella vaccine (live) BRP | 90 mg | n/a | |
| Y0001919 | Rupatadine for system suitability CRS | 10 mg | n/a | |
| Y0001922 | Rupatadine fumarate CRS | 10 mg | 182349-12-8 | |
| Y0000494 | Ruscogenins CRS | 10 mg | 472-11-7 | |
| Y0000105 | Rutoside trihydrate CRS | 100 mg | 250249-75-3 | |
| S0040000 | Saccharin CRS | 30 mg | 81-07-2 | |
| S0050000 | Saccharin sodium CRS | 50 mg | 128-44-9 | |
| Y0001932 | Saikosaponin A CRS | 25 mg | 20736-09-8 | |
| S0100000 | Salbutamol CRS | 50 mg | 18559-94-9 | |
| Y0000030 | Salbutamol impurity B CRS | 5 mg | n/a | |
| Y0000071 | Salbutamol impurity D CRS | 10 mg | 156339-88-7 | |
| Y0000031 | Salbutamol impurity F CRS | 10 mg | n/a | |
| Y0000034 | Salbutamol impurity G CRS | 10 mg | 24085-08-3 (HCl) | |
| Y0000032 | Salbutamol impurity I CRS | 0.006 mg | n/a | |
| Y0001186 | Salbutamol impurity J CRS | 0.00045 mg | n/a | |
| S0150000 | Salbutamol sulfate CRS | 50 mg | 51022-70-9 | |
| Y0001288 | Salbutamol sulfate for system suitability CRS | 0.4 mg | 51022-70-9 | |
| Y0000669 | Salicin CRS | 50 mg | 138-52-3 | |
| S0200000 | Salicylic acid CRS | 100 mg | 69-72-7 | |
| Y0000405 | Salicylic acid impurity B CRS | 15 mg | 636-46-4 | |
| Y0000422 | Salmeterol xinafoate CRS | 70 mg | 94749-08-3 | |
| Y0001625 | Salmeterol xinafoate for peak identification CRS | 15 mg | 94749-08-3 | |
| Y0000423 | Salmeterol xinafoate for system suitability CRS | 25 mg | 94749-08-3 | |
| Y0001559 | Salvianolic acid B CRS | 15 mg | 115939-25-8 | |
| Y0001052 | Santonin CRS | 20 mg | 481-06-1 | |
| Y0001049 | Saquinavir mesilate CRS | 70 mg | 149845-06-7 | |
| Y0001056 | Saquinavir for system suitability CRS | 0.3033 mg | 149845-06-7 | |
| Y0001483 | Saw palmetto extract HRS | 8000 mg | 90106-85-7 | |
| Y0001818 | Schisandrin CRS | 15 mg | 7432-28-2 | |
| Y0000814 | Selamectin CRS | 120 mg | 165108-07-6 | |
| Y0001734 | Selamectin for peak identification CRS | 5 mg | 165108-07-6 | |
| Y0001661 | Selamectin impurity B CRS | 0.005 mg | n/a | |
| S0360000 | Selegiline hydrochloride CRS | 50 mg | 14611-52-0 | |
| S0360090 | (RS)-Selegiline hydrochloride CRS | 25 mg | 14611-51-9 | |
| S0400000 | Senna extract CRS | 50 mg | 85085-71-8 | |
| Y0002151 | Senna Extract HRS | 25 mg | | |
| Y0002143 | Sennoside B CRS | 15 mg | 128-57-4 | |
| S0450000 | Serine CRS | 50 mg | 56-45-1 | |
| S0460000 | Sertaconazole nitrate CRS | 125 mg | 99592-39-9 | |
| Y0000828 | Sertraline hydrochloride CRS | 200 mg | 79559-97-0 | |
| Y0001285 | Sertraline impurity E CRS | 15 mg | 611-71-2 | |
| Y0000866 | Sertraline for peak identification CRS | 5.4 mg | 79559-97-0 | |
| Y0000867 | Sertraline for system suitability CRS | 6.2 mg | 79559-97-0 | |
| Y0000371 | Sestamibi labelling kit CRS | 22 mg | NA | |
| Y0001046 | Sevoflurane CRS | 0.5 mL | 28523-86-6 | |
| Y0001993 | Sevoflurane for system suitability CRS | 0.5 mL | n/a | |
| Y0001578 | Sildenafil citrate CRS | 100 mg | 171599-83-0 | |
| Y0001891 | Sildenafil for peak identification CRS | 15 mg | 171599-83-0 | |
| Y0001579 | Sildenafil impurity A CRS | 5 mg | N/A | |
| S0500000 | Silicone elastomer CRS | 2000 mg | n/a | |
| S0600000 | Silicone oil CRS | 1 mL | 63148-62-9 | |
| S0650000 | Simvastatin CRS | 200 mg | 79902-63-9 | |
| Y0002069 | Simvastatin for system suitability CRS | 5 mg | n/a | |
| Y0002051 | Simvastatin impurity K CRS | 10 mg | N/A | |
| Y0001208 | Sinomenine CRS | 20 mg | 115-53-7 | |
| S0660000 | Sisomicin sulfate CRS | 60 mg | 53179-09-2 | |
| Y0001812 | Sitagliptin phosphate monohydrate CRS | 120 mg | 654671-77-9 | |
| Y0001811 | Sitagliptin containing impurity A CRS | 15 mg | N/A | |
| Y0001727 | Sodium alendronate trihydrate CRS | 150 mg | 121268-17-5 | |
| Y0001678 | Sodium alendronate for system suitability CRS | 5 mg | 121268-17-5 | |
| S0695000 | Sodium amidotrizoate CRS | 125 mg | 737-31-5 | |
| Y0001669 | Sodium aminosalicylate dihydrate CRS | 10 mg | 6018-19-5 | |
| Y0000300 | Sodium aminosalicylate dihydrate - reference spectrum | n/a | n/a | |
| Y0001816 | Sodium Aminosalicylate dihydrate for equipment qualification CRS | 5000 mg | 6018-19-5 | |
| Y0000039 | Sodium ascorbate CRS | 50 mg | 134-03-2 | |
| S0700000 | Sodium calcium edetate CRS | 100 mg | 62-33-9 | |
| S0710000 | Sodium cetostearyl sulfate CRS | 100 mg | 59186-41-3 | |
| S0750000 | Sodium cromoglicate CRS | 10 mg | 15826-37-6 | |
| Y0001300 | Sodium cromoglicate for system suitability CRS | 20 mg | 15826-37-6 | |
| S0760000 | Sodium cyclamate CRS | 100 mg | 139-05-9 | |
| Y0001410 | Sodium fusidate CRS | 10 mg | 751-94-0 | |
| S0780000 | Sodium hyaluronate BRP | 300 mg | 9067-32-7 | |
| S0781000 | Sodium hyaluronate - reference spectrum | n/a | n/a | |
| Y0001468 | Sodium iodohippurate CRS | 15 mg | 5990-94-3 | |
| Y0000620 | Sodium laurilsulfate CRS | 40 mg | 151-21-3 | |
| Y0001772 | Sodium lauroylsarcosinate CRS | 550 mg | 137-16-6 | |
| Y0000808 | Sodium phenylbutyrate CRS | 5 mg | 1716-12-7 | |
| Y0000809 | Sodium phenylbutyrate impurity C CRS | 10 mg | 4441-63-8 | |
| S0785000 | Sodium picosulfate CRS | 40 mg | 10040-45-6 | |
| Y0000210 | Sodium polystyrene sulfonate - reference spectrum | n/a | n/a | |
| Y0000268 | Sodium propionate - reference spectrum | n/a | n/a | |
| S0800000 | Sodium salicylate CRS | 100 mg | 54-21-7 | |
| S0808000 | Sodium stearyl fumarate CRS | 50 mg | 4070-80-8 | |
| Y0002027 | Zoledronic acid impurity B CRS | 15 mg | 1627731-61-6 | |
| S0808060 | Sodium stearyl maleate CRS | 15 mg | n/a | |
| S0900000 | Sodium taurocholate BRP | 10000 mg | 145-42-6 | |
| S0930000 | Sodium valproate CRS | 50 mg | 1069-66-5 | |
| Y0001743 | Solifenacin for system suitability CRS | 2.52 mg | 242478-38-2 | |
| Y0001763 | Solifenacin succinate CRS | 5 mg | 242478-38-2 | |
| S0945000 | Somatostatin CRS | 2.09 mg | 38916-34-6 | |
| S0947000 | Somatropin CRS | 55 mg | 12629-01-5 | |
| Y0000711 | Somatropin/desamidosomatropin resolution mixture CRS | 3 mg | n/a | |
| Y0002098 | Sorafenib CRS | 10 mg | 475207-59-1 | |
| Y0002236 | Sorafenib for peak identification CRS | 15 mg | N/A | |
| Y0002233 | Sorafenib impurity H CRS | 10 mg | N/A | |
| Y0002224 | Sorafenib tosilate CRS | 120 mg | | |
| S0950000 | Sorbic acid CRS | 10 mg | 110-44-1 | |
| Y0000385 | 1,4-Sorbitan CRS | 50 mg | 27299-12-3 | |
| S1000000 | Sorbitol CRS | 1250 mg | 50-70-4 | |
| Y0000114 | Sotalol hydrochloride CRS | 25 mg | 959-24-0 | |
| Y0000115 | Sotalol impurity B CRS | 20 mg | 60735-85-5 | |
| Y0001011 | Spanish sage oil for peak identification CRS | 250 mg | 8016-65-7 | |
| Y0000549 | Spectinomycin for system suitability CRS | 20 mg | 22189-32-8 | |
| Y0000597 | Spectinomycin hydrochloride CRS | 100 mg | 22189-32-8 | |
| Y0000655 | Spectinomycin sulfate tetrahydrate CRS | 10 mg | 64058-48-6 | |
| Y0001126 | Spike lavender oil CRS | 400 µl | 8016-78-2 | |
| S1100000 | Spiramycin CRS | 200 mg | 8025-81-8 | |
| Y0000381 | Spirapril hydrochloride monohydrate CRS | 60 mg | 94841-17-5 | |
| Y0000332 | Spirapril for system suitability CRS | 15 mg | 94841-17-5 | |
| S1200000 | Spironolactone CRS | 160 mg | 52-01-7 | |
| Y0001295 | Spironolactone for system suitability CRS | 2.06 mg | 52-01-7 | |
| Y0000185 | Squalane CRS | 300 µL | 111-01-3 | |
| Y0002131 | Squalene CRS | 500 mg | 111-02-4 | |
| Y0001050 | St. John's wort dry extract HRS | 500 mg | 84082-80-4 | |
| S1250000 | Stanozolol CRS | 50 mg | 10418-03-8 | |
| S1250010 | Stanozolol impurity A CRS | 10 mg | 521-11-9 | |
| Y0001420 | Stanozolol impurity B CRS | 10 mg | 434-07-1 | |
| S1300000 | Starch BRP | 50000 mg | 9005-84-9 | |
| Y0000408 | Stavudine CRS | 100 mg | 3056-17-5 | |
| Y0001683 | Stavudine impurity I CRS | 5 mg | 122567-97-9 | |
| Y0000421 | Stavudine for system suitability CRS | 10 mg | 3056-17-5 | |
| S1340000 | Stearic acid CRS | 100 mg | 57-11-4 | |
| S1350000 | Stearyl alcohol CRS | 250 mg | 112-92-5 | |
| Y0000868 | Streptokinase for system suitability CRS | 30 µl | n/a | |
| S1400000 | Streptomycin sulfate CRS | 100 mg | 3810-74-0 | |
| Y0002232 | Streptomycin sulfate for identification CRS | 25 mg | 3810-74-0 | |
| Y0001195 | Strychnine CRS | 40 mg | 57-24-9 | |
| Y0001988 | Succinic acid CRS | 20 mg | 110-15-6 | |
| Y0001324 | Sucralfate CRS | 10 mg | 54182-58-0 | |
| Y0001344 | Sucralose CRS | 550 mg | 56038-13-2 | |
| Y0001342 | Sucralose impurity B CRS | 0.5 mg | n/a | |
| S1600000 | Sucrose CRS | 200 mg | 57-50-1 | |
| S1608100 | Sufentanil - reference spectrum | n/a | n/a | |
| S1609000 | Sufentanil citrate - reference spectrum | n/a | n/a | |
| Y0000528 | Sulbactam CRS | 150 mg | 68373-14-8 | |
| Y0000529 | Sulbactam sodium CRS | 10 mg | 69388-84-7 | |
| Y0000550 | Sulbactam for peak identification CRS | 20 mg | 68373-14-8 | |
| S1700000 | Sulfacetamide sodium CRS | 50 mg | 127-56-0 | |
| S1800000 | Sulfadiazine CRS | 100 mg | 68-35-9 | |
| Y0001480 | Sulfadiazine for identification of impurity F CRS | 15 mg | 68-35-9 | |
| Y0001469 | Sulfadiazine impurity A CRS | 20 mg | 109-12-6 | |
| Y0001677 | Sulfadimethoxine CRS | 60 mg | 122-11-2 | |
| Y0001679 | Sulfadimethoxine for peak identification CRS | 10 mg | 122-11-2 | |
| S1900000 | Sulfadimidine CRS | 100 mg | 57-68-1 | |
| Y0001495 | Sulfadimidine for peak identification CRS | 50 mg | 57-68-1 | |
| S1950000 | Sulfadoxine CRS | 50 mg | 2447-57-6 | |
| S1975000 | Sulfafurazole CRS | 100 mg | 127-69-5 | |
| S1975600 | Sulfaguanidine CRS | 60 mg | 57-67-0 | |
| S2000000 | Sulfamerazine CRS | 100 mg | 127-79-7 | |
| Y0002168 | Sulfamethizole for system suitability CRS | 10 mg | n/a | |
| S2050000 | Sulfamethizole CRS | 100 mg | 144-82-1 | |
| S2100000 | Sulfamethoxazole CRS | 50 mg | 723-46-6 | |
| Y0000412 | Sulfamethoxazole impurity A CRS | 5 mg | 21312-10-7 | |
| Y0000413 | Sulfamethoxazole impurity F CRS | 5 mg | n/a | |
| S2150000 | Sulfamethoxypyridazine CRS | 50 mg | 80-35-3 | |
| S2151000 | Sulfanilamide CRS | 100 mg | 63-74-1 | |
| S2159100 | Sulfapyridine CRS | 20 mg | 144-83-2 | |
| S2155000 | Sulfasalazine CRS | 320 mg | 599-79-1 | |
| S2155010 | Sulfasalazine derivative for resolution CRS | 20 mg | n/a | |
| S2158000 | Sulfathiazole CRS | 100 mg | 72-14-0 | |
| S2159000 | Sulfinpyrazone CRS | 30 mg | 57-96-5 | |
| S2159010 | Sulfinpyrazone impurity A CRS | 20 mg | 1106-50-9 | |
| S2159015 | Sulfinpyrazone impurity B CRS | 20 mg | n/a | |
| Y0001238 | Sulfinpyrazone for system suitability CRS | 0.5 mg | 57-96-5 | |
| Y0002007 | Sulfobutylbetadex impurity B CRS | 110 mg | 1633-83-6 | |
| Y0002008 | Sulfobutylbetadex impurity C CRS | 35 mg | 2386-54-1 | |
| Y0002006 | Sulfobutylbetadex impurity D CRS | 40 mg | 183278-30-0 | |
| Y0001998 | Sulfobutylbetadex sodium CRS | 850 mg | 182410-00-0 | |
| S2180000 | Sulindac CRS | 100 mg | 38194-50-2 | |
| Y0002255 | Sulindac for system suitability | 15 mg | 38194-50-2 | |
| S2190000 | Sulpiride CRS | 100 mg | 15676-16-1 | |
| S2191000 | Sulpiride impurity A CRS | 20 mg | 26116-12-1 | |
| S2192000 | Sulpiride impurity B CRS | 10 mg | 33045-52-2 | |
| Y0000530 | Sultamicillin CRS | 10 mg | 76497-13-7 | |
| Y0000532 | Sultamicillin for peak identification CRS | 10 mg | 76497-13-7 | |
| Y0000531 | Sultamicillin tosilate CRS | 200 mg | 83105-70-8 | |
| Y0000022 | Sumatriptan succinate CRS | 50 mg | 103628-48-4 | |
| Y0000026 | Sumatriptan impurity mixture CRS | 3 mg | 103628-48-4 | |
| Y0000027 | Sumatriptan for system suitability CRS | 10 mg | 103628-48-4 | |
| S2200000 | Suxamethonium chloride CRS | 1000 mg | 6101-15-1 | |
| Y0001778 | Rabeprazole for system suitability CRS | 15 mg | 891191-56-3 | |
| S2400000 | Suxibuzone CRS | 50 mg | 27470-51-5 | |
| S2400004 | Suxibuzone impurity B CRS | 10 mg | n/a | |
| S2400006 | Suxibuzone impurity C CRS | 10 mg | n/a | |
| S5000001 | Swine erysipelas bacteria, serotyp 1 (for vaccines - vet. use) BRP | 1 mg | n/a | |
| S5000002 | Swine erysipelas bacteria, serotyp 2 (for vaccines - vet. use) BRP | 1 mg | n/a | |
| Y0001854 | Tacalcitol monohydrate CRS | 15 mg | 93129-94-3 | |
| Y0001610 | Tacalcitol for system suitability CRS | 0.025 mg | 93129-94-3 | |
| Y0001824 | Tacalcitol impurity A CRS | 0.001 mg | 1294517-97-7 | |
| Y0001926 | Tacrolimus monohydrate CRS | 80 mg | 109581-93-3 | |
| Y0001933 | Tacrolimus for system suitability CRS | 10 mg | | |
| Y0001910 | Tacalcitol monohydrate - reference spectrum | 1 | N/A | |
| Y0001417 | Tadalafil CRS | 200 mg | 171596-29-5 | |
| T0010000 | Talampicillin hydrochloride CRS | 50 mg | 39878-70-1 | |
| T0014000 | Tamoxifen citrate CRS | 60 mg | 54965-24-1 | |
| T0015000 | Tamoxifen citrate for performance test CRS | 10 mg | 54965-24-1 | |
| Y0000650 | Tamsulosin hydrochloride CRS | 10 mg | 106463-17-6 | |
| Y0000651 | Tamsulosin impurity D CRS | 10 mg | n/a | |
| Y0000652 | Tamsulosin impurity H CRS | 10 mg | 1510821-28-9 | |
| Y0000653 | Tamsulosin racemate CRS | 10 mg | 106463-17-6 | |
| Y0001560 | Tanshinone IIa CRS | 15 mg | 568-72-9 | |
| Y0002120 | Tapentadol hydrochloride CRS - * narc | 80 mg | 175591-09-0 | |
| Y0002113 | Tapentadol impurity A CRS | 10 mg | 953400-57-2 | |
| Y0002114 | Tapentadol impurity C CRS | 10 mg | | |
| Y0001840 | Taxifolin CRS | 15 mg | 480-18-2 | |
| Y0001102 | Teicoplanin CRS | 50 mg | 61036-62-2 | |
| Y0001047 | Teicoplanin for identification CRS | 50 mg | 61036-62-2 | |
| Y0000648 | Telmisartan CRS | 30 mg | 144701-48-4 | |
| Y0000649 | Telmisartan for peak identification CRS | 10 mg | 144701-48-4 | |
| Y0001003 | Telmisartan for system suitability CRS | 0.26 mg | 144701-48-4 | |
| T0040000 | Temazepam CRS - * psy | 50 mg | 846-50-4 | |
| Y0000344 | Temazepam impurity C CRS | 5 mg | 18818-64-9 | |
| Y0000345 | Temazepam impurity D CRS | 5 mg | 17191-70-7 | |
| Y0000346 | Temazepam impurity F CRS | 10 mg | 3294-96-0 | |
| Y0000347 | Temazepam impurity G CRS | 5 mg | 93329-92-1 | |
| Y0001827 | Temozolomide CRS | 70 mg | 85622-93-1 | |
| Y0001960 | Temozolomide for peak identification CRS | 10 mg | N/A | |
| T0040800 | Tenoxicam CRS | 100 mg | 59804-37-4 | |
| Y0001114 | Tenoxicam impurity mixture CRS | 0.0042 mg | n/a | |
| Y0000621 | Terazosin hydrochloride dihydrate CRS | 40 mg | 70024-40-7 | |
| Y0000622 | Terazosin impurity A CRS | 10 mg | 23680-84-4 | |
| Y0000665 | Terazosin impurity E CRS | 10 mg | n/a | |
| Y0000623 | Terazosin impurity L CRS | 10 mg | n/a | |
| Y0000624 | Terazosin impurity N CRS | 15 mg | n/a | |
| Y0000666 | Terazosin for system suitability CRS | 0.59 mg | 70024-40-7 | |
| Y0002286 | Terazosin for system suitability A | 0.59 mg | | |
| Y0000535 | Terbinafine hydrochloride CRS | 10 mg | 78628-80-5 | |
| Y0001143 | Terbinafine for system suitability CRS | 10 mg | 78628-80-5 | |
| T0050000 | Terbutaline sulfate CRS | 100 mg | 23031-32-5 | |
| T0050015 | Terbutaline impurity C CRS | 15 mg | n/a | |
| T0060000 | Terconazole CRS | 180 mg | 67915-31-5 | |
| T0071000 | Terfenadine CRS | 100 mg | 50679-08-8 | |
| T0080000 | Terfenadine impurity A CRS | 20 mg | n/a | |
| Y0002247 | Teriflunomide CRS | 15 mg | 163451-81-8 | |
| Y0002253 | Teriflunomide for assay | 50 mg | 163451-81-8 | |
| Y0002254 | Teriflunomide impurity B | 15 mg | | |
| Y0001916 | Teriparatide CRS | 1 mg | 52232-67-4 | |
| Y0001895 | Teriparatide for system suitability CRS | 1.3 mg | 52232-67-4 | |
| Y0001897 | Terlipressin CRS | 1 mg | 14636-12-5 | |
| Y0001898 | Terlipressin for NMR identification CRS | 2.9 mg | 14636-12-5 | |
| Y0001899 | Terlipressin impurity mixture CRS | 0.03 mg | N/A | |
| Y0002049 | Terpin monohydrate CRS | 200 mg | 2451-01-6 | |
| T0100000 | Testosterone CRS | 30 mg | 58-22-0 | |
| T0210000 | Testosterone caproate CRS | 50 mg | n/a | |
| T0240000 | Testosterone decanoate CRS | 50 mg | 5721-91-5 | |
| Y0000696 | Testosterone decanoate for system suitability CRS | 0.4 mg | 5721-91-5 | |
| T0250000 | Testosterone enantate CRS | 40 mg | 315-37-7 | |
| Y0001312 | Testosterone enantate for peak identification CRS | 10 mg | 315-37-7 | |
| Y0001317 | Testosterone enantate for system suitability CRS | 2 mg | 315-37-7 | |
| Y0001313 | Testosterone enantate impurity H CRS | 10 mg | n/a | |
| Y0002163 | Testosterone for ID and assay CRS | 90 mg | 58-22-0 | |
| Y0002174 | Testosterone for system suitability A CRS | 20 mg | n/a | |
| Y0002145 | Testosterone impurity I CRS | 20 mg | 2484-30-2 | |
| T0260000 | Testosterone isocaproate CRS | 50 mg | 15262-86-9 | |
| Y0000716 | Testosterone isocaproate for system suitability CRS | 5 mg | 15262-86-9 | |
| T0300000 | Testosterone propionate CRS | 60 mg | 57-85-2 | |
| T0400000 | Tetanus vaccine (adsorbed) BRP | 30 mg | n/a | |
| Y0001087 | Tetra-O-acetyl-mannose triflate CRS | 80 mg | 92051-23-5 | |
| T0500000 | Tetracaine hydrochloride CRS | 20 mg | 136-47-0 | |
| Y0002117 | Tetracaine CRS | 10 mg | | |
| Y0001002 | Tetracaine for system suitability CRS | 2 mg | 136-47-0 | |
| T0550000 | Tetracosactide CRS | 20.5 mg | N/A | |
| T0600000 | Tetracycline hydrochloride CRS | 80 mg | 64-75-5 | |
| Y0002056 | Tetrahydropalmatine CRS | 15 mg | 2934-97-6 | |
| Y0001165 | Tetrandrine CRS | 20 mg | 518-34-3 | |
| Y0000015 | Tetrazepam - reference spectrum | n/a | n/a | |
| Y0000008 | Tetrazepam impurity C CRS | 20 mg | n/a | |
| Y0000460 | Tetryzoline hydrochloride CRS | 10 mg | 522-48-5 | |
| Y0000723 | Thebaine CRS - * narc | 15 mg | 115-37-7 | |
| T0700000 | Theobromine CRS | 25 mg | 83-67-0 | |
| T0800000 | Theophylline CRS | 100 mg | 58-55-9 | |
| Y0000294 | Theophylline - reference spectrum | n/a | n/a | |
| Y0000336 | Thiamazole CRS | 30 mg | 60-56-0 | |
| Y0000372 | Thiamazole impurity A CRS | 15 mg | n/a | |
| Y0001409 | Testosterone propionate for system suitability CRS | 10 mg | 57-85-2 | |
| Y0000373 | Thiamazole impurity C CRS | 20 mg | N/A | |
| Y0000467 | Thiamine hydrochloride CRS | 10 mg | 67-03-8 | |
| Y0001749 | Thiamine for system suitability CRS | 0.5 mg | 67-03-8 | |
| Y0001758 | Thiamine nitrate CRS | 15 mg | 532-43-4 | |
| T1100000 | Thiamphenicol CRS | 125 mg | 15318-45-3 | |
| Y0001789 | Thiocolchicoside hydrate CRS | 60 mg | 602-41-5 | |
| Y0001790 | Thiocolchicoside crystallised from ethanol CRS | 10 mg | 602-41-5 | |
| Y0001791 | Thiocolchicoside for system suitability CRS | 10 mg | 602-41-5 | |
| Y0000546 | Thioctic acid CRS | 110 mg | 1077-28-7 | |
| Y0000545 | Thioctic acid containing impurity B CRS | 25 mg | 1077-28-7 | |
| Y0000592 | Thioctic acid for system suitability CRS | 15 mg | 1077-28-7 | |
| Y0000109 | Thiomersal CRS | 30 mg | 54-64-8 | |
| T1200000 | Thiopental CRS | 500 mg | 76-75-5 | |
| Y0001478 | Thiopental for system suitability CRS | 10 mg | 76-75-5 | |
| Y0000704 | Thioridazine CRS | 10 mg | 50-52-2 | |
| T1300000 | Thioridazine hydrochloride CRS | 100 mg | 130-61-0 | |
| Y0000541 | Thioridazine for system suitability CRS | 0.21 mg | 50-52-2 | |
| T1305100 | Thioxanthene CRS | 20 mg | 261-31-4 | |
| T1305000 | Thioxanthone CRS | 10 mg | 492-22-8 | |
| T1340000 | Threonine CRS | 50 mg | 72-19-5 | |
| T1350000 | Thymol CRS | 50 mg | 89-83-8 | |
| T1410000 | Tiabendazole CRS | 50 mg | 148-79-8 | |
| Y0000379 | Tiamulin - reference spectrum | n/a | n/a | |
| Y0000333 | Tiamulin hydrogen fumarate CRS | 500 mg | 55297-96-6 | |
| Y0000414 | Tiamulin for peak identification CRS | 10 mg | 55297-96-6 | |
| Y0000151 | Tianeptine sodium - reference spectrum | n/a | n/a | |
| Y0000153 | Tianeptine impurity A CRS | 30 mg | 29823-18-5 | |
| Y0000152 | Sodium Tianeptine for system suitability CRS | 30 mg | 30123-17-2 | |
| T1405000 | Tiapride hydrochloride CRS | 60 mg | 51012-33-0 | |
| T1405050 | Tiapride N-oxide CRS | 15 mg | 63484-11-7 | |
| T1410900 | Tiaprofenic acid CRS | 50 mg | 33005-95-7 | |
| T1410910 | Tiaprofenic acid impurity C CRS | 20 mg | n/a | |
| Y0000748 | Tibolone - reference spectrum | n/a | n/a | |
| Y0000668 | Tibolone for system suitability CRS | 10 mg | 5630-53-5 | |
| Y0002222 | Ticagrelor CRS | 120 mg | 274693-27-5 | |
| Y0000465 | Ticarcillin monosodium CRS | 250 mg | 4697-14-7 | |
| Y0002223 | Ticagrelor for system suitability CRS | 15 mg | | |
| T1420010 | Ticarcillin impurity A CRS | 50 mg | | |
| Y0002221 | Ticagrelor impurity E CRS | 15 mg | 376608-71-8 | |
| T1423000 | Ticlopidine hydrochloride CRS | 50 mg | 53885-35-1 | |
| T1423025 | Ticlopidine impurity F CRS | 15 mg | n/a | |
| Y0001940 | Tigecycline for system suitability CRS | 10 mg | 220620-09-7 | |
| Y0001961 | Tigecycline CRS | 150 mg | 220620-09-7 | |
| Y0001944 | Tigecycline impurity B CRS | 10 mg | 149934-21-4 | |
| Y0002172 | Tilidine for system suitability - * narc CRS | 10 mg | n/a | |
| Y0002173 | Tilidine hydrochloride hemihydrate CRS - * narc | 20 mg | 255733-17-6 | |
| Y0000325 | Tilidine hydrochloride hemihydrate - reference spectrum | n/a | n/a | |
| Y0000644 | (R)-timolol CRS | 20 mg | n/a | |
| T1450000 | Timolol maleate CRS | 100 mg | 26921-17-5 | |
| Y0001690 | Timolol impurity F CRS | 10 mg | 30165-96-9 | |
| Y0001270 | Timolol for system suitability CRS | 5.045 mg | 26921-17-5 | |
| T1470000 | Tinidazole CRS | 100 mg | 19387-91-8 | |
| Y0000899 | Tinidazole impurity A CRS | 15 mg | 88054-22-2 | |
| T1471000 | Tinidazole impurity B CRS | 20 mg | 25459-12-5 | |
| T1490000 | Tinzaparin sodium CRS | 250 mg | 9041-08-1 | |
| Y0000292 | Tioconazole - reference spectrum | n/a | n/a | |
| Y0000282 | Tioconazole for system suitability CRS | 50 mg | 65899-73-2 | |
| Y0001188 | Tiotropium bromide monohydrate CRS | 10 mg | 139404-48-1 | |
| Y0001929 | Tiotropium for system suitability 1 CRS | 10 mg | 139404-48-1 | |
| Y0001179 | Tiotropium impurity mixture CRS | 0.08 mg | n/a | |
| Y0001700 | Tizanidine hydrochloride CRS | 100 mg | 64461-82-1 | |
| Y0001698 | Tizanidine impurity B CRS | 10 mg | 64461-82-1 | |
| T1500000 | Tobramycin CRS | 25 mg | 32986-56-4 | |
| Y0001210 | Tobramycin for identification CRS | 250 mg | 32986-56-4 | |
| T1550000 | alpha-Tocopherol CRS | 1.5 mL | 10191-41-0 | |
| T1600000 | alpha-Tocopheryl acetate CRS | 500 mg | 7695-91-2 | |
| Y0000383 | All-rac-alpha-tocopherol for peak identification CRS | 50 mg | 59-02-9 | |
| Y0000384 | All-rac-alpha-tocopheryl acetate for peak identification CRS | 30 mg | 7695-91-2 | |
| T1610000 | RRR-alpha-Tocopheryl hydrogen succinate CRS | 150 mg | 4345-03-3 | |
| T1700000 | Tolbutamide CRS | 100 mg | 64-77-7 | |
| Y0000154 | Tolfenamic acid CRS | 100 mg | 13710-19-5 | |
| T1707000 | Tolnaftate CRS | 60 mg | 2398-96-1 | |
| Y0001123 | Tolnaftate for system suitability CRS | 10 mg | 2398-96-1 | |
| Y0001696 | Tolterodine tartrate CRS | 5 mg | 124937-52-6 | |
| Y0001699 | Tolterodine impurity E CRS | 5 mg | n/a | |
| Y0002134 | Topiramate CRS | 70 mg | 97240-79-4 | |
| Y0001697 | Tolterodine for system suitability CRS | 5 mg | n/a | |
| Y0002133 | Topiramate impurity A | 20 mg | N/A | |
| Y0002132 | Topiramate impurity E CRS | 40 mg | | |
| Y0000461 | Torasemide anhydrous CRS | 10 mg | 56211-40-6 | |
| Y0001366 | Torasemide impurity E CRS | 0.0006 mg | n/a | |
| Y0000462 | Torasemide for system suitability CRS | 5 mg | 56211-40-6 | |
| Y0000155 | Tramadol hydrochloride CRS | 75 mg | 36282-47-0 | |
| Y0000156 | Tramadol impurity A CRS | 20 mg | 73806-49-2 | |
| Y0000157 | Tramadol impurity E CRS | 15 mg | n/a | |
| Y0000072 | Tramazoline hydrochloride monohydrate CRS | 20 mg | 74195-73-6 | |
| Y0000065 | Tramazoline impurity A CRS | 15 mg | n/a | |
| Y0000066 | Tramazoline impurity B CRS | 15 mg | n/a | |
| Y0000501 | Trandolapril CRS | 10 mg | 87679-37-6 | |
| Y0000495 | Trandolapril impurity C CRS | 10 mg | n/a | |
| Y0000496 | Trandolapril impurity D CRS | 10 mg | n/a | |
| T1810000 | Tranexamic acid CRS | 50 mg | 1197-18-8 | |
| Y0002155 | Tranexamic acid impurity B CRS | 15 mg | N/A | |
| Y0002162 | Tranexamic acid impurity D CRS | 15 mg | 56-91-7 | |
| Y0002154 | Tranexamic acid impurity C CRS | 10 mg | | |
| Y0002149 | Tranexamic acid impurity E CRS | 10 mg | 82755-59-7 | |
| Y0002153 | Tranexamic acid impurity F CRS | 10 mg | | |
| T1820000 | Trapidil CRS | 50 mg | 15421-84-8 | |
| T1820002 | Trapidil impurity A CRS | 20 mg | 2503-56-2 | |
| T1820004 | Trapidil impurity B CRS | 20 mg | 61-82-5 | |
| Y0001172 | Trehalose dihydrate CRS | 250 mg | 6138-23-4 | |
| T1850000 | Tretinoin CRS | 50 mg | 302-79-4 | |
| G0400010 | Triacetin - reference spectrum | n/a | n/a | |
| T1899990 | Triamcinolone CRS | 100 mg | 124-94-7 | |
| T1900000 | Triamcinolone acetonide CRS | 150 mg | 76-25-5 | |
| Y0001459 | Triamcinolone acetonide for system suitability CRS | 10 mg | 76-25-5 | |
| Y0000050 | Triamcinolone impurity C CRS | 10 mg | n/a | |
| T1950000 | Triamcinolone hexacetonide CRS | 100 mg | 5611-51-8 | |
| Y0001843 | Triamcinolone hexacetonide for system suitability CRS | 10 mg | 5611-51-8 | |
| Y0000837 | Triamterene CRS | 10 mg | 396-01-0 | |
| Y0000870 | Triamterene impurity B CRS | 0.5 mg | n/a | |
| T1975000 | Triazolam CRS - * psy | 10 mg | 28911-01-5 | |
| Y0000165 | Tribenoside CRS | 150 mg | 10310-32-4 | |
| Y0000166 | Tribenoside impurity A CRS | 70 mg | 53928-30-6 | |
| Y0001628 | Tribenoside impurity D CRS | 100 mg | 103-50-4 | |
| Y0001055 | Tributyl acetylcitrate CRS | 1 mL | 77-90-7 | |
| Y0000799 | Tributyl acetylcitrate for peak identification CRS | 25 mg | 77-90-7 | |
| T1977990 | Tricaprin CRS | 150 mg | 621-71-6 | |
| T1977995 | Tricaproin CRS | 40 mg | 621-70-5 | |
| T1978000 | Tricaprylin CRS | 450 mg | 538-23-8 | |
| Y0000111 | Trichloroacetic acid - reference spectrum | n/a | n/a | |
| T1985000 | Trichlorotrifluoroethane CRS | 2.5 ml | 76-13-1 | |
| Y0001737 | Triclabendazole CRS | 10 mg | 68786-66-3 | |
| Y0001723 | Triclabendazole for system suitability CRS | 0.012 mg | 68786-66-3 | |
| T1986000 | Triethyl citrate - reference spectrum | n/a | n/a | |
| T2000000 | Trifluoperazine hydrochloride CRS | 30 mg | 440-17-5 | |
| Y0002182 | Trifluridine CRS | 60 mg | 70-00-8 | |
| Y0002207 | Trifluridine impurity A CRS | 0.002 mg | 14599-46-3 | |
| T2005000 | Triflusal CRS | 50 mg | 322-79-2 | |
| T2005010 | Triflusal impurity B CRS | 15 mg | n/a | |
| Y0000720 | Triglycerol diisostearate CRS | 200 mg | n/a | |
| Y0000108 | Trihexyphenidyl hydrochloride CRS | 100 mg | 52-49-3 | |
| Y0000068 | Trihexyphenidyl impurity A CRS | 20 mg | n/a | |
| T2009000 | Trilaurin CRS | 1250 mg | 538-24-9 | |
| Y0001319 | Trimebutine maleate CRS | 10 mg | 34140-59-5 | |
| Y0001260 | Trimebutine for system suitability CRS | 1.02 mg | 34140-59-5 | |
| Y0000092 | Trimetazidine dihydrochloride - reference spectrum | n/a | n/a | |
| Y0000093 | Trimetazidine for system suitability CRS | 50 mg | 13171-25-0 | |
| T2100000 | Trimethadione CRS | 250 mg | 127-48-0 | |
| T2200000 | Trimethoprim CRS | 50 mg | 738-70-5 | |
| T2200010 | Trimethoprim impurity B CRS | 15 mg | n/a | |
| Y0000684 | Trimethoprim for system suitability CRS | 0.00075 mg | 738-70-5 | |
| Y0001497 | 3-trimethylsilyl-1-propanesulfonic acid sodium salt CRS | 120 mg | 2039-96-5 | |
| T2450000 | Trimethyltetradecylammonium bromide CRS | 200 mg | 1119-97-7 | |
| T2500000 | Trimipramine maleate CRS | 100 mg | 521-78-8 | |
| Y0000759 | Trimipramine for peak identification CRS | 0.51 mg | 521-78-8 | |
| T2500100 | Trimyristin CRS | 1000 mg | 555-45-3 | |
| Y0000279 | Tri-n-butyl phosphate CRS | 300 µl | 126-73-8 | |
| Y0001113 | Triolein CRS | 30 mg | 122-32-7 | |
| T2501200 | Tristearin CRS | 180 mg | 555-43-1 | |
| T2545000 | Trolamine CRS | 1125 mg | 102-71-6 | |
| Y0001184 | Trolamine impurity A CRS | 250 mg | 141-43-5 | |
| Y0001183 | Trolamine impurity B CRS | 1.5 mL | 111-42-2 | |
| T2550000 | Trometamol CRS | 100 mg | 77-86-1 | |
| T2580000 | Tropicamide CRS | 50 mg | 1508-75-4 | |
| Y0001247 | Tropicamide impurity C CRS | 10 mg | 529-64-6 | |
| Y0001248 | Tropicamide impurity D CRS - * Drug Precursor Cat. 2 (see Add info) | 10 mg | 103-82-2 | |
| Y0001316 | Tropicamide for peak identification CRS | 10 mg | 1508-75-4 | |
| T2580300 | Tropine CRS | 50 mg | 120-29-6 | |
| Y0000616 | Tropisetron hydrochloride CRS | 40 mg | 105826-92-4 | |
| Y0000618 | Tropisetron impurity B CRS | 10 mg | 771-50-6 | |
| Y0000429 | Trospium chloride CRS | 10 mg | 10405-02-4 | |
| Y0000432 | Trospium impurity A CRS | 20 mg | 76-93-7 | |
| Y0000431 | Trospium impurity B CRS | 20 mg | 16444-19-2 | |
| Y0000430 | Trospium impurity C CRS | 5 mg | 3464-71-9 | |
| Y0000497 | Troxerutin CRS | 30 mg | 7085-55-4 | |
| T2600000 | Trypsin BRP | 100 mg | 9002-07-7 | |
| T2610000 | Tryptophan CRS | 100 mg | 73-22-3 | |
| T2880000 | Tylosin CRS | 150 mg | 1401-69-0 | |
| Y0001927 | Tylosin phosphate CRS | 10 mg | 1405-53-4 | |
| Y0001914 | Tylosin for system suitability CRS | 10 mg | N/A | |
| T2880200 | Tylosin tartrate - reference spectrum | n/a | n/a | |
| Y0001928 | Tylosin tartrate CRS | 10 mg | 1405-54-5 | |
| Y0002068 | Typhae pollen dry extract for system suitability HRS | 250 mg | n/a | |
| Y0002045 | TyphaneosideCRS | 20 mg | 104472-68-6 | |
| T2900000 | Tyrosine CRS | 50 mg | 60-18-4 | |
| T3000000 | Tyrothricin CRS | 20 mg | 1404-88-2 | |
| U0020000 | Ubidecarenone CRS | 70 mg | 303-98-0 | |
| U0020008 | Ubidecarenone impurity D CRS | 5 mg | 303-97-9 | |
| Y0001861 | Uncaria stem with hooks dry extract for system suitability HRS | 10 mg | N/A | |
| U0020001 | Ubidecarenone for system suitability CRS | 1 mg | 303-98-0 | |
| U0100000 | Uracil arabinoside CRS | 60 mg | N/A | |
| U0600000 | Urea CRS | 100 mg | 57-13-6 | |
| U0800000 | Ursodeoxycholic acid CRS | 100 mg | 128-13-2 | |
| Y0001163 | Ursodeoxycholic acid for system suitability CRS | 1.26 mg | 128-13-2 | |
| Y0001523 | Ursolic acid CRS | 25 mg | 77-52-1 | |
| Y0000834 | Valaciclovir hydrochloride (anhydrous) CRS | 100 mg | 124832-27-5 | |
| Y0001096 | Valaciclovir impurity D CRS | 10 mg | n/a | |
| Y0001097 | Valaciclovir impurity E CRS | 10 mg | n/a | |
| Y0001098 | Valaciclovir impurity F para-toluenesulfonate CRS | 12 mg | n/a | |
| Y0001099 | Valaciclovir impurity G CRS | 10 mg | 1122-58-3 | |
| Y0001662 | Valaciclovir impurity P CRS | 5 mg | N/A | |
| Y0001655 | Valaciclovir impurity S CRS | 15 mg | n/a | |
| Y0001225 | Valaciclovir for system suitability CRS | 10 mg | 124832-27-5 | |
| Y0000583 | Valerian dry extract HRS | 500 mg | 8057-49-6 | |
| V0030000 | Valine CRS | 50 mg | 72-18-4 | |
| Y0000584 | Valnemulin hydrochloride CRS | 10 mg | 133868-46-9 | |
| Y0000586 | Valnemulin impurity E CRS | 10 mg | 125-65-5 | |
| Y0000585 | Valnemulin for peak identification CRS | 20 mg | N/Ap | |
| Y0000533 | Valnemulin hydrogen tartrate CRS | 120 mg | N/A | |
| V0033000 | Valproic acid CRS | 100 mg | 99-66-1 | |
| Y0001422 | Valproic acid for system suitability CRS | 10 mg | 99-66-1 | |
| Y0001132 | Valsartan CRS | 15 mg | 137862-53-4 | |
| Y0001131 | Valsartan for peak identification CRS | 10 mg | 137862-53-4 | |
| Y0001145 | Valsartan for system suitability CRS | 0.202 mg | 137862-53-4 | |
| Y0002080 | Vancomycin for system suitability CRS | 15 mg | n/a | |
| V0045000 | Vancomycin hydrochloride CRS | 100 mg | 1404-93-9 | |
| V0050000 | Vanillin CRS | 100 mg | 121-33-5 | |
| Y0001648 | Vardenafil for system suitability CRS | 10 mg | N/Ap | |
| Y0001647 | Vardenafil hydrochloride CRS | 130 mg | 330808-88-3 | |
| Y0001198 | Varicella vaccine (live) BRP | 420 mg | n/a | |
| Y0000561 | Vecuronium bromide CRS | 10 mg | 50700-72-6 | |
| Y0001862 | Vecuronium for system suitability CRS | 15 mg | 50700-72-6 | |
| Y0001093 | Vedaprofen CRS | 5 mg | 71109-09-6 | |
| Y0001118 | Vedaprofen impurity mixture CRS | 0.006 mg | n/a | |
| Y0000587 | Venlafaxine hydrochloride CRS | 50 mg | 99300-78-4 | |
| Y0000588 | Venlafaxine for system suitability CRS | 1.002 mg | 99300-78-4 | |
| V0100000 | Verapamil hydrochloride CRS | 50 mg | 152-11-4 | |
| V0100018 | Verapamil impurity I CRS | 5 mg | 1794-55-4 | |
| V0100026 | Verapamil impurity M CRS | 10 mg | n/a | |
| Y0000661 | Verbenalin CRS | 11 mg | 548-37-8 | |
| V0180000 | VERO cell line | 1 ml | n/a | |
| Y0001400 | Vigabatrin CRS | 10 mg | 60643-86-9 | |
| Y0001401 | Vigabatrin impurity A CRS | 40 mg | 7529-16-0 | |
| Y0001402 | Vigabatrin impurity B CRS | 20 mg | n/a | |
| Y0001404 | Vigabatrin impurity D CRS | 50 mg | 56-12-2 | |
| Y0001403 | Vigabatrin impurity E CRS | 10 mg | n/a | |
| V0300000 | Vinblastine sulfate CRS | 5 mg | 143-67-9 | |
| V0305000 | Vinblastine sulfate - reference spectrum | n/a | n/a | |
| Y0002124 | Vincamine CRS | 10 mg | 1617-90-9 | |
| Y0002126 | Vincamine for system suitability CRS | 10 mg | 1617-90-9 | |
| V0400000 | Vincristine sulfate CRS | 4.96 mg | 2068-78-2 | |
| V0405000 | Vincristine sulfate - reference spectrum | n/a | n/a | |
| V0500000 | Vindesine sulfate CRS | 5 mg | 59917-39-4 | |
| V0500010 | Vindesine sulfate - reference spectrum | n/a | n/a | |
| Y0000463 | Vinorelbine tartrate CRS | 50 mg | 125317-39-7 | |
| Y0001938 | Vinorelbine for peak identification A CRS | 10 mg | 125317-39-7 | |
| Y0001939 | Vinorelbine for peak identification B CRS | 10 mg | 125317-39-7 | |
| Y0000589 | Vinpocetine CRS | 10 mg | 42971-09-5 | |
| Y0000590 | Vinpocetine impurity A CRS | 15 mg | n/a | |
| Y0000591 | Vinpocetine impurity B CRS | 10 mg | n/a | |
| Y0000790 | Vinpocetine impurity C CRS | 15 mg | n/a | |
| Y0000760 | Vinpocetine impurity D CRS | 10 mg | n/a | |
| Y0000793 | Vinyl acetate CRS | 100 mg | 108-05-4 | |
| Y0002191 | Vitexin-2-O-Rhamnoside CRS | 10 mg | 64820-99-1 | |
| Y0001395 | Voriconazole CRS | 120 mg | 137234-62-9 | |
| Y0001396 | Voriconazole impurity B CRS | 10 mg | n/a | |
| Y0001398 | Voriconazole impurity D CRS | 10 mg | n/a | |
| Y0001397 | Voriconazole impurity E CRS | 50 mg | 5872-08-2 | |
| Y0001975 | Zolmitriptan CRS | 30 mg | 139264-17-8 | |
| Y0001991 | Zolmitriptan for system suitability CRS | 10 mg | n/a | |
| Y0001986 | Zolmitriptan impurity A CRS | 10 mg | N/A | |
| W0100000 | Warfarin sodium CRS | 10 mg | 129-06-6 | |
| Y0000778 | Warfarin sodium clathrate CRS | 10 mg | N/A | |
| Y0001599 | Wedelolactone CRS | 15 mg | 524-12-9 | |
| X0075000 | Xylazine hydrochloride CRS | 125 mg | 23076-35-9 | |
| X0080000 | Xylitol CRS | 220 mg | 87-99-0 | |
| X0100000 | Xylometazoline hydrochloride CRS | 100 mg | 1218-35-5 | |
| X0101000 | Xylometazoline impurity A CRS | 15 mg | n/a | |
| X0200000 | Xylose CRS | 100 mg | 58-86-6 | |
| Y0000656 | Yohimbine hydrochloride CRS | 20 mg | 65-19-0 | |
| Y0001715 | Zanamivir hydrate CRS | 5 mg | 139110-80-8 | |
| Y0001703 | Zanamivir impurity F CRS | 10 mg | 4023-02-3 | |
| Y0001702 | Zanamivir for assay CRS | 50 mg | 139110-80-8 | |
| Y0001708 | Zanamivir for system suitability CRS | 10 mg | N/A | |
| Z1900000 | Zidovudine CRS | 60 mg | 30516-87-1 | |
| Y0001641 | Zidovudine for system suitability CRS | 10 mg | 30516-87-1 | |
| Y0002266 | Zidovudine for system suitability A CRS | 10 mg | 30516-87-1 | |
| Z1904000 | Zidovudine impurity B CRS | 5 mg | n/a | |
| Y0001654 | Zidovudine impurity D CRS | 15 mg | 76-84-6 | |
| Y0001807 | Pregabalin impurity B CRS | 5 mg | N/A | |
| Z2000000 | Zinc acexamate CRS | 50 mg | 70020-71-2 | |
| Z2000010 | Zinc acexamate impurity A CRS | 50 mg | n/a | |
| Y0001286 | Ziprasidone hydrochloride monohydrate CRS | 100 mg | 138982-67-9 | |
| Y0001626 | Ziprasidone mesilate trihydrate CRS | 30 mg | 199191-69-0 | |
| Y0002011 | Zoledronic acid impurity A CRS | 15 mg | 1627731-60-5 | |
| Y0001272 | Ziprasidone for system suitability 1 CRS | 10 mg | 138982-67-9 | |
| Y0001241 | Ziprasidone for system suitability 2 CRS | 0.465 mg | 138982-67-9 | |
| Y0002139 | Zolpidem for system suitability CRS - * psy (Zolpidem tartrate) | 10 mg | n/a | |
| Z2500000 | Zolpidem tartrate CRS - * psy | 200 mg | 99294-93-6 | |
| Y0002020 | Zoledronic acid monohydrate CRS | 15 mg | 165800-06-6 | |
| Z3000000 | Zopiclone CRS - * psy | 40 mg | 43200-80-2 | |
| Y0001822 | Zopiclone impurity B CRS | 10 mg | N/A | |
| Z3001000 | Zopiclone oxide CRS | 20 mg | N/A | |
| Y0000062 | Zuclopenthixol decanoate - reference spectrum | n/a | n/a | |
| Y0000083 | Zuclopenthixol impurity B CRS | 10 mg | n/a | |
| Y0000534 | Zuclopenthixol for system suitability CRS | 0.26 mg | n/a | |